FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Arnau-Soler, A
   Adams, MJ
   Hayward, C
   Thomson, PA
AF Arnau-Soler, Aleix
   Adams, Mark J.
   Hayward, Caroline
   Thomson, Pippa A.
CA Generation Scotland
   Psychiat Genomics Consortium
TI Genome-wide interaction study of a proxy for stress-sensitivity and its
   prediction of major depressive disorder
SO PLOS ONE
LA English
DT Article
ID LIFE EVENTS; PERCEIVED STRESS; PTP4A1-PHF3-EYS VARIANTS; GENETIC
   EPIDEMIOLOGY; ASSOCIATION ANALYSIS; ALCOHOL-USE; PERSONALITY; ANXIETY;
   NEUROTICISM; METAANALYSIS
AB Individual response to stress is correlated with neuroticism and is an important predictor of both neuroticism and the onset of major depressive disorder (MDD). Identification of the genetics underpinning individual differences in response to negative events (stress-sensitivity) may improve our understanding of the molecular pathways involved, and its association with stress-related illnesses. We sought to generate a proxy for stress-sensitivity through modelling the interaction between SNP allele and MDD status on neuroticism score in order to identify genetic variants that contribute to the higher neuroticism seen in individuals with a lifetime diagnosis of depression compared to unaffected individuals. Meta-analysis of genome-wide interaction studies (GWIS) in UK Biobank (N = 23,092) and Generation Scotland: Scottish Family Health Study (N = 7,155) identified no genome-wide significance SNP interactions. However, gene-based tests identified a genome-wide significant gene, ZNF366, a negative regulator of glucocorticoid receptor function implicated in alcohol dependence (p = 1.48x10(-7); Bonferroni-corrected significance threshold p < 2.79x10(-6)). Using summary statistics from the stress-sensitivity term of the GWIS, SNP heritability for stress-sensitivity was estimated at 5.0%. In models fitting polygenic risk scores of both MDD and neuroticism derived from independent GWAS, we show that polygenic risk scores derived from the UK Biobank stress-sensitivity GWIS significantly improved the prediction of MDD in Generation Scotland. This study may improve interpretation of larger genome-wide association studies of MDD and other stress-related illnesses, and the understanding of the etiological mechanisms underpinning stress-sensitivity.
C1 [Arnau-Soler, Aleix; Thomson, Pippa A.] Univ Edinburgh, Ctr Genom & Expt Med, MRC Inst Genet & Mol Med, Med Genet Sect, Edinburgh, Midlothian, Scotland.
   [Adams, Mark J.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh, Midlothian, Scotland.
   [Hayward, Caroline] Univ Edinburgh, Inst Genet & Mol Med, Med Res Council Human Genet Unit, Edinburgh, Midlothian, Scotland.
RP Thomson, PA (reprint author), Univ Edinburgh, Ctr Genom & Expt Med, MRC Inst Genet & Mol Med, Med Genet Sect, Edinburgh, Midlothian, Scotland.
EM aleix.amau.soler@igmm.ed.ac.uk; Pippa.Thomson@ed.ac.uk
RI McIntosh, Andrew M/B-9379-2008; Middeldorp, Christel/L-7728-2017;
   Nyholt, Dale/J-3174-2017; Hansen, Thomas Folkmann/O-5965-2014; Hickie,
   Ian/K-8975-2015; Breen, Gerome/A-5540-2010; Sigurdsson,
   Engilbert/D-2486-2014; Derks, Eske/A-1652-2017; Lewis,
   Cathryn/A-5225-2010; Grove, Jakob/K-8112-2015
OI McIntosh, Andrew M/0000-0002-0198-4588; Middeldorp,
   Christel/0000-0002-6218-0428; Coleman, Jonathan/0000-0002-6759-0944;
   Posthuma, Danielle/0000-0001-7582-2365; Adams, Mark
   James/0000-0002-3599-6018; Nyholt, Dale/0000-0001-7159-3040; Hansen,
   Thomas Folkmann/0000-0001-6703-7762; Hickie, Ian/0000-0001-8832-9895;
   Breen, Gerome/0000-0003-2053-1792; Sigurdsson,
   Engilbert/0000-0001-9404-7982; Arnau Soler, Aleix/0000-0001-9768-0513;
   Derks, Eske/0000-0002-6292-6883; Lewis, Cathryn/0000-0002-8249-8476;
   Mbarek, Hamdi/0000-0002-1108-0371; O'Reilly, Paul/0000-0001-7515-0845;
   Grove, Jakob/0000-0003-2284-5744
FU Chief Scientist Office of the Scottish Government Health Directorates
   [CZD/16/6]; Scottish Funding Council [HR03006]; Medical Research Council
   UK; Wellcome Trust (Wellcome Trust Strategic Award "STratifying
   Resilience and Depression Longitudinally" (STRADL)) [104036/Z/14/Z]; US
   National Institute of Mental Health; National Institute of Drug Abuse
   [U01 MH109528, U01 MH1095320]; University of Edinburgh; Medical Research
   Council; Wellcome Trust Strategic Award STRADL [104036/Z/14/Z]; UK
   Biobank [4844]
FX Generation Scotland received core support from the Chief Scientist
   Office of the Scottish Government Health Directorates [CZD/16/6] and the
   Scottish Funding Council [HR03006]. Genotyping of the GS: SFHS samples
   was carried out by the Genetics Core Laboratory at the Wellcome Trust
   Clinical Research Facility, Edinburgh, Scotland and was funded by the
   Medical Research Council UK and the Wellcome Trust (Wellcome Trust
   Strategic Award "STratifying Resilience and Depression Longitudinally"
   (STRADL), Reference 104036/Z/14/Z). The Psychiatric Genomics Consortium
   has received major funding from the US National Institute of Mental
   Health and the US National Institute of Drug Abuse (U01 MH109528 and U01
   MH1095320). The 1st author AAS is funded by University of Edinburgh
   (www.ed.ac.uk) and Medical Research Council for his PhD study at the
   University of Edinburgh Institute of Genetics and Molecular Medicine
   (www.ed.ac.uk/igmm).MA is supported by the Wellcome Trust Strategic
   Award STRADL (Reference 104036/Z/14/Z). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; We thank all participants from UK
   Biobank, including families, volunteers, technicians and scientist who
   helped collect the samples and prepare the data. Analyses were performed
   under UK Biobank project 4844.
CR Amador C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1605-2
   Aragam N, 2011, J AFFECT DISORDERS, V133, P516, DOI 10.1016/j.jad.2011.04.054
   Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110
   Bazana P.G., 2004, PSYCHOBIOLOGY PERSON, P113
   Biobank U, 2015, GEN IMP GEN ASS STUD
   Biobank U, TOUCHSCR QUEST 2012
   Biobank U, UK BIOB PROT LARG SC
   Bleys D, 2018, J AFFECT DISORDERS, V226, P339, DOI 10.1016/j.jad.2017.09.050
   Bogdan R, 2013, NEUROBIOL DIS, V52, P12, DOI 10.1016/j.nbd.2012.05.007
   Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112
   Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406
   Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211
   Cai N, 2015, NATURE, V523, P588, DOI 10.1038/nature14659
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Chen GB, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00107
   Colodro-Conde L, 2018, MOL PSYCHIATR, V23, P1590, DOI 10.1038/mp.2017.130
   Cook MN, 2015, PHYSIOL GENOMICS, V47, P308, DOI 10.1152/physiolgenomics.00114.2014
   de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219
   de Mola CL, 2014, BRIT J PSYCHIAT, V205, P340, DOI 10.1192/bjp.bp.113.139014
   de Moor MHM, 2015, JAMA PSYCHIAT, V72, P642, DOI 10.1001/jamapsychiatry.2015.0554
   Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348
   Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848
   Eysenck HJ, 1975, MANUAL EYSENCK PERSO
   EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P21, DOI 10.1016/0191-8869(85)90026-1
   Fernandez-Pujals AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142197
   Fidalgo TM, 2008, AM J DRUG ALCOHOL AB, V34, P83, DOI 10.1080/00952990701764664
   First MB, 2002, STRUCTURED CLIN INTE
   Gage SH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40653
   Glahn DC, 2012, BIOL PSYCHIAT, V71, P6, DOI 10.1016/j.biopsych.2011.08.022
   Harris ML, 2013, ANN BEHAV MED, V46, P9, DOI 10.1007/s12160-013-9478-6
   Hartz SM, 2018, SCHIZOPHR RES, V194, P86, DOI 10.1016/j.schres.2017.02.022
   Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506
   Hayman LW, 2014, J NERV MENT DIS, V202, P807, DOI 10.1097/NMD.0000000000000198
   Herr RM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020255
   Hirschfeld RMA, 2000, AM J PSYCHIAT, V157, P1873, DOI 10.1176/appi.ajp.157.11.1873
   HIRSCHFELD RMA, 1983, AM J PSYCHIAT, V140, P695
   HIRSCHFELD RMA, 1979, AM J PSYCHIAT, V136, P67
   Hontelez S, 2013, J IMMUNOL, V190, P3172, DOI 10.4049/jimmunol.1201776
   Hovens JGFM, 2016, DEPRESS ANXIETY, V33, P27, DOI 10.1002/da.22429
   Hyde CL, 2016, NAT GENET, V48, P1031, DOI 10.1038/ng.3623
   Jafri SHR, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.1575
   Jeronimus BF, 2013, PSYCHOL MED, V43, P2403, DOI 10.1017/S0033291713000159
   Jeronimus BF, 2014, J PERS SOC PSYCHOL, V107, P751, DOI 10.1037/a0037009
   Kendler KS, 2010, PSYCHOL MED, V40, P801, DOI 10.1017/S0033291709991140
   Kendler KS, 2007, PSYCHOL MED, V37, P615, DOI 10.1017/S0033291706009524
   Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631
   KENDLER KS, 1995, AM J PSYCHIAT, V152, P833
   Kerr SM, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-38
   Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191
   Kim SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147745
   Lazarus R. S., 1987, EUROPEAN J PERSONALI, V1, P141, DOI DOI 10.1002/PER.2410010304
   Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002
   Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024
   Lin Y, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-53
   Lopez B, 2005, J ANXIETY DISORD, V19, P275, DOI 10.1016/j.janxdis.2004.03.001
   Lopez-Garcia J, 2006, NUCLEIC ACIDS RES, V34, P6126, DOI 10.1093/nar/gkl875
   Low NC, 2008, FAM PRACT, V25, P321, DOI 10.1093/fampra/cmn049
   Luciano M, 2018, NAT GENET, V50, P6, DOI 10.1038/s41588-017-0013-8
   Luciano M, 2010, INTELLIGENCE, V38, P304, DOI 10.1016/j.intell.2010.03.002
   Mailman MD, 2007, NAT GENET, V39, P1181
   MCGUE M, 1993, DEV PSYCHOL, V29, P96, DOI 10.1037/0012-1649.29.1.96
   Middeldorp CM, 2005, PSYCHOL MED, V35, P611, DOI 10.1017/S003329170400412X
   Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289
   Monroe SM, 2008, ANNU REV CLIN PSYCHO, V4, P33, DOI 10.1146/annurev.clinpsy.4.022007.141207
   Moore RC, 2015, AM J GERIAT PSYCHIAT, V23, P622, DOI 10.1016/j.jagp.2014.08.004
   Mullins N, 2016, PSYCHOL MED, V46, P759, DOI 10.1017/S0033291715002172
   Nivard MG, 2015, TWIN RES HUM GENET, V18, P746, DOI 10.1017/thg.2015.80
   Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890
   Peyrot WJ, 2014, BRIT J PSYCHIAT, V205, P113, DOI 10.1192/bjp.bp.113.143081
   Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285
   Porcelli B, 2016, AUTOIMMUN REV, V15, P325, DOI 10.1016/j.autrev.2015.12.005
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555
   Riese H, 2014, EUR J PERSONALITY, V28, P193, DOI 10.1002/per.1929
   Rietschel L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11852-3
   Rietschel L, 2014, BEHAV GENET, V44, P639, DOI 10.1007/s10519-013-9636-4
   Rutledge PC, 2001, J STUD ALCOHOL, V62, P457, DOI 10.15288/jsa.2001.62.457
   Schmidt NB, 2007, BEHAV MODIF, V31, P202, DOI 10.1177/0145445506297019
   Schneider TR, 2012, STRESS HEALTH, V28, P102, DOI 10.1002/smi.1409
   Shen EY, 2016, NEUROPSYCHOPHARMACOL, V41, P3103, DOI 10.1038/npp.2016.144
   Silberg J, 2001, BRIT J PSYCHIAT, V179, P116, DOI 10.1192/bjp.179.2.116
   Smith BH, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-74
   Smith BH, 2013, INT J EPIDEMIOL, V42, P689, DOI 10.1093/ije/dys084
   Smith DJ, 2016, MOL PSYCHIATR, V21, P749, DOI 10.1038/mp.2016.49
   Smith DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075362
   Smith MA, 2018, STRESS, V21, P229, DOI 10.1080/10253890.2018.1435637
   Smits DJM, 2006, EUR J PERSONALITY, V20, P255, DOI 10.1002/per.583
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552
   Tak LM, 2015, J PSYCHOSOM RES, V79, P112, DOI 10.1016/j.jpsychores.2015.05.013
   Team RC, 2015, R LANG ENV STAT COMP
   Tennant C, 2002, AUST NZ J PSYCHIAT, V36, P173, DOI 10.1046/j.1440-1614.2002.01007.x
   Torigata K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158562
   van den Berg SM, 2014, BEHAV GENET, V44, P295, DOI 10.1007/s10519-014-9654-x
   Varlinskaya EI, 2017, BRAIN RES, V1654, P145, DOI 10.1016/j.brainres.2016.03.050
   Vukasovic T, 2015, PSYCHOL BULL, V141, P769, DOI 10.1037/bul0000017
   Walsh RM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15142
   Watanabe K, 2017, FUMA FUNCTIONAL MAPP, DOI [10.1101/110023, DOI 10.1101/110023]
   Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340
   Wong ML, 2017, MOL PSYCHIATR, V22, P1015, DOI 10.1038/mp.2016.174
   Wray NR, 2007, TWIN RES HUM GENET, V10, P695, DOI 10.1375/twin.10.5.695
   Wray NR, 2018, NAT GENET, V50, P668, DOI 10.1038/s41588-018-0090-3
   Zuo LJ, 2015, ALCOHOL CLIN EXP RES, V39, P1388, DOI 10.1111/acer.12786
   Zuo LJ, 2014, AM J ADDICTION, V23, P411, DOI [10.1111/j.1521-0391.2013.12115.x, 10.1111/j.1521-0391.2014.12115.x]
   Zuo LJ, 2013, J HUM GENET, V58, P178, DOI 10.1038/jhg.2012.153
   Zuo LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026726
NR 106
TC 1
Z9 1
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 20
PY 2018
VL 13
IS 12
AR e0209160
DI 10.1371/journal.pone.0209160
PG 29
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HF0HP
UT WOS:000453841700039
PM 30571770
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Bielinski, M
   Lesiewska, N
   Bielinska, J
   Liebert, A
   Mieczkowski, A
   Soponska-Brzoszczyk, P
   Brzoszczyk, B
   Klopocka, M
   Borkowska, A
AF Bielinski, Maciej
   Lesiewska, Natalia
   Bielinska, Joanna
   Liebert, Ariel
   Mieczkowski, Artur
   Soponska-Brzoszczyk, Pauline
   Brzoszczyk, Bartosz
   Klopocka, Maria
   Borkowska, Aline
TI Affective temperament in inflammatory bowel diseases: Another brick in
   the wall of differentiation
SO PLOS ONE
LA English
DT Article
ID QUALITY-OF-LIFE; CROHNS-DISEASE; DEPRESSIVE SYMPTOMS;
   ULCERATIVE-COLITIS; BIPOLAR DISORDER; HOSPITAL ANXIETY; ACTIVITY INDEX;
   TERM OUTCOMES; RISK-FACTORS; TEMPS
AB Psychiatric disorders are significantly common complications among patients suffering from inflammatory bowel diseases (IBD). Affective temperament is a concept of core personality traits, which can decribe the vulnerability to mood disorders, therefore its evaluation might convey useful information about patients' mental status in autoimmune disorders. The aim of the study was to evaluate the affective temperament in patients with Crohn's disease (CD) and ulcerative colitis (UC) as characteristic features of these diseases, but also in the clinical course and the severity of anxiety and depression. Due to our knowledge this is the first study of this kind. The study enrolled 130 patients with IBD, including 68 with CD and 62 with UC. We used TEMPS-A to evaluate affective temperament and HADS scales to assess the intensity of depressive and anxiety symptoms. Harvey Bradshaw scale, Crohn's Disease Activity Index (CDAI) and Mayo Score were used to evaluate clinical severity of the diseases. We observed significantly higher prevalence of depressive, cyclothymic and anxiety temperaments in CD patients compared to the control group. Harvey Bradshaw scale, CDAI and Mayo Self Report showed statistically significant outcomes, including significant positive correlations with depressive, cyclothymic and anxiety subscales of TEMPS-A, and negative correlation with the hyperthymic temperament in CD subjects. Our findings indicate significant differences between CD and UC due to temperament traits, and suggest distinct pathogenesis of mood disorders in IBD.
C1 [Bielinski, Maciej; Lesiewska, Natalia; Mieczkowski, Artur; Borkowska, Aline] Nicolaus Copernicus Univ, Chair & Dept Clin Neuropsychol, Torun, Poland.
   [Bielinski, Maciej; Lesiewska, Natalia; Bielinska, Joanna; Liebert, Ariel; Mieczkowski, Artur; Soponska-Brzoszczyk, Pauline; Klopocka, Maria; Borkowska, Aline] Coll Med, Bydgoszcz, Poland.
   [Bielinska, Joanna; Liebert, Ariel; Klopocka, Maria] Nicolaus Copernicus Univ, Inst Gastroenterol Nursing, Torun, Poland.
   [Soponska-Brzoszczyk, Pauline] Nicolaus Copernicus Univ, Dept Obstet & Gynecol, Torun, Poland.
   [Brzoszczyk, Bartosz] Dr Jan Biziel Univ Hosp 2, Dept Urol, Bydgoszcz, Poland.
RP Bielinski, M (reprint author), Nicolaus Copernicus Univ, Chair & Dept Clin Neuropsychol, Torun, Poland.; Bielinski, M (reprint author), Coll Med, Bydgoszcz, Poland.
EM bielinskim@gmail.com
FU Collegium Medicum's (NCU) scientific units
FX The research was made from funds for the statutory activities of
   Collegium Medicum's (NCU) scientific units. This research was not
   supported by external financing.; The research was made from funds for
   the statutory activities of Collegium Medicum's (NCU) scientific units.
   All authors declare no conflict of interests connected with this
   manuscript.
CR Aguiar FA, 2013, J AFFECT DISORDERS, V148, P53
   Akiskal H. S., 1992, AMER P PR R, V11, P43
   Akiskal HS, 2005, J AFFECT DISORDERS, V85, P3, DOI 10.1016/j.jad.2004.12.001
   Akiskal HS, 2005, J AFFECT DISORDERS, V85, P1, DOI 10.1016/j.jad.2004.12.003
   AKISKAL HS, 1995, ARCH GEN PSYCHIAT, V52, P114
   Ananthakrishnan AN, 2013, AM J GASTROENTEROL, V108, P594, DOI 10.1038/ajg.2012.471
   Asik M, 2015, J AFFECT DISORDERS, V185, P214, DOI 10.1016/j.jad.2015.06.043
   Bernstein CN, 2016, DIGEST DIS, V34, P58, DOI 10.1159/000442929
   BEST WR, 1979, GASTROENTEROLOGY, V77, P843
   Best WR, 2006, INFLAMM BOWEL DIS, V12, P304, DOI 10.1097/01.MIB.0000215091.77492.2a
   Bielinska J., 2017, MED RES J, V2, P6
   Borkowska A, 2010, J AFFECT DISORDERS, V123, P36, DOI 10.1016/j.jad.2009.09.024
   Mella LFB, 2010, REV BRAS PSIQUIATR, V32, P257, DOI 10.1590/S1516-44462010005000021
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Coates MD, 2017, ALIMENT PHARM THER, V46, P569, DOI 10.1111/apt.14226
   Dembinska-Krajewski D, 2014, J PSYCHIAT POL, V48, P261
   Eory A, 2014, EUR J GEN PRACT, V20, P247, DOI 10.3109/13814788.2013.868431
   Evans L, 2005, J AFFECT DISORDERS, V85, P153, DOI 10.1016/j.jad.2003.10.015
   Evertsz FB, 2017, J CONSULT CLIN PSYCH, V85, P918, DOI 10.1037/ccp0000227
   Gois C, 2011, J AFFECT DISORDERS, V134, P52, DOI 10.1016/j.jad.2011.05.021
   Gonda X, 2006, J AFFECT DISORDERS, V91, P125, DOI 10.1016/j.jad.2005.12.048
   Goodwin FK, 2007, MANIC DEPRESSIVE ILL
   Greenwood TA, 2012, BIOL PSYCHIAT, V72, P303, DOI 10.1016/j.biopsych.2012.01.018
   Gulamhusein AF, 2016, AM J GASTROENTEROL, V111, P705, DOI 10.1038/ajg.2016.55
   GUYATT HL, 1991, T ROY SOC TROP MED H, V85, P778, DOI 10.1016/0035-9203(91)90453-6
   Hall PA, 2008, PSYCHOSOM MED, V70, P837, DOI 10.1097/PSY.0b013e31817bb8e5
   HARVEY RF, 1980, LANCET, V1, P1134
   Hong JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084564
   Ishak WW, 2017, INFLAMM BOWEL DIS, V23, P798, DOI 10.1097/MIB.0000000000001060
   Jaffe C. L., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P47
   Janke KH, 2005, INFLAMM BOWEL DIS, V11, P272, DOI 10.1097/01.MIB.0000160809.38611.f7
   Janowski K, 2008, BRIT J DERMATOL, V158, P633, DOI 10.1111/j.1365-2133.2007.08381.x
   Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582
   Karam EG, 2010, WORLD PSYCHIATRY, V9, P103
   Kesebir S, 2013, J AFFECT DISORDERS, V148, P352, DOI 10.1016/j.jad.2012.12.023
   Kim MC, 2016, GUT LIVER, V10, P399, DOI 10.5009/gnl15188
   Levenstein S, 2000, AM J GASTROENTEROL, V95, P1213, DOI 10.1111/j.1572-0241.2000.02012.x
   Litaiem N, 2013, J AFFECT DISORDERS, V151, P321, DOI 10.1016/j.jad.2013.05.099
   Lonnfors S, 2014, J CROHNS COLITIS, V8, P1281, DOI 10.1016/j.crohns.2014.03.005
   Lucendo AJ, 2014, EUR J GASTROEN HEPAT, V26, P1399, DOI 10.1097/MEG.0000000000000226
   Marrie RA, 2017, J PSYCHOSOM RES, V101, P17, DOI 10.1016/j.jpsychores.2017.07.015
   Martin-Subero M, 2016, CNS SPECTRUMS, V21, P184, DOI 10.1017/S1092852915000449
   Mendlowicz MV, 2005, J AFFECT DISORDERS, V85, P147, DOI 10.1016/j.jad.2004.01.012
   Nasiri S, 2017, SEMIN PEDIATR SURG, V26, P398, DOI 10.1053/j.sempedsurg.2017.10.010
   Panara AJ, 2014, ALIMENT PHARM THER, V39, P802, DOI 10.1111/apt.12669
   Primas C, 2013, J CROHNS COLITIS, V7, P630, DOI DOI 10.1016/J.CR0HNS.2013.05.001
   Ramsey M, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.54
   Rezvani A, 2014, INT J RHEUM DIS, V17, P34, DOI 10.1111/1756-185X.12033
   SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603
   Serafini G, 2014, CNS NEUROL DISORD-DR, V13, P1708
   Simoes CC, 2018, BMJ CASE REP
   Stern AF, 2014, OCCUP MED-OXFORD, V64, P393, DOI 10.1093/occmed/kqu024
   Vazquez GH, 2018, HARVARD REV PSYCHIAT, V26, P8, DOI 10.1097/HRP.0000000000000153
   Verma S, 2001, DIGEST DIS SCI, V46, P865, DOI 10.1023/A:1010725106411
   Vermeire S, 2010, CLIN GASTROENTEROL H, V8, P357, DOI 10.1016/j.cgh.2010.01.001
   von Zerssen D, 1998, J AFFECT DISORDERS, V51, P1
   Walker JR, 2008, AM J GASTROENTEROL, V103, P1989, DOI 10.1111/j.1572-0241.2008.01980.x
   Wichowicz HM, 2011, PSYCHIATR POL, V45, P505
   Yildirim Tulay, 2017, J Phys Ther Sci, V29, P394, DOI 10.1589/jpts.29.394
NR 59
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 1
PY 2018
VL 13
IS 11
AR e0205606
DI 10.1371/journal.pone.0205606
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GZ0DG
UT WOS:000449027600020
PM 30383791
OA DOAJ Gold
DA 2019-06-25
ER

PT J
AU Dainer-Best, J
   Disner, SG
   McGeary, JE
   Hamilton, BJ
   Beevers, CG
AF Dainer-Best, Justin
   Disner, Seth G.
   McGeary, John E.
   Hamilton, Bethany J.
   Beevers, Christopher G.
TI Negative self-referential processing is associated with genetic
   variation in the serotonin transporter-linked polymorphic region
   (5-HTTLPR): Evidence from two independent studies
SO PLOS ONE
LA English
DT Article
ID BY-ENVIRONMENT INTERACTION; PROMOTER REGION; CANDIDATE GENE;
   PSYCHOPHYSIOLOGICAL ENDOPHENOTYPES; COGNITIVE VULNERABILITY; CLINICAL
   DEPRESSION; BIASED ATTENTION; INFORMATION; MODELS; ADOLESCENTS
AB The current research examined whether carriers of the short 5-HTTLPR allele (in SLC6A4), who have been shown to selectively attend to negative information, exhibit a bias towards negative self-referent processing. The self-referent encoding task (SRET) was used to measure self-referential processing of positive and negative adjectives. Ratcliff's diffusion model isolated and extracted decision-making components from SRET responses and reaction times. Across the initial (N = 183) and replication (N = 137) studies, results indicated that short 5-HTTLPR allele carriers more easily categorized negative adjectives as self-referential (i.e., higher drift rate). Further, drift rate was associated with recall of negative self-referential stimuli. Findings across both studies provide further evidence that genetic variation may contribute to the etiology of negatively biased processing of self-referent information. Large scale studies examining the genetic contributions to negative self-referent processing may be warranted.
C1 [Dainer-Best, Justin; Disner, Seth G.; Hamilton, Bethany J.; Beevers, Christopher G.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA.
   [Dainer-Best, Justin; Disner, Seth G.; Beevers, Christopher G.] Univ Texas Austin, Inst Mental Hlth Res, Austin, TX 78712 USA.
   [McGeary, John E.] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA.
   [McGeary, John E.] Providence Vet Affairs Med Ctr, Providence, RI USA.
   [Disner, Seth G.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA.
RP Dainer-Best, J (reprint author), Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA.; Dainer-Best, J (reprint author), Univ Texas Austin, Inst Mental Hlth Res, Austin, TX 78712 USA.
EM dainerbest@utexas.edu
OI Dainer-Best, Justin/0000-0002-1868-0337
FU NIDA [DA032457]; NIMH [MH108650]; NIH [1R01AA025593]
FX This work was supported by NIDA (drugabuse.gov) grant DA032457 to CGB,
   NIMH (nimh.nih.gov) grant MH108650 to CGB and JEM, and NIH (nih.gov)
   grant 1R01AA025593 to JEM. This material is also the result of work
   supported with resources and the use of facilities at the Providence
   Veterans Affairs Medical Center. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alloy LB, 1997, COGNITION EMOTION, V11, P539, DOI 10.1080/026999397379854a
   Anokhin AP, 2003, NEUROREPORT, V14, P1975, DOI 10.1097/01.wnr.0000089570.45990.a2
   Bates D, 2015, J STAT SOFTW, V67, P1
   Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721
   Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510
   Beevers CG, 2009, J ABNORM PSYCHOL, V118, P670, DOI 10.1037/a0016198
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Chabris CF, 2015, CURR DIR PSYCHOL SCI, V24, P304, DOI 10.1177/0963721415580430
   Dainer- Best J, PSYCHOL ASSESS
   Dannlowski U, 2010, NEUROIMAGE, V53, P893, DOI 10.1016/j.neuroimage.2009.11.073
   DAVIS H, 1979, COGNITIVE THER RES, V3, P97, DOI 10.1007/BF01172724
   De Raedt R, 2010, COGN AFFECT BEHAV NE, V10, P50, DOI 10.3758/CABN.10.1.50
   DERRY PA, 1981, J ABNORM PSYCHOL, V90, P286, DOI 10.1037/0021-843X.90.4.286
   Devins G. M., 1988, PSYCHOL HEALTH, V2, P139, DOI DOI 10.1080/08870448808400349
   Disner SG, 2017, COGNITION EMOTION, V31, P632, DOI 10.1080/02699931.2016.1146123
   Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027
   DOBSON KS, 1987, J ABNORM PSYCHOL, V96, P34, DOI 10.1037/0021-843X.96.1.34
   Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191
   Fleurkens P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193787
   Freeman B, 1997, BEHAV GENET, V27, P251, DOI 10.1023/A:1025614231190
   Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201
   Gibb BE, 2013, COGNITION EMOTION, V27, P193, DOI 10.1080/02699931.2012.712950
   Gotlib IH, 1998, BEHAV THER, V29, P603, DOI 10.1016/S0005-7894(98)80020-8
   Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005
   Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011
   Hayden EP, 2008, J AFFECT DISORDERS, V107, P227, DOI 10.1016/j.jad.2007.07.028
   Hewitt JK, 2012, BEHAV GENET, V42, P1, DOI 10.1007/s10519-011-9504-z
   Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62
   Iacono WG, 2014, PSYCHOPHYSIOLOGY, V51, P1339, DOI 10.1111/psyp.12358
   Iacono WG, 2014, PSYCHOPHYSIOLOGY, V51, P1207, DOI 10.1111/psyp.12343
   Lau JYF, 2006, J CHILD PSYCHOL PSYC, V47, P696, DOI 10.1111/j.1469-7610.2005.01532.x
   Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8
   Lee T, 2012, BEHAV GENET, V42, P528, DOI 10.1007/s10519-012-9526-1
   LENCH N, 1988, LANCET, V1, P1356
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   Loken E, 2017, SCIENCE, V355, P584, DOI 10.1126/science.aal3618
   Malone SM, 2014, PSYCHOPHYSIOLOGY, V51, P1246, DOI 10.1111/psyp.12345
   MEULENBELT I, 1995, AM J HUM GENET, V57, P1252
   Moore MN, 2013, CLIN PSYCHOL SCI, V1, P316, DOI 10.1177/2167702612472884
   Neshat-Doost HT, 1999, PERS INDIV DIFFER, V27, P433
   Okbay A, 2015, EMOTION, V15, P531, DOI 10.1037/emo0000076
   Perez-Edgar K, 2010, BIOL PSYCHOL, V83, P269, DOI 10.1016/j.biopsycho.2009.08.009
   Pergamin-Hight L, 2012, BIOL PSYCHIAT, V71, P373, DOI 10.1016/j.biopsych.2011.10.030
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59
   Rodebaugh TL, 2016, J ABNORM PSYCHOL, V125, P840, DOI 10.1037/abn0000184
   Sakakibara E, 2014, NEUROIMAGE, V85, P508, DOI 10.1016/j.neuroimage.2013.03.052
   SEGAL ZV, 1988, PSYCHOL BULL, V103, P147, DOI 10.1037//0033-2909.103.2.147
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi
   Spitz E, 1996, BEHAV GENET, V26, P55, DOI 10.1007/BF02361159
   Taylor L, 1999, J ABNORM PSYCHOL, V108, P202, DOI 10.1037/0021-843X.108.2.202
   Timbremont B, 2004, BEHAV RES THER, V42, P423, DOI 10.1016/S0005-7967(03)00151-7
   Venables W. N, 2002, MODERN APPL STAT S
   Voss A, 2007, BEHAV RES METHODS, V39, P767, DOI 10.3758/BF03192967
   Voss A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00336
   Voss A, 2013, EXP PSYCHOL, V60, P385, DOI 10.1027/1618-3169/a000218
   Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789
   White CN, 2010, J MATH PSYCHOL, V54, P39, DOI 10.1016/j.jmp.2010.01.004
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Wigg KG, 2006, AM J MED GENET B, V141B, P566, DOI 10.1002/ajmg.b.30247
   Zalsman G, 2006, AM J PSYCHIAT, V163, P1588, DOI 10.1176/appi.ajp.163.9.1588
NR 61
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 13
PY 2018
VL 13
IS 6
AR e0198950
DI 10.1371/journal.pone.0198950
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GJ2HI
UT WOS:000435090700081
PM 29897965
OA DOAJ Gold
DA 2019-06-25
ER

PT J
AU Fleurkens, P
   van Minnen, A
   Becker, ES
   van Oostrom, I
   Speckens, A
   Rinck, M
   Vrijsen, JN
AF Fleurkens, Pascal
   van Minnen, Agnes
   Becker, Eni S.
   van Oostrom, Iris
   Speckens, Anne
   Rinck, Mike
   Vrijsen, Janna N.
TI Automatic approach-avoidance tendencies as a candidate intermediate
   phenotype for depression: Associations with childhood trauma and the
   5-HTTLPR transporter polymorphism
SO PLOS ONE
LA English
DT Article
ID STRESSFUL LIFE EVENTS; SOCIAL APPROACH; ATTENTION; GENE; VULNERABILITY;
   RELIABILITY; IMPLICIT; FACES; PSYCHOPATHOLOGY; ENDOPHENOTYPE
AB Depression risk genes in combination with childhood events have been associated with biased processing as an intermediate phenotype for depression. The aim of the present conceptual replication study was to investigate the role of biased automatic approach-avoidance tendencies as a candidate intermediate phenotype for depression, in the context of genes (5-HTTLPR polymorphism) and childhood trauma. A naturalistic remitted depressed patients sample (N = 209) performed an Approach-Avoidance Task (AAT) with facial expressions (angry, sad, happy and neutral). Childhood trauma was assessed with a questionnaire. Genotype groups were created based on allele frequency: LaLa versus S/L-g-carriers. The latter is associated with depression risk. We found that remitted S/L-g-carriers who experienced childhood trauma automatically avoided sad facial expressions relatively more than LaLa homozygotes with childhood trauma. Remitted LaLa-carriers who had not experienced childhood trauma, avoided sad faces relatively more than LaLa homozygotes with childhood trauma. We did not find a main effect of childhood trauma, nor differential avoidance of any of the other facial expressions. Although tentative, the results suggest that automatic approach-avoidance tendencies for disorder-congruent materials may be a fitting intermediate phenotype for depression. The specific pattern of tendencies, and the relation to depression, may depend on the genetic risk profile and childhood trauma, but replication is needed before firm conclusions can be drawn.
C1 [Fleurkens, Pascal; van Minnen, Agnes; Becker, Eni S.; Rinck, Mike] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands.
   [van Minnen, Agnes] Psychotrauma Expertise Ctr PSYTREC, Bilthoven, Netherlands.
   [van Oostrom, Iris; Speckens, Anne; Vrijsen, Janna N.] Radboud Univ Nijmegen, Dept Psychiat, Med Ctr, Nijmegen, Netherlands.
   [Vrijsen, Janna N.] Pro Persona Inst Integrated Mental Hlth Care, Nijmegen, Netherlands.
RP Fleurkens, P (reprint author), Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands.
EM p.fleurkens@psych.ru.nl
RI Becker, Eni S/A-2668-2010; Rinck, Mike/A-6944-2010
OI Becker, Eni S/0000-0003-3524-426X; 
CR Aguilera M, 2009, PSYCHOL MED, V39, P1425, DOI 10.1017/S0033291709005248
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Bartoszek G, 2015, J BEHAV THER EXP PSY, V46, P1, DOI 10.1016/j.jbtep.2014.07.012
   Beck A. T., 1996, MANUAL BECK DEPRESSI
   Beck AT, 2016, CLIN PSYCHOL SCI, V4, P596, DOI 10.1177/2167702616628523
   Becker ES, 2016, COGNITIVE THER RES, V40, P57, DOI 10.1007/s10608-015-9716-2
   Beevers CG, 2015, CLIN PSYCHOL REV
   Beevers CG, 2011, J ABNORM PSYCHOL, V120, P187, DOI 10.1037/a0022125
   Bhagwagar Z, 2008, PSYCHOL MED, V38, P307, DOI 10.1017/S0033291707001250
   BREWIN CR, 1993, PSYCHOL BULL, V113, P82, DOI 10.1037//0033-2909.113.1.82
   Browning Michael, 2013, Curr Top Behav Neurosci, V14, P243, DOI 10.1007/7854_2012_212
   BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Cassano Giovanni B, 2002, Dialogues Clin Neurosci, V4, P271
   Conway CC, 2014, BIOL MOOD ANXIETY DI, V4, DOI 10.1186/2045-5380-4-2
   Culverhouse RC, 2017, MOL PSYCHIAT
   De Raedt R, 2010, COGN AFFECT BEHAV NE, V10, P50, DOI 10.3758/CABN.10.1.50
   Derntl B, 2011, SOC NEUROSCI-UK, V6, P482, DOI 10.1080/17470919.2011.579800
   Donohue JM, 2007, PHARMACOECONOMICS, V25, P7, DOI 10.2165/00019053-200725010-00003
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   First MB, 1997, STRUCTURED CLIN INTE
   Fitzgerald DA, 2011, NEUROIMAGE, V56, P1783, DOI 10.1016/j.neuroimage.2011.02.061
   Fleurkens P, 2014, EUR J PSYCHOTRAUMATO, P5
   Fox E, 2011, BIOL PSYCHIAT, V70, P1049, DOI 10.1016/j.biopsych.2011.07.004
   Gibb BE, 2013, COGNITION EMOTION, V27, P193, DOI 10.1080/02699931.2012.712950
   Goldstein BL, 2014, CLIN PSYCHOL REV, V34, P417, DOI 10.1016/j.cpr.2014.06.003
   Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305
   Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636
   Hammen CL, 2010, VULNERABILITY PSYCHO, P282
   Hankin BL, 2015, J ABNORM PSYCHOL, V124, P803, DOI 10.1037/abn0000089
   Hayes SC, 2013, BEHAV THER, V44, P180, DOI 10.1016/j.beth.2009.08.002
   Heimberg RG, 1999, PSYCHOL MED, V29, P199, DOI 10.1017/S0033291798007879
   Heuer K, 2007, BEHAV RES THER, V45, P2990, DOI 10.1016/j.brat.2007.08.010
   Hornung OP, 2014, FRONT ENDOCRINOL, P5
   Hovens JGFM, 2010, ACTA PSYCHIAT SCAND, V122, P66, DOI 10.1111/j.1600-0447.2009.01491.x
   Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62
   Jenness JL, 2017, J PSYCHIATR RES, V91, P83, DOI 10.1016/j.jpsychires.2017.02.023
   Jenness JL, 2016, CLIN PSYCHOL SCI, V4, P386, DOI 10.1177/2167702615601000
   Kar Gupta R, 2012, FRONT PSYCHIATRY, P3
   Kendler KS, 2010, MOL PSYCHIATR, V15, P789, DOI 10.1038/mp.2010.8
   Kenna GA, 2012, PHARMACOGN PERS MED, V5, P19, DOI 10.2147/PGPM.S23462
   Klein AM, 2011, J CHILD FAM STUD, V20, P224, DOI 10.1007/s10826-010-9402-7
   Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076
   LEWINSOHN PM, 1981, J ABNORM PSYCHOL, V90, P213, DOI 10.1037//0021-843X.110.2.203
   Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141
   Liu LP, 2017, ADV MATH PHYS, DOI 10.1155/2017/2695894
   Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693
   McCabe SB, 2000, COGNITIVE THER RES, V24, P427, DOI 10.1023/A:1005579719849
   Monroe SM, 2011, PSYCHOL REV, V118, P655, DOI 10.1037/a0025190
   Papousek I, 2013, EMOTION, V13, P1173, DOI 10.1037/a0033997
   Peeters F, 2015, J CLIN PSYCHIAT, V76, pE1313, DOI 10.4088/JCP.14com09737
   Phaf RH, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00378
   Radke S, 2014, PSYCHIAT RES, V219, P513, DOI 10.1016/j.psychres.2014.07.011
   Reinecke A, 2010, Z PSYCHOL, V218, P4, DOI 10.1027/0044-3409/a000002
   Richards D, 2011, CLIN PSYCHOL REV, V31, P1117, DOI 10.1016/j.cpr.2011.07.004
   Rinck M, 2007, J BEHAV THER EXP PSY, V38, P105, DOI 10.1016/j.jbtep.2006.10.001
   Scher CD, 2005, CLIN PSYCHOL REV, V25, P487, DOI 10.1016/j.cpr.2005.01.005
   Schuck K, 2012, J BEHAV THER EXP PSY, V43, P685, DOI 10.1016/j.jbtep.2011.09.004
   Seidel EM, 2010, PSYCHIAT RES, V177, P124, DOI 10.1016/j.psychres.2010.02.001
   Spijker J, 2004, J AFFECT DISORDERS, V81, P231, DOI 10.1016/j.jad.2003.08.005
   Stein MB, 2009, AM J MED GENET B, V150B, P900, DOI 10.1002/ajmg.b.30916
   Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1
   Stuhrmann A, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-10
   Trew JL, 2011, CLIN PSYCHOL REV, V31, P1156, DOI 10.1016/j.cpr.2011.07.007
   Uher R, 2011, HARVARD REV PSYCHIAT, V19, P109, DOI 10.3109/10673229.2011.586551
   Van der Does AJW, 2002, MANUAL OF THE DUTCH
   Van Groenestijn MAC, 1999, STRUCTURED CLIN INTE
   Van Ijzendoorn MH, 2012, TRANSL PSYCHIAT, P2
   van Oostrom I, 2012, BIOL PSYCHOL, V89, P214, DOI 10.1016/j.biopsycho.2011.10.012
   von dem Hagen EAH, 2011, NEUROPSYCHOLOGIA, V49, P674, DOI 10.1016/j.neuropsychologia.2010.12.013
   Vrijsen JN, 2014, GENES BRAIN BEHAV, V13, P508, DOI 10.1111/gbb.12129
   Vrijsen JN, 2015, PSYCHIAT GENET, V25, P99, DOI 10.1097/YPG.0000000000000081
   Vrijsen JN, 2014, PLOS ONE, P9
   Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048
   Watson DE, 2005, INT J TOXICOL, V24, P139, DOI 10.1080/10915810590948299
   Wiers RW, 2009, GENES BRAIN BEHAV, V8, P101, DOI 10.1111/j.1601-183X.2008.00454.x
   Zalsman G, 2006, AM J PSYCHIAT, V163, P1588, DOI 10.1176/appi.ajp.163.9.1588
   Zisook S, 2007, AM J PSYCHIAT, V164, P1539, DOI 10.1176/appi.ajp.2007.06101757
NR 78
TC 1
Z9 1
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 16
PY 2018
VL 13
IS 3
AR e0193787
DI 10.1371/journal.pone.0193787
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ6JH
UT WOS:000427703500011
PM 29547643
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Plass-Christl, A
   Haller, AC
   Otto, C
   Barkmann, C
   Wiegand-Grefe, S
   Holling, H
   Schulte-Markwort, M
   Ravens-Sieberer, U
   Klasen, F
AF Plass-Christl, Angela
   Haller, Anne-Catherine
   Otto, Christiane
   Barkmann, Claus
   Wiegand-Grefe, Silke
   Hoelling, Heike
   Schulte-Markwort, Michael
   Ravens-Sieberer, Ulrike
   Klasen, Fionna
TI Parents with mental health problems and their children in a German
   population based sample: Results of the BELLA study
SO PLOS ONE
LA English
DT Article
ID STRESSFUL LIFE EVENTS; ILL PARENTS; DIFFICULTIES QUESTIONNAIRE;
   CHILDHOOD ADVERSITIES; PSYCHIATRIC-DISORDERS; AFFECTIVELY ILL;
   ADOLESCENTS; PREVALENCE; PSYCHOPATHOLOGY; METAANALYSIS
AB Background Mental health problems (MHP) of parents are associated with an increased risk of psychological and developmental difficulties in their children. This study aims at analyzing population-based data of parents with MHP and their children and the effects of associated risk factors in order to further targeted preventive and therapeutic interventions.
   Methods The BELLA study is the mental health module of the German National Health Interview and Examination Survey among Children and Adolescents. MHP in parents and in their children as well as associated risk factors were examined in a sample of N = 1158 parents with children aged 11 to 17 years.
   Results Parental MHP were identified in 18.6% of the sample. Risk factors associated with parental MHP were low SES, parental unemployment, stressful life events, parental daily strain, parental chronic disease, and child MHP. A rate of 19.1% of the children of parents with MHP reported MHP themselves, the corresponding rate among children of parents without MHP was 7.7%. In multiple regression analyses the risk for children of parents with MHP to report MHP themselves was almost two times higher than the risk of children of parents without MHP. Other significant associations with child MHP included gender, the parents' age, and stressful life events.
   Conclusions Parental MHP constitute a significant risk for the mental health of their children. Targeted screening methods and preventive interventions are needed.
C1 [Plass-Christl, Angela; Haller, Anne-Catherine; Otto, Christiane; Barkmann, Claus; Wiegand-Grefe, Silke; Schulte-Markwort, Michael; Ravens-Sieberer, Ulrike; Klasen, Fionna] Univ Med Ctr Hamburg Eppendorf, Dept Child & Adolescent Psychiat Psychotherapy &, Hamburg, Germany.
   [Hoelling, Heike] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.
RP Ravens-Sieberer, U (reprint author), Univ Med Ctr Hamburg Eppendorf, Dept Child & Adolescent Psychiat Psychotherapy &, Hamburg, Germany.
EM ravens-sieberer@uke.de
CR Angelini V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167703
   Barkmann C, 2012, J EPIDEMIOL COMMUN H, V66, P194, DOI 10.1136/jech.2009.102467
   Beardslee WR, 2011, J AM ACAD CHILD PSY, V50, P1098, DOI 10.1016/j.jaac.2011.07.020
   Beardslee WR, 2003, PEDIATRICS, V112, pE119, DOI 10.1542/peds.112.2.e119
   Belfer ML, 2008, J CHILD PSYCHOL PSYC, V49, P226, DOI 10.1111/j.1469-7610.2007.01855.x
   Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098
   Bohlmeijer E, 2010, J PSYCHOSOM RES, V68, P539, DOI 10.1016/j.jpsychores.2009.10.005
   Brent DA, 2015, JAMA PSYCHIAT, V30, P1
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Franke G.H, 2002, SCL 90 R SYMPTOM CHE
   Frasquilho D, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2720-y
   Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015
   Goodman SH, 2007, ANNU REV CLIN PSYCHO, V3, P107, DOI 10.1146/annurev.clinpsy.3.022806.091401
   Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186
   Herpertz-Dahlmann B, 2008, EUR CHILD ADOLES PSY, V17, P82, DOI 10.1007/s00787-008-1009-9
   Holling H, 2014, BUNDESGESUNDHEITSBLA, V57, P807, DOI 10.1007/s00103-014-1979-3
   IBM Corp, 2013, IBM SPSS STAT WIND V
   Ihle W, 2002, PSYCHOL RUNDSCH, V53, P159, DOI 10.1026//0033-3042.53.4.159
   Jacobi F, 2015, INT J METH PSYCH RES, V24, P305, DOI 10.1002/mpr.1479
   Jacobi F, 2014, INT J METH PSYCH RES, V23, P304, DOI 10.1002/mpr.1439
   Johnson S, 2014, DEV MED CHILD NEUROL, V56, P453, DOI 10.1111/dmcn.12360
   Kamtsiuris P, 2007, BUNDESGESUNDHEITSBLA, V50, P547, DOI 10.1007/s00103-007-0215-9
   Karow A, 2013, FORTSCHR NEUROL PSYC, V81, P628, DOI 10.1055/s-0033-1355840
   Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191
   Kessler RC, 2012, ARCH GEN PSYCHIAT, V69, P372, DOI 10.1001/archgenpsychiatry.2011.160
   Klaghofer R, 2001, Z KLIN PSYCHOL PSYCH, V49, P115
   Kuhn C, 2016, CHILD PSYCHIAT HUM D
   Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P631, DOI 10.1007/s00103-012-1663-4
   Lapalme M, 1997, CAN J PSYCHIAT, V42, P623, DOI 10.1177/070674379704200609
   Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027
   Mattejat F, 2008, DTSCH ARZTEBL INT, V105, P413, DOI [10.3238/arztebl.2008.413, 10.3238/arztebl.2008.0413]
   McLaughlin KA, 2012, ARCH GEN PSYCHIAT, V69, P1151, DOI 10.1001/archgenpsychiatry.2011.2277
   McLaughlin KA, 2012, BRIT J PSYCHIAT, V200, P290, DOI 10.1192/bjp.bp.111.101253
   McLaughlin KA, 2009, J ADOLESCENT HEALTH, V44, P153, DOI 10.1016/j.jadohealth.2008.06.019
   Meltzer H, 2000, MENTAL HLTH CHILDREN
   Middeldorp CM, 2016, EUR CHILD ADOLES PSY, V25, P919, DOI 10.1007/s00787-015-0813-2
   Najman JM, 2000, J AM ACAD CHILD PSY, V39, P592, DOI 10.1097/00004583-200005000-00013
   PELLEGRINI DS, 1990, J DEV BEHAV PEDIATR, V11, P201
   Petermann F, 2005, KINDH ENTWICKL, V14, P48, DOI 10.1026/0942-5403.14.1.48
   Petermann F., 1999, KINDH ENTWICKL, V8, P3
   Plass A, 2016, KINDH ENTWICKL, V25, P41, DOI 10.1026/0942-5403/a000187
   Prinz U, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-104
   Ravens-Sieberer U, 2015, EUR CHILD ADOLES PSY, V24, P651, DOI 10.1007/s00787-014-0638-4
   Ravens-Sieberer U, 2008, EUR CHILD ADOLES PSY, V17, P10, DOI 10.1007/s00787-008-1002-3
   Ravens-Sieberer U, 2008, EUR CHILD ADOLES PSY, V17, P22, DOI 10.1007/s00787-008-1003-2
   Siegenthaler E, 2012, J AM ACAD CHILD PSY, V51, P8, DOI 10.1016/j.jaac.2011.10.018
   Statistisches Bundesamt WBfS, 2016, DAT REP 2016 KAP 2 F
   TARULLO LB, 1995, J CLIN CHILD PSYCHOL, V24, P173, DOI 10.1207/s15374424jccp2402_5
   van der Pol LD, 2016, J CHILD FAM STUD, V25, P3367, DOI 10.1007/s10826-016-0490-x
   Wiegand-Grefe S, 2016, KINDH ENTWICKL, V25, P77, DOI 10.1026/0942-5403/a000192
   Wiegand-Grefe S, 2016, KINDH ENTWICKL, V25, P63, DOI 10.1026/0942-5403/a000190
   Wiegand-Grefe S, 2009, KINDH ENTWICKL, V18, P111, DOI 10.1026/0942-5403.18.2.111
   Wille N, 2008, EUR CHILD ADOLES PSY, V17, P133, DOI 10.1007/s00787-008-1015-y
   Winkler J., 1999, GESUNDHEITSWESEN, V61, P178
   Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018
   Zechmeister I, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-20
NR 56
TC 9
Z9 9
U1 2
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 3
PY 2017
VL 12
IS 7
AR e0180410
DI 10.1371/journal.pone.0180410
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA2JX
UT WOS:000405268500052
PM 28671981
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Otowa, T
   Kawamura, Y
   Tsutsumi, A
   Kawakami, N
   Kan, C
   Shimada, T
   Umekage, T
   Kasai, K
   Tokunaga, K
   Sasaki, T
AF Otowa, Takeshi
   Kawamura, Yoshiya
   Tsutsumi, Akizumi
   Kawakami, Norito
   Kan, Chiemi
   Shimada, Takafumi
   Umekage, Tadashi
   Kasai, Kiyoto
   Tokunaga, Katsushi
   Sasaki, Tsukasa
TI The First Pilot Genome-Wide Gene-Environment Study of Depression in the
   Japanese Population
SO PLOS ONE
LA English
DT Article
ID NATIONAL COMORBIDITY SURVEY; PROTEIN SIGNALING RGS; STRESSFUL LIFE
   EVENTS; MAJOR DEPRESSION; SURVEY REPLICATION; DSM-IV; ASSOCIATION;
   DISORDERS; ONSET; POLYMORPHISM
AB Stressful events have been identified as a risk factor for depression. Although gene-environment (G x E) interaction in a limited number of candidate genes has been explored, no genome-wide search has been reported. The aim of the present study is to identify genes that influence the association of stressful events with depression. Therefore, we performed a genome-wide G x E interaction analysis in the Japanese population. A genome-wide screen with 320 subjects was performed using the Affymetrix Genome-Wide Human Array 6.0. Stressful life events were assessed using the Social Readjustment Rating Scale (SRRS) and depression symptoms were assessed with self-rating questionnaires using the Center for Epidemiologic Studies Depression (CES-D) scale. The p values for interactions between single nucleotide polymorphisms (SNPs) and stressful events were calculated using the linear regression model adjusted for sex and age. After quality control of genotype data, a total of 534,848 SNPs on autosomal chromosomes were further analyzed. Although none surpassed the level of the genome-wide significance, a marginal significant association of interaction between SRRS and rs10510057 with depression were found (p = 4.5 x 10 -8). The SNP is located on 10q26 near Regulators of G-protein signaling 10 (RGS10), which encodes a regulatory molecule involved in stress response. When we investigated a similar G x E interaction between depression (K6 scale) and work-related stress in an independent sample (n = 439), a significant G x E effect on depression was observed (p = 0.015). Our findings suggest that rs10510057, interacting with stressors, may be involved in depression risk. Incorporating G x E interaction into GWAS can contribute to find susceptibility locus that are potentially missed by conventional GWAS.
C1 [Otowa, Takeshi] Teikyo Heisei Univ Major Profess Clin Psychol, Grad Sch Clin Psychol, Tokyo, Japan.
   [Otowa, Takeshi; Shimada, Takafumi; Umekage, Tadashi; Kasai, Kiyoto] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan.
   [Kawamura, Yoshiya] Shonan Kamakura Gen Hosp, Dept Psychiat, Kamakura, Kanagawa, Japan.
   [Tsutsumi, Akizumi] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa, Japan.
   [Kawakami, Norito; Kan, Chiemi] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo, Japan.
   [Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan.
   [Sasaki, Tsukasa] Univ Tokyo, Grad Sch Educ, Lab Hlth Educ, Tokyo, Japan.
RP Otowa, T (reprint author), Teikyo Heisei Univ Major Profess Clin Psychol, Grad Sch Clin Psychol, Tokyo, Japan.; Otowa, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan.
EM totowa-psy@umin.org
FU Ministry of Education, Science, Sports and Culture of Japan [17019029,
   21300242, 25461723, 21119002]
FX This work was supported by the Grants-in-Aid for Scientific Research on
   Priority Areas "Comprehensive Genomics" and "Applied Genomics" (T.
   Sasaki received No. 17019029 and No. 21300242; TO received No. 25461723)
   and for Scientific Research on Innovative Areas; "Elucidation of social
   stratification mechanism and control over health inequality in
   contemporary Japan: New interdisciplinary area of social and health
   sciences" (The Project "Social Stratification and Health": AT and NK
   received No. 21119002) from the Ministry of Education, Science, Sports
   and Culture of Japan. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR BEBBINGTON P, 1993, BRIT J PSYCHIAT, V162, P358, DOI 10.1192/bjp.162.3.358
   Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209
   Brown GW, 2008, J AFFECT DISORDERS, V111, P1, DOI 10.1016/j.jad.2008.04.009
   BROWN GW, 1995, PSYCHOL MED, V25, P7, DOI 10.1017/S003329170002804X
   BRUGHA TS, 1985, BRIT J PSYCHIAT, V147, P641, DOI 10.1192/bjp.147.6.641
   Burgon PG, 2001, J BIOL CHEM, V276, P32828, DOI 10.1074/jbc.M100960200
   Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Dunn EC, 2015, HARVARD REV PSYCHIAT, V23, P1, DOI 10.1097/HRP.0000000000000054
   Eaves LJ, 2006, TWIN RES HUM GENET, V9, P1, DOI 10.1375/183242706776403073
   Ensel WM, 1996, J AGING HEALTH, V8, P389, DOI 10.1177/089826439600800305
   Flint J, 2014, NEURON, V81, P484, DOI 10.1016/j.neuron.2014.01.027
   Gold SJ, 1997, J NEUROSCI, V17, P8024
   Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186
   Hek K, 2013, BIOL PSYCHIAT, V73, P667, DOI 10.1016/j.biopsych.2012.09.033
   Hishimoto A, 2004, PSYCHIAT CLIN NEUROS, V58, P579, DOI 10.1111/j.1440-1819.2004.01303.x
   HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4
   Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x
   Kawamura Y, 2010, J AFFECT DISORDERS, V127, P31, DOI 10.1016/j.jad.2010.04.014
   Kendler KS, 1998, J NERV MENT DIS, V186, P661, DOI 10.1097/00005053-199811000-00001
   Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   Kessler RC, 1997, PSYCHOL MED, V27, P1101, DOI 10.1017/S0033291797005588
   Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095
   Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183
   Lee JK, 2012, J NEUROCHEM, V122, P333, DOI 10.1111/j.1471-4159.2012.07780.x
   Lewis CM, 2010, AM J PSYCHIAT, V167, P949, DOI 10.1176/appi.ajp.2010.09091380
   Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088
   Menke A, 2014, DIALOGUES CLIN NEURO, V16, P395
   Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8
   Narahara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100924
   Nugent NR, 2011, PSYCHOPHARMACOLOGY, V214, P175, DOI 10.1007/s00213-010-2151-x
   Pinheiro AP, 2010, AM J MED GENET B, V153B, P1070, DOI 10.1002/ajmg.b.31082
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Renzaho AMN, 2014, EUR J PUBLIC HEALTH, V24, P57, DOI 10.1093/eurpub/ckt007
   Rivero G, 2012, NEUROPHARMACOLOGY, V62, P1044, DOI 10.1016/j.neuropharm.2011.10.015
   Rojo-Moreno L, 2002, SOC PSYCH PSYCH EPID, V37, P592, DOI 10.1007/s00127-002-0595-y
   Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795
   Rudolph KD, 2009, DEV PSYCHOPATHOL, V21, P1155, DOI 10.1017/S0954579409990095
   Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi
   Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124
   Shima S, 1985, CLIN PSYCHIATR, V27, P717, DOI DOI 10.11477/MF.1405203967
   Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125
   Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21
   Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552
   Suzuki T, 2013, J AFFECT DISORDERS, V150, P490, DOI 10.1016/j.jad.2013.04.044
   Tennant C, 2002, AUST NZ J PSYCHIAT, V36, P173, DOI 10.1046/j.1440-1614.2002.01007.x
   van der Sluis S, 2013, MOL PSYCHIATR, V18, P2, DOI 10.1038/mp.2012.65
   Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019
   ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2
NR 54
TC 7
Z9 7
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 16
PY 2016
VL 11
IS 8
AR e0160823
DI 10.1371/journal.pone.0160823
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT4UN
UT WOS:000381476700025
PM 27529621
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Zahavi, AY
   Sabbagh, MA
   Washburn, D
   Mazurka, R
   Bagby, RM
   Strauss, J
   Kennedy, JL
   Ravindran, A
   Harkness, KL
AF Zahavi, Arielle Y.
   Sabbagh, Mark A.
   Washburn, Dustin
   Mazurka, Raegan
   Bagby, R. Michael
   Strauss, John
   Kennedy, James L.
   Ravindran, Arun
   Harkness, Kate L.
TI Serotonin and Dopamine Gene Variation and Theory of Mind Decoding
   Accuracy in Major Depression: A Preliminary Investigation
SO PLOS ONE
LA English
DT Article
ID THEORY-OF-MIND; TRANSPORTER GENE; METHYLTRANSFERASE COMT; BIASED
   ATTENTION; CANDIDATE GENE; WORD STIMULI; POLYMORPHISM; ASSOCIATION;
   AMYGDALA; BRAIN
AB Theory of mind-the ability to decode and reason about others' mental states-is a universal human skill and forms the basis of social cognition. Theory of mind accuracy is impaired in clinical conditions evidencing social impairment, including major depressive disorder. The current study is a preliminary investigation of the association of polymorphisms of the serotonin transporter (SLC6A4), dopamine transporter (DAT1), dopamine receptor D4 (DRD4), and catechol-O-methyl transferase (COMT) genes with theory of mind decoding in a sample of adults with major depression. Ninety-six young adults (38 depressed, 58 non-depressed) completed the 'Reading the Mind in the Eyes task' and a non-mentalistic control task. Genetic associations were only found for the depressed group. Specifically, superior accuracy in decoding mental states of a positive valence was seen in those homozygous for the long allele of the serotonin transporter gene, 9-allele carriers of DAT1, and long-allele carriers of DRD4. In contrast, superior accuracy in decoding mental states of a negative valence was seen in short-allele carriers of the serotonin transporter gene and 10/10 homozygotes of DAT1. Results are discussed in terms of their implications for integrating social cognitive and neurobiological models of etiology in major depression.
C1 [Zahavi, Arielle Y.; Sabbagh, Mark A.; Washburn, Dustin; Mazurka, Raegan; Harkness, Kate L.] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.
   [Bagby, R. Michael] Univ Toronto Scarborough, Dept Psychol, Toronto, ON, Canada.
   [Strauss, John; Kennedy, James L.; Ravindran, Arun] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada.
RP Harkness, KL (reprint author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.
EM harkness@queensu.ca
OI Harkness, Kate/0000-0002-0319-8994
FU Canadian Institutes of Health Research operating grant [79320]
FX This study was funded by a Canadian Institutes of Health Research
   operating grant #79320 http://www.cihr-irsc.gc.ca/e/193.html awarded to
   KLH ( principal investigator), RMB, JS, JLK, and AR. The funder had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Abraham JE, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-19
   Abu-Akel A, 2003, MED HYPOTHESES, V60, P382, DOI 10.1016/S0306-9877(02)00406-1
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Barnes JJM, 2011, BIOL PSYCHIAT, V69, pE127, DOI 10.1016/j.biopsych.2010.12.040
   Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715
   Beck A. T., 1996, BECK DEPRESSION INVE
   Beevers CG, 2007, J ABNORM PSYCHOL, V116, P208, DOI 10.1037/0021-843X.116.1.208
   Bosia M, 2015, NEUROL SCI, V36, P215, DOI 10.1007/s10072-014-1936-9
   Bruder GE, 2005, BIOL PSYCHIAT, V58, P901, DOI 10.1016/j.biopsych.2005.05.010
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589
   CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G
   Creswell KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028914
   Dannlowski U, 2008, NEUROPSYCHOPHARMACOL, V33, P418, DOI 10.1038/sj.npp.1301411
   Defrancesco M, 2011, J INT NEUROPSYCH SOC, V17, P1014, DOI 10.1017/S135561771100097X
   Demaree HA, 2009, MAGN RESON IMAGING, V27, P441, DOI 10.1016/j.mri.2008.08.006
   Diamond A, 2004, AM J PSYCHIAT, V161, P125, DOI 10.1176/appi.ajp.161.1.125
   Diamond A, 2007, CEREB CORTEX, V17, pI161, DOI 10.1093/cercor/blini082
   DiCiccio TJ, 1996, STAT SCI, V11, P189
   Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191
   First MB, 2002, STRUCTURED CLIN INTE
   Garcia JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014162
   HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56
   Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146
   Harkness KL, 2015, J ABNORM PSYCHOL, V124, P275, DOI 10.1037/abn0000034
   Harkness KL, 2011, PSYCHIAT RES, V189, P91, DOI 10.1016/j.psychres.2011.06.007
   Harkness KL, 2005, COGNITION EMOTION, V19, P999, DOI 10.1080/02699930541000110
   Hart AB, 2013, NEUROPSYCHOPHARMACOL, V38, P802, DOI 10.1038/npp.2012.245
   Hindmarch T, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-54
   Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024
   Hu YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033968
   Inoue Y, 2006, J AFFECT DISORDERS, V95, P125, DOI 10.1016/j.jad.2006.04.018
   Kwang T, 2010, DEPRESS ANXIETY, V27, P746, DOI 10.1002/da.20708
   Lackner C, 2012, DEVELOPMENTAL SCI, V15, P272, DOI 10.1111/j.1467-7687.2011.01124.x
   Lee L, 2005, J AFFECT DISORDERS, V86, P247, DOI 10.1016/j.jad.2005.02.007
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   Little K, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.85
   Moses LJ, 2001, CHILD DEV, V72, P688, DOI 10.1111/1467-8624.00306
   Muller DJ, 2008, AM J MED GENET B, V147B, P1461, DOI 10.1002/ajmg.b.30706
   Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018
   Sabbagh MA, 2004, BRAIN COGNITION, V55, P209, DOI 10.1016/j.banc.2003.04.002
   Sabbagh MA, 2004, J COGNITIVE NEUROSCI, V16, P415, DOI 10.1162/089892904322926755
   Sabbagh MA, 2013, UNDERSTANDING OTHER
   Sabbagh MA, 2008, DEVELOPMENTAL SCI, V11, P354, DOI 10.1111/j.1467-7687.2008.00680.x
   Sabbagh MA, 2009, CHILD DEV, V80, P1147, DOI 10.1111/j.1467-8624.2009.01322.x
   Saxe R, 2006, SOC COGN AFFECT NEUR, V1, P229, DOI 10.1093/scan/nsl034
   Schaafsma SM, 2015, TRENDS COGN SCI, V19, P65, DOI 10.1016/j.tics.2014.11.007
   Schoots O, 2003, PHARMACOGENOMICS J, V3, P343, DOI 10.1038/sj.tpj.6500208
   Stone VE, 2003, NEUROPSYCHOLOGIA, V41, P209, DOI 10.1016/S0028-3932(02)00151-3
   Tsuchimine S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076763
   Uher R, 2012, DEPRESS ANXIETY, V29, P1043, DOI 10.1002/da.21993
   Webb CA, 2014, PSYCHOL MED, V44, P2833, DOI 10.1017/S0033291714000348
   Wellman H, 1990, CHILDS THEORY MIND
   Xia HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049768
NR 54
TC 4
Z9 4
U1 1
U2 23
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 14
PY 2016
VL 11
IS 3
AR e0150872
DI 10.1371/journal.pone.0150872
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH1UO
UT WOS:000372570600036
PM 26974654
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Haberstick, BC
   Boardman, JD
   Wagner, B
   Smolen, A
   Hewitt, JK
   Killeya-Jones, LA
   Tabor, J
   Halpern, CT
   Brummett, BH
   Williams, RB
   Siegler, IC
   Hopfer, CJ
   Harris, KM
AF Haberstick, Brett C.
   Boardman, Jason D.
   Wagner, Brandon
   Smolen, Andrew
   Hewitt, John K.
   Killeya-Jones, Ley A.
   Tabor, Joyce
   Halpern, Carolyn T.
   Brummett, Beverly H.
   Williams, Redford B.
   Siegler, Ilene C.
   Hopfer, Christian J.
   Harris, Kathleen Mullan
TI Depression, Stressful Life Events, and the Impact of Variation in the
   Serotonin Transporter: Findings from the National Longitudinal Study of
   Adolescent to Adult Health (Add Health)
SO PLOS ONE
LA English
DT Article
ID GENE-ENVIRONMENT INTERACTIONS; MAJOR DEPRESSION; PROMOTER POLYMORPHISM;
   SUICIDAL-BEHAVIOR; 5-HTTLPR; ASSOCIATION; RISK; METAANALYSIS;
   MODERATION; 5HTTLPR
AB Background
   The low transcriptionally efficient short-allele of the 5HTTLPR serotonin transporter polymorphism has been implicated to moderate the relationship between the experience of stressful life events (SLEs) and depression. Despite numerous attempts at replicating this observation, results remain inconclusive.
   Methods
   We examined this relationship in young-adult Non-Hispanic white males and females between the ages of 22 and 26 (n = 4724) participating in the National Longitudinal Study of Adolescent to Adult Health (Add Health) with follow-up information every six years since 1995.
   Results
   Linear and logistic regression models, corrected for multiple testing, indicated that carriers of one or more of the S-alleles were more sensitive to stress than those with two L-alleles and at a higher risk for depression. This relationship behaved in a dose-response manner such that the risk for depression was greatest among those who reported experiencing higher numbers of SLEs. In post-hoc analyses we were not able to replicate an interaction effect for suicide ideation but did find suggestive evidence that the effects of SLEs and 5HTTLPR on suicide ideation differed for males and females. There were no effects of childhood maltreatment.
   Discussion
   Our results provide partial support for the original hypothesis that 5-HTTLPR genotype interacts with the experience of stressful life events in the etiology of depression during young adulthood. However, even with this large sample, and a carefully constructed a priori analysis plan, the results were still not definitive. For the purposes of replication, characterizing the 5HTTLPR in other large data sets with extensive environmental and depression measures is needed.
C1 [Haberstick, Brett C.; Smolen, Andrew; Hewitt, John K.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA.
   [Boardman, Jason D.] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA.
   [Wagner, Brandon; Harris, Kathleen Mullan] Univ N Carolina, Dept Sociol, Chapel Hill, NC USA.
   [Killeya-Jones, Ley A.; Tabor, Joyce; Halpern, Carolyn T.; Harris, Kathleen Mullan] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA.
   [Halpern, Carolyn T.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC USA.
   [Brummett, Beverly H.; Williams, Redford B.; Siegler, Ilene C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA.
   [Hopfer, Christian J.] Univ Colorado, Hlth Sci Ctr, Dept Psychiat, Denver, CO 80262 USA.
RP Haberstick, BC (reprint author), Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA.
EM Brett.Haberstick@Colorado.edu
FU National Institute for Child Health and Human Development [P01-HD31921];
   National Heart, Lung, Blood Institute [P01-HL36587]; National Institute
   on Aging [AG046938]; Eunice Kennedy Shriver National Institute of Child
   Health and Human Development [P01-HD31921]
FX This work was supported by National Institute for Child Health and Human
   Development, P01-HD31921; National Heart, Lung, Blood Institute,
   P01-HL36587 (to Redford Williams); National Institute on Aging, AG046938
   (to Chandra A. Reynolds and Sally Wadsworth).; This research uses data
   from Add Health, a program project directed by Kathleen Mullan Harris
   and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan
   Harris at the University of North Carolina at Chapel Hill, and funded by
   grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of
   Child Health and Human Development, with cooperative funding from 23
   other federal agencies and foundations. Special acknowledgement is due
   Ronald R. Rindfuss and Barbara Entwisle for assistance in the original
   design. Information on how to obtain Add Health data files is available
   at the Add Health website (http://www.cpc.unc.edu/addhealth). This
   research was also supported by grant P01-HL36587 from the National
   Heart, Lung, Blood Institute to Redford Williams and by grant AG046938
   from the National Institute on Aging to Chandra A. Reynolds and Sally
   Wadsworth (Co-PI's)
CR Adkins DE, 2009, SOC FORCES, V88, P31, DOI 10.1353/sof.0.0238
   Anguelova M, 2003, MOL PSYCHIATR, V8, P646, DOI 10.1038/sj.mp.4001336
   Atmaca M, 2011, J ANXIETY DISORD, V25, P680, DOI 10.1016/j.janxdis.2011.03.002
   Beaver KM, 2012, AM J ORTHOPSYCHIAT, V82, P260, DOI 10.1111/j.1939-0025.2012.01148.x
   Brown GW, 2008, J AFFECT DISORDERS, V111, P1, DOI 10.1016/j.jad.2008.04.009
   Brummett BH, 2008, BEHAV GENET, V38, P476, DOI 10.1007/s10519-008-9219-y
   Brummett BH, 2008, BEHAV GENET, V38, P34, DOI 10.1007/s10519-007-9172-1
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Chorbov VM, 2007, AM J MED GENET B, V144B, P830, DOI 10.1002/ajmg.b.30534
   Coventry WL, 2009, AM J MED GENET B, V153B, P757
   Deneris ES, 2012, NAT NEUROSCI, V15, P519, DOI 10.1038/nn.3039
   Dickey B, 2003, BRIT J PSYCHIAT, V183, P93
   Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191
   Ely TC, 2004, MOL PSYCHIATR, V9, P908
   Gillespie NA, 2005, PSYCHOL MED, V35, P101, DOI 10.1017/S0033291704002727
   Gonda X, 2005, J AFFECT DISORDERS, V87, P291, DOI 10.1016/j.jad.2005.05.007
   Gonzalez HM, 2010, J PSYCHIATR RES, V44, P1043, DOI 10.1016/j.jpsychires.2010.03.017
   Grabe HJ, 2005, MOL PSYCHIATR, V10, P220, DOI 10.1038/sj.mp.4001555
   Haberstick BC, 2015, BEHAV GENET, V45, P255, DOI 10.1007/s10519-014-9703-5
   Haberstick BC, 2014, BEHAV GENET, V44, P487, DOI 10.1007/s10519-014-9662-x
   Harris K., 2011, DESIGN FEATURES ADD
   Harris KM, 2006, TWIN RES HUM GENET, V9, P988, DOI 10.1375/183242706779462787
   Heils A, 1996, J NEUROCHEM, V66, P2621
   Henry B., 1994, PSYCHOL ASSESSMENT, V6, P92, DOI DOI 10.1037/1040-3590.6.2.92
   HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4
   Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850
   Jacobs N, 2006, ARCH GEN PSYCHIAT, V63, P989, DOI 10.1001/archpsyc.63.9.989
   Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189
   Kendler KS, 1998, J NERV MENT DIS, V186, P661, DOI 10.1097/00005053-199811000-00001
   Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529
   KENDLER KS, 1995, AM J PSYCHIAT, V152, P833
   Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   Lin PY, 2004, BIOL PSYCHIAT, V55, P1023, DOI 10.1016/j.biopsych.2004.02.006
   Loncar D, 2006, PLOS MED, V3, pe442
   MCGEE RA, 1995, CHILD ABUSE NEGLECT, V19, P233, DOI 10.1016/0145-2134(94)00119-F
   Moffitt TE, 2006, PERSPECT PSYCHOL SCI, V1, P5, DOI 10.1111/j.1745-6916.2006.00002.x
   Monroe SM, 2008, PSYCHOL SCI, V19, P947, DOI 10.1111/j.1467-9280.2008.02181.x
   Moya PR, 2011, CURR OPIN PHARMACOL, V11, P3
   Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878
   Sjoberg RL, 2006, INT J NEUROPSYCHOPH, V9, P443, DOI 10.1017/S1461145705005936
   Thapar A, 2007, DEV PSYCHOPATHOL, V19, P989, DOI 10.1017/S0954579407000491
   Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764
   Turecki G, 2012, TRENDS NEUROSCI, V35, P14, DOI 10.1016/j.tins.2011.11.008
   Uher R, 2010, MOL PSYCHIATR, V15, P18, DOI 10.1038/mp.2009.123
   Williams DR, 2007, ARCH GEN PSYCHIAT, V64, P305, DOI 10.1001/archpsyc.64.3.305
   Wray NR, 2009, BIOL PSYCHIAT, V66, P468, DOI 10.1016/j.biopsych.2009.04.030
NR 50
TC 7
Z9 7
U1 2
U2 31
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 3
PY 2016
VL 11
IS 3
AR e0148373
DI 10.1371/journal.pone.0148373
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DG0EB
UT WOS:000371735200007
PM 26938215
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Davin, A
   Monti, MC
   Polito, L
   Vaccaro, R
   Abbondanza, S
   Gnesi, M
   Villani, S
   Guaita, A
AF Davin, Annalisa
   Monti, Maria Cristina
   Polito, Letizia
   Vaccaro, Roberta
   Abbondanza, Simona
   Gnesi, Marco
   Villani, Simona
   Guaita, Antonio
TI Influence of Serotonin Transporter Gene Polymorphisms and Adverse Life
   Events on Depressive Symptoms in the Elderly: A Population-Based Study
SO PLOS ONE
LA English
DT Article
ID 5-HTTLPR POLYMORPHISM; AFFECTIVE-DISORDERS; MAJOR DEPRESSION;
   AGE-DIFFERENCES; OLDER-ADULTS; ASSOCIATION; SUSCEPTIBILITY; DEMENTIA;
   ONSET; METAANALYSIS
AB Background
   Depression is common in the elderly. The role of genetic and environmental factors in modulating depressive symptoms is not clear.
   Methods
   We evaluated the influence of serotonin transporter gene polymorphisms and recent adverse life events on depressive symptoms in an elderly Italian population. We used data from "InveCe.Ab", a population-based study of 1321 subjects aged 70-74 years. We used the 15-item Geriatric Depression Scale (GDS) to assess depressive symptoms-a GDS score >= 5 points (GDS >= 5) indicated the presence of clinically relevant symptoms-and performed 5-HTTLPR and rs25531 genotyping to obtain the triallelic polymorphism of the serotonin transporter. We used the Geriatric Adverse Life Events Scale to measure adverse life events, and logistic regression models to evaluate the role of genotype and recent adverse life events in depressive symptoms, controlling for potential confounders and independent predictors.
   Results
   Two hundred subjects (15.76%) had a GDS >= 5. The 5-HTTLPR triallelic polymorphism was significantly associated with GDS >= 5. Only S'S' carriers showed an increased risk of depressive symptoms (ORadj = 1.81, p = .022); one extra adverse life event increased this risk by 14%(p = .061) independently of genotype. Other factors significantly related to GDS >= 5 were: female gender (ORadj = 2.49, p < .001), age (ORadj = 1.19, p = .007), a history of depression (ORadj = 4.73, p < .001), and comorbidity (ORadj = 1.23, p = .001). One extra adverse life event increased the risk of depressive symptoms by 57%(p = .005) only in the L'L' carriers, while antidepressant intake was directly related to GDS >= 5 in the L'S' carriers (ORadj = 2.46, p = .036) and borderline significant in the S'S' carriers (ORadj = 2.41, p = .081).
   Discussion
   The S'S' genotype and recent exposure to adverse life events were independently associated with depressive symptoms. The S'S' genotype, compared with the environment, exerted a predominant effect on depressive symptoms, suggesting that it reduces the efficacy of antidepressant therapy. We conclude that genetics may be an important risk factor for depressive symptoms in late adulthood.
C1 [Davin, Annalisa; Polito, Letizia; Vaccaro, Roberta; Abbondanza, Simona; Guaita, Antonio] Golgi Cenci Fdn, Abbiategrasso, Italy.
   [Monti, Maria Cristina; Gnesi, Marco; Villani, Simona] Univ Pavia, Dept Publ Hlth Expt & Forens Med, Sect Biostat & Clin Epidemiol, I-27100 Pavia, Italy.
   [Vaccaro, Roberta] C Golgi Geriatr Inst, Abbiategrasso, Italy.
RP Davin, A (reprint author), Golgi Cenci Fdn, Abbiategrasso, Italy.
EM a.davin@golgicenci.it
RI Guaita, Antonio/Q-1787-2019
OI Guaita, Antonio/0000-0003-3954-5932; Gnesi, Marco/0000-0001-6022-6325;
   /0000-0003-2517-6515
CR Aldwin CM, 1996, J GERONTOL B-PSYCHOL, V51, pP179, DOI 10.1093/geronb/51B.4.P179
   Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8
   Andreoli V, 2007, DSM 4 TR MANUALE DIA
   Bjorklof GH, 2013, DEMENT GERIATR COGN, V35, P121, DOI 10.1159/000346633
   Blazer DG, 2005, PSYCHOL MED, V35, P1241, DOI 10.1017/S0033291705004411
   Bogdan R, 2014, J CHILD PSYCHOL PSYC, V55, P448, DOI 10.1111/jcpp.12142
   Brown SM, 2006, COGN AFFECT BEHAV NE, V6, P44, DOI 10.3758/CABN.6.1.44
   Buber I, 2011, COMP POPUL STUD, V36, P103, DOI 10.4232/10.CPoS-2011-02en
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Cho HJ, 2005, MOL PSYCHIATR, V10, P771, DOI 10.1038/sj.mp.4001663
   Choi S, 2014, PSYCHIAT Q
   Chou KL, 2008, J AFFECT DISORDERS, V106, P191, DOI 10.1016/j.jad.2007.05.028
   Cicirelli VG, 2009, J GERONTOL B-PSYCHOL, V64, P24, DOI 10.1093/geronb/gbn024
   Cohen-Woods S, 2013, PSYCHOL MED, V43, P673, DOI 10.1017/S0033291712001286
   Cole MG, 2008, AM J GERIAT PSYCHIAT, V16, P435, DOI 10.1097/JGP.0b013e318162f174
   CONWELL Y, 1993, J AM GERIATR SOC, V41, P38, DOI 10.1111/j.1532-5415.1993.tb05945.x
   Costafreda SG, 2013, J AFFECT DISORDERS, V150, P96, DOI 10.1016/j.jad.2013.02.028
   de Craen AJM, 2003, INT J GERIATR PSYCH, V18, P63, DOI 10.1002/gps.773
   Devanand DP, 2002, AM J GERIAT PSYCHIAT, V10, P265
   Diniz BS, 2014, DEPRESS ANXIETY, V31, P787, DOI 10.1002/da.22226
   Djernes JK, 2006, ACTA PSYCHIAT SCAND, V113, P372, DOI 10.1111/j.1600-0447.2006.00770.x
   Eley TC, 2004, MOL PSYCHIATR, V9, P908, DOI 10.1038/sj.mp.4001546
   Fabbri C, 2014, CAN J PSYCHIAT, V59, P62
   Favaro A, 2014, PSYCHIAT RES-NEUROIM, V223, P157, DOI 10.1016/j.pscychresns.2014.05.006
   Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621
   Furlong RA, 1998, AM J MED GENET, V81, P58, DOI 10.1002/(SICI)1096-8628(19980207)81:1<58::AID-AJMG11>3.0.CO;2-V
   Grabe HJ, 2005, MOL PSYCHIATR, V10, P220, DOI 10.1038/sj.mp.4001555
   Guaita A, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-98
   Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146
   Heils A, 1996, J NEUROCHEM, V66, P2621
   Hoehe MR, 1998, AM J MED GENET, V81, P1, DOI 10.1002/(SICI)1096-8628(19980207)81:1<1::AID-AJMG1>3.0.CO;2-2
   Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850
   Janzing JGE, 2002, INT J GERIATR PSYCH, V17, P1, DOI 10.1002/gps.526
   KENDLER KS, 1995, AM J PSYCHIAT, V152, P833
   Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191
   Kim JM, 2007, BIOL PSYCHIAT, V62, P423, DOI 10.1016/j.biopsych.2006.11.020
   Knight BG, 2007, AGING MENT HEALTH, V11, P538, DOI 10.1080/13607860601086561
   Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001
   Luijendijk HJ, 2008, ARCH GEN PSYCHIAT, V65, P1394, DOI 10.1001/archpsyc.65.12.1394
   Luppa M, 2012, J AFFECT DISORDERS, V136, P212, DOI 10.1016/j.jad.2010.11.033
   Luppa M, 2013, INT PSYCHOGERIATR, V25, P292, DOI 10.1017/S1041610212001688
   Mast BT, 2008, BIOL PSYCHIAT, V64, P320, DOI 10.1016/j.biopsych.2008.01.025
   Mazure CM, 2002, AM J GERIAT PSYCHIAT, V10, P297, DOI 10.1176/appi.ajgp.10.3.297
   McHugh RK, 2010, DRUG ALCOHOL DEPEN, V108, P1, DOI 10.1016/j.drugalcdep.2009.11.017
   Mendlewicz J, 2004, EUR J HUM GENET, V12, P377, DOI 10.1038/sj.ejhg.5201149
   Mezuk B, 2012, INT J GERIATR PSYCH, V27, P879, DOI 10.1002/gps.2807
   Narasimhan S, 2012, PHARMACOGENOMICS, V13, P441, DOI [10.2217/PGS.12.1, 10.2217/pgs.12.1]
   Nolen-Hoeksema S, 2002, PSYCHOL AGING, V17, P116, DOI 10.1037//0882-7974.17.1.116
   Ornstein K, 2014, INT J AGING HUM DEV, V78, P133, DOI 10.2190/AG.78.2.c
   Parker GB, 2015, J AFFECT DISORDERS, V182, P91, DOI 10.1016/j.jad.2015.04.041
   Peerenboom L, 2015, J AFFECT DISORDERS, V182, P26, DOI 10.1016/j.jad.2015.04.033
   Polito L, 2015, J SLEEP RES, V24, P215, DOI 10.1111/jsr.12248
   Power T, 2010, NEUROBIOL AGING, V31, P886, DOI 10.1016/j.neurobiolaging.2008.06.006
   Regan CO, 2013, INT J GERIATR PSYCH, V28, P1280, DOI 10.1002/gps.3955
   Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803
   Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878
   Schwarzbach M, 2014, INT J GERIATR PSYCH, V29, P1, DOI 10.1002/gps.3971
   SHEIKH J I, 1986, Clinical Gerontologist, V5, P165
   Sobocki P, 2006, J MENT HEALTH POLICY, V9, P87
   Starkstein SE, 2008, INT REV PSYCHIATR, V20, P382, DOI 10.1080/09540260802094480
   Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21
   Surtees PG, 2006, BIOL PSYCHIAT, V59, P224, DOI 10.1016/j.biopsych.2005.07.014
   Wancata J, 2006, ACTA PSYCHIAT SCAND, V114, P398, DOI 10.1111/j.1600-0447.2006.00888.x
   Way BM, 2010, PSYCHOSOM MED, V72, P107, DOI 10.1097/PSY.0b013e3181ce6a7d
   Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789
   Whitbourne SK, 2011, HDB PSYCHOL AGING, P311, DOI DOI 10.1016/B978-0-12-380882-0.00020-6
   Yan XY, 2011, J INT MED RES, V39, P1142, DOI 10.1177/147323001103900402
   Zalsman G, 2006, AM J PSYCHIAT, V163, P1588, DOI 10.1176/appi.ajp.163.9.1588
NR 70
TC 1
Z9 1
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 23
PY 2015
VL 10
IS 11
AR e0143395
DI 10.1371/journal.pone.0143395
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CX7AW
UT WOS:000365853900107
PM 26598970
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Heininga, VE
   Oldehinkel, AJ
   Veenstra, R
   Nederhof, E
AF Heininga, Vera E.
   Oldehinkel, Albertine J.
   Veenstra, Rene
   Nederhof, Esther
TI I Just Ran a Thousand Analyses: Benefits of Multiple Testing in
   Understanding Equivocal Evidence on Gene-Environment Interactions
SO PLOS ONE
LA English
DT Article
ID SEROTONIN TRANSPORTER GENE; STRESSFUL LIFE EVENTS; 5-HTTLPR GENOTYPE;
   SENSITIVE PERIODS; DEPRESSION; POLYMORPHISM; MODERATION; ADVERSITY;
   METAANALYSIS; REPLICATION
AB Background
   In psychiatric genetics research, the volume of ambivalent findings on gene-environment interactions (G x E) is growing at an accelerating pace. In response to the surging suspicions of systematic distortion, we challenge the notion of chance capitalization as a possible contributor. Beyond qualifying multiple testing as a mere methodological issue that, if uncorrected, leads to chance capitalization, we advance towards illustrating the potential benefits of multiple tests in understanding equivocal evidence in genetics literature.
   Method
   We focused on the interaction between the serotonin-transporter-linked promotor region (5-HTTLPR) and childhood adversities with regard to depression. After testing 2160 interactions with all relevant measures available within the Dutch population study of adolescents TRAILS, we calculated percentages of significant (p < .05) effects for several subsets of regressions. Using chance capitalization (i.e. overall significance rate of 5% alpha and randomly distributed findings) as a competing hypothesis, we expected more significant effects in the subsets of regressions involving: 1) interview-based instead of questionnaire-based measures; 2) abuse instead of milder childhood adversities; and 3) early instead of later adversities. Furthermore, we expected equal significance percentages across 4) male and female subsamples, and 5) various genotypic models of 5-HTTLPR.
   Results
   We found differences in the percentages of significant interactions among the subsets of analyses, including those regarding sex-specific subsamples and genetic modeling, but often in unexpected directions. Overall, the percentage of significant interactions was 7.9% which is only slightly above the 5% that might be expected based on chance.
   Conclusion
   Taken together, multiple testing provides a novel approach to better understand equivocal evidence on G x E, showing that methodological differences across studies are a likely reason for heterogeneity in findings - but chance capitalization is at least equally plausible.
C1 [Heininga, Vera E.; Oldehinkel, Albertine J.; Nederhof, Esther] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.
   [Veenstra, Rene] Univ Groningen, Dept Sociol, Groningen, Netherlands.
RP Heininga, VE (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.
EM v.e.heininga@umcg.nl
RI Veenstra, Rene/G-6696-2011
OI Veenstra, Rene/0000-0001-6686-6307; Heininga, Vera/0000-0003-0889-8524
FU VICI grant from the Netherlands Organization for Scientific Research
   [NWO Vici 016.001/002]; Netherlands Organization for Scientific Research
   NWO (Medical Research Council) [GB-MW 940-38-011]; Netherlands
   Organization for Scientific Research NWO (ZonMW Brainpower grant)
   [100-001-004]; Netherlands Organization for Scientific Research NWO
   (ZonMw Risk Behaviour and Dependence grants) [60-60600-97-118];
   Netherlands Organization for Scientific Research NWO (ZonMw Culture and
   Health grant) [261-98-710]; Netherlands Organization for Scientific
   Research NWO (Social Sciences Council medium-sized investment grants)
   [GB-MaGW 480-01-006, GB-MaGW 480-07-001]; Netherlands Organization for
   Scientific Research NWO (Social Sciences Council project) [GB-MaGW
   452-04-314, GB-MaGW 452-06-004]; Netherlands Organization for Scientific
   Research NWO (NWO large-sized investment grant) [175.010.2003.005];
   Netherlands Organization for Scientific Research NWO (NWO Longitudinal
   Survey and Panel Funding) [481-08-013]; Dutch Ministry of Justice
   (WODC); European Science Foundation (EuroSTRESS project) [FP-006];
   Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL
   [CP 32]; Accare Center for Child and Adolescent Psychiatry
FX This research was made possible by a VICI grant from the Netherlands
   Organization for Scientific Research (NWO Vici 016.001/002) to Dr.
   Oldehinkel. The data used were collected as part of the TRacking
   Adolescents' Individual Lives Survey (TRAILS). Participating centers of
   TRAILS include various departments of the University Medical Center and
   University of Groningen, the Erasmus University Medical Center
   Rotterdam, the University of Utrecht, the Radboud Medical Center
   Nijmegen, and the Parnassia Bavo group, all in the Netherlands. TRAILS
   has been financially supported by various grants from the Netherlands
   Organization for Scientific Research NWO (Medical Research Council
   program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004;
   ZonMw Risk Behaviour and Dependence grants 60-60600-97-118; ZonMw
   Culture and Health grant 261-98-710; Social Sciences Council
   medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW
   480-07-001; Social Sciences Council project grants GB-MaGW 452-04-314
   and GB-MaGW 452-06-004; NWO large-sized investment grant
   175.010.2003.005; NWO Longitudinal Survey and Panel Funding 481-08-013),
   the Dutch Ministry of Justice (WODC), the European Science Foundation
   (EuroSTRESS project FP-006), Biobanking and Biomolecular Resources
   Research Infrastructure BBMRI-NL (CP 32), the participating
   universities, and Accare Center for Child and Adolescent Psychiatry.
CR Achenbach TM, 2003, J CLIN CHILD ADOLESC, V32, P328, DOI 10.1207/S15374424JCCP3203_02
   Achenbach TM, 2001, MANUAL ASEBA SCH AGE, DOI [10.1007/s00127-013-0685-z, DOI 10.1007/S00127-013-0685-Z]
   *AM PSYCHIAT ASS, 2000, DIAGN STAT MAN MENT
   Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004
   Bernstein D, 1998, CHILDHOOD TRAUMA QUE
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8
   de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6
   Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191
   Eaves LJ, 2006, TWIN RES HUM GENET, V9, P1, DOI 10.1375/183242706776403073
   Fergusson DM, 2011, BRIT J PSYCHIAT, V198, P129, DOI 10.1192/bjp.bp.110.085993
   Flint J, 2013, CURR OPIN NEUROBIOL, V23, P57, DOI 10.1016/j.conb.2012.07.005
   Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196
   Heim C, 2012, EXP NEUROL, V233, P102, DOI 10.1016/j.expneurol.2011.10.032
   Homberg JR, 2012, PROG NEUROBIOL, V99, P117, DOI 10.1016/j.pneurobio.2012.08.003
   Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850
   IBM Corp, 2012, IBM SPSS STAT WIND V
   Ioannidis JPA, 2014, TRENDS COGN SCI, V18, P235, DOI 10.1016/j.tics.2014.02.010
   Ioannidis JPA, 2007, PLOS MED, V4, P1132, DOI 10.1371/journal.pmed.0040215
   Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749
   Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189
   Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168
   Kessler RC, 2009, INT J METH PSYCH RES, V18, P69, DOI 10.1002/mpr.279
   Laucht M, 2009, INT J NEUROPSYCHOPH, V12, P737, DOI 10.1017/S1461145708009875
   Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639
   Markus CR, 2013, PSYCHIAT GENET, V23, P108, DOI 10.1097/YPG.0b013e32835fe3e1
   Martel MM, 2013, PSYCHOL BULL, V139, P1221, DOI 10.1037/a0032247
   Martin J, 2007, MOL PSYCHIATR, V12, P421, DOI 10.1038/sj.mp.4001952
   McEwen BS, 2000, BIOL PSYCHIAT, V48, P721, DOI 10.1016/S0006-3223(00)00964-1
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Monroe SM, 2008, ANNU REV CLIN PSYCHO, V4, P33, DOI 10.1146/annurev.clinpsy.4.022007.141207
   Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016
   Munafo MR, 2009, INT J NEUROPSYCHOPH, V12, P727, DOI 10.1017/S1461145709000479
   Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009
   Nederhof E, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-93
   Nederhof E, 2010, BIOL PSYCHIAT, V68, P209, DOI 10.1016/j.biopsych.2010.04.006
   Ormel J, 2012, J AM ACAD CHILD PSY, V51, P1020, DOI 10.1016/j.jaac.2012.08.004
   Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878
   Roisman GI, 2012, DEV PSYCHOPATHOL, V24, P389, DOI 10.1017/S0954579412000065
   Sheikh HI, 2008, PERS INDIV DIFFER, V45, P425, DOI 10.1016/j.paid.2008.05.020
   Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632
   Sullivan PF, 2007, BIOL PSYCHIAT, V61, P1121, DOI 10.1016/j.biopsych.2006.11.010
   Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067
   Uher R, 2010, MOL PSYCHIATR, V15, P18, DOI 10.1038/mp.2009.123
   Williams RB, 2003, NEUROPSYCHOPHARMACOL, V28, P533, DOI 10.1038/sj.npp.1300054
   Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201
   Zalsman G, 2010, EUR PSYCHIAT, V25, P284, DOI 10.1016/j.eurpsy.2010.01.007
NR 48
TC 8
Z9 8
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 27
PY 2015
VL 10
IS 5
AR e0125383
DI 10.1371/journal.pone.0125383
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CJ0RO
UT WOS:000355185600020
PM 26016887
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Chen, J
   Kang, Q
   Jiang, WH
   Fan, J
   Zhang, MD
   Yu, SY
   Zhang, C
AF Chen, Jue
   Kang, Qing
   Jiang, Wenhui
   Fan, Juan
   Zhang, Mingdao
   Yu, Shunying
   Zhang, Chen
TI The 5-HTTLPR Confers Susceptibility to Anorexia Nervosa in Han Chinese:
   Evidence from a Case-Control and Family-Based Study
SO PLOS ONE
LA English
DT Article
ID SEROTONIN TRANSPORTER GENE; LINKED POLYMORPHIC REGION; EATING-DISORDERS;
   RISK-FACTORS; PSYCHOPATHOLOGICAL TRAITS; BULIMIA-NERVOSA; ASSOCIATION;
   SCHIZOPHRENIA; DEPRESSION; SYMPTOMS
AB Accumulating evidence has implied that serotonin system dysfunction may be involved in the etiology of anorexia nervosa (AN). Serotonin-transporter-linked promoter region (5-HTTLPR) polymorphism is the genetic variant coding for the serotonin transporter and has a modulatory effect on its expression. This study aimed to investigate the possible association between the 5-HTTLPR and the susceptibility and severity of AN in Han Chinese using a case-control (255 patients and 351 controls) and family based study (198 trios). Eating disorder examination was used to measure the severity of AN behavioral symptoms. For the case-control study, the 5-HTTLPR showed significant association with AN in our sample (genotypic P = 0.03). The frequency of S allele was significantly higher in patients than that in controls (OR = 1.38, 95% CI: 1.06-1.79, P = 0.017). For the family-based study, the S allele of 5-HTTLPR was preferentially transmitted rather than non-transmitted from the parents to affected offspring (P = 0.013). The results of ANCOVA test revealed no significant association between the 5-HTTLPR polymorphism and severity of AN. Our findings suggested that 5-HTTLPR is able to confer susceptibility to AN in Han Chinese.
C1 [Chen, Jue; Kang, Qing; Jiang, Wenhui; Fan, Juan; Zhang, Mingdao; Yu, Shunying; Zhang, Chen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China.
RP Yu, SY (reprint author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China.
EM yushuny@yahoo.com; zhangchen645@gmail.com
FU National Natural Science Foundation of China [81201055]; National Key
   Clinical Disciplines at Shanghai Mental Health Center [OMA-MH2011-873]
FX This work was supported by the National Natural Science Foundation of
   China (81201055) and the National Key Clinical Disciplines at Shanghai
   Mental Health Center (OMA-MH2011-873).
CR Aberg KA, 2013, JAMA PSYCHIAT, V70, P573, DOI 10.1001/jamapsychiatry.2013.288
   Antypa N, 2013, EUR NEUROPSYCHOPHARM, V23, P1125, DOI 10.1016/j.euroneuro.2013.03.013
   Bailer UF, 2007, PSYCHOPHARMACOLOGY, V195, P315, DOI 10.1007/s00213-007-0896-7
   Blaya C, 2010, NEUROSCI LETT, V485, P11, DOI 10.1016/j.neulet.2010.08.042
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Castellini G, 2012, AM J MED GENET B, V159B, P491, DOI 10.1002/ajmg.b.32052
   Denys D, 2006, J AFFECT DISORDERS, V91, P39, DOI 10.1016/j.jad.2005.12.01
   Di Bella D, 2000, MOL PSYCHIATR, V5, P233, DOI 10.1038/sj.mp.4000689
   Fairburn CG, 1999, ARCH GEN PSYCHIAT, V56, P468, DOI 10.1001/archpsyc.56.5.468
   Favaro A, 2014, PSYCHIAT RES-NEUROIM, V223, P157, DOI 10.1016/j.pscychresns.2014.05.006
   Fuglset TS, 2015, NEUROCASE, V21, P169, DOI 10.1080/13554794.2013.878728
   Fumeron F, 2001, MOL PSYCHIATR, V6, P9, DOI 10.1038/sj.mp.4000824
   Gadow KD, 2013, PROG NEURO-PSYCHOPH, V40, P292, DOI 10.1016/j.pnpbp.2012.10.019
   Gauthier C, 2014, PSYCHONEUROENDOCRINO, V39, P170, DOI 10.1016/j.psyneuen.2013.09.009
   Gervasini G, 2013, J CLIN PSYCHOPHARM, V33, P551, DOI 10.1097/JCP.0b013e3182970469
   Gervasini G, 2012, J CLIN PSYCHOPHARM, V32, P426, DOI 10.1097/JCP.0b013e3182539f2b
   Giordano GD, 2001, J ENDOCRINOL INVEST, V24, P510, DOI 10.1007/BF03343884
   Godart NT, 2007, J AFFECT DISORDERS, V97, P37, DOI 10.1016/j.jad.2006.06.023
   Grilo CM, 2004, INT J EAT DISORDER, V35, P80, DOI 10.1002/eat.10238
   Heils A, 1996, J NEUROCHEM, V66, P2621
   Hinney A, 1997, LIFE SCI, V61, pPL295, DOI 10.1016/S0024-3205(97)00888-6
   Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8
   Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682
   Klump KL, 2005, INT J EAT DISORDER, V37, pS43, DOI 10.1002/eat.20116
   Kotte A, 2013, AM J MED GENET B, V162, P718, DOI 10.1002/ajmg.b.32171
   Lauzurica N, 2003, NEUROSCI LETT, V352, P226, DOI 10.1016/S0304-3940(03)01066-8
   Lee Y, 2010, INT J EAT DISORDER, V43, P498, DOI 10.1002/eat.20732
   Li Q, 2006, MOL NEUROBIOL, V34, P51, DOI 10.1385/MN:34:1:51
   Lohoff FW, 2013, PHARMACOGENOMICS J, V13, P464, DOI 10.1038/tpj.2012.33
   Lonsdorf TB, 2009, PROG NEURO-PSYCHOPH, V33, P1479, DOI 10.1016/j.pnpbp.2009.08.004
   Mainz V, 2012, PSYCHOSOM MED, V74, P574, DOI 10.1097/PSY.0b013e31824ef10e
   Matsushita S, 2004, AM J MED GENET B, V128B, P114, DOI 10.1002/ajmg.b.30022
   Mehta D, 2012, J AFFECT DISORDERS, V136, P1192, DOI 10.1016/j.jad.2011.11.042
   Monteleone P, 2008, PHARMACOGENOMICS, V9, P1487, DOI 10.2217/14622416.9.10.1487
   Nisoli E, 2007, EAT WEIGHT DISORD-ST, V12, P91, DOI 10.1007/BF03327583
   Pike KM, 2008, PSYCHOL MED, V38, P1443, DOI 10.1017/S0033291707002310
   Ricca V, 2004, NEUROSCI LETT, V365, P92, DOI 10.1016/j.neulet.2004.04.057
   Rizvi SL, 2000, INT J EAT DISORDER, V28, P311, DOI 10.1002/1098-108X(200011)28:3<311::AID-EAT8>3.0.CO;2-K
   Rybakowski F, 2006, NEUROPSYCHOBIOLOGY, V53, P33, DOI 10.1159/000090701
   Saiz PA, 2007, PROG NEURO-PSYCHOPH, V31, P741, DOI 10.1016/j.pnpbp.2007.01.012
   Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272
   Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240
   Sundaramurthy D, 2000, AM J MED GENET, V96, P53, DOI 10.1002/(SICI)1096-8628(20000207)96:1<53::AID-AJMG11>3.3.CO;2-O
   Wankerl M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.37
   Xu J, 2013, LUPUS, V22, P1001, DOI 10.1177/0961203313498793
   Zhang C, 2014, AM J MED GENET B, V165, P564, DOI 10.1002/ajmg.b.32259
   Zhang C, 2014, PROG NEURO-PSYCHOPH, V50, P110, DOI 10.1016/j.pnpbp.2013.12.010
   Zhang C, 2009, NEUROSCI LETT, V462, P308, DOI 10.1016/j.neulet.2009.06.085
NR 48
TC 3
Z9 4
U1 1
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 18
PY 2015
VL 10
IS 3
AR UNSP e0119378
DI 10.1371/journal.pone.0119378
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE9BN
UT WOS:000352138500100
PM 25785698
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Nomura, M
   Kaneko, M
   Okuma, Y
   Nomura, J
   Kusumi, I
   Koyama, T
   Nomura, Y
AF Nomura, Michio
   Kaneko, Masayuki
   Okuma, Yasunobu
   Nomura, Jun
   Kusumi, Ichiro
   Koyama, Tsukasa
   Nomura, Yasuyuki
TI Involvement of Serotonin Transporter Gene Polymorphisms (5-HTT) in
   Impulsive Behavior in the Japanese Population
SO PLOS ONE
LA English
DT Article
ID TRYPTOPHAN DEPLETION; RESPONSE-INHIBITION; PREFRONTAL CORTEX; REGULATORY
   REGION; PROMOTER POLYMORPHISM; PROLACTIN RESPONSE; EMOTION REGULATION;
   HUMAN AMYGDALA; ASSOCIATION; INDIVIDUALS
AB The serotonergic pathway has been implicated in the pathogenesis of impulsivity, and sensitivity to aversive outcomes may be linked to serotonin (5-HT) levels. Polymorphisms in the gene that encodes the serotonin transporter (5-HTT), which have differential effects on the level of serotonin transmission, display alternate responses to aversive stimuli. However, recent studies have shown that 5-HT does not affect motor function, which suggests that the functioning of the serotonin-transporter-linked polymorphic region (5-HTTLPR) does not directly affect the behavioral regulatory process itself, but instead exerts an effect via the evaluation of the potential risk associated with particular behavioral outputs. The aim of the present study was to examine the effect of specific 5-HTTLPR genotypes on the motor regulatory process, as observed during a Go/Nogo punishment feedback task. 5-HTT gene-linked promoter polymorphisms were analyzed by polymerase chain reaction, using lymphocytes from 61 healthy Japanese volunteers. Impulsivity was defined as the number of commission errors (responding when one should not) made during a Go/Nogo task. We found that the s/s genotype group made fewer impulsive responses, specifically under aversive conditions for committing such errors, compared to those in the s/l group, without affecting overall motor inhibition. These results suggest that 5-HTTLPRs do not directly affect the behavioral regulatory process itself, but may instead exert an effect on the evaluation of potential risk. The results also indicate that under such aversive conditions, decreased expression of 5-HTT may promote motor inhibitory control.
C1 [Nomura, Michio] Kyoto Univ, Grad Sch Educ, Sakyo Ku, Kyoto, Japan.
   [Kaneko, Masayuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Biochem, Minami Ku, Hiroshima, Japan.
   [Okuma, Yasunobu] Chiba Inst Sci, Fac Pharmaceut Sci, Dept Pharmacol, Choshi, Japan.
   [Nomura, Jun] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Biomed Res, Minami Ku, Hiroshima, Japan.
   [Kusumi, Ichiro; Koyama, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan.
   [Nomura, Yasuyuki] Kurume Univ, Sch Med, Dept Pharmacol, Kurume, Fukuoka 830, Japan.
RP Nomura, M (reprint author), Kyoto Univ, Grad Sch Educ, Sakyo Ku, Kyoto, Japan.
EM nomura.michio.8u@kyoto-u.ac.jp
RI Kaneko, Masayuki/F-9302-2011; Nomura, Jun/C-2411-2011
OI Kaneko, Masayuki/0000-0002-0477-0171; 
FU Japan Society for the Promotion of Science [23500329]
FX This work was supported by grants from the Japan Society for the
   Promotion of Science (23500329). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR American Psychiatric Association, 1994, DIAGN STAT MAN MEN D
   Armony JL, 1997, TRENDS COGN SCI, V1, P28, DOI 10.1016/S1364-6613(97)01007-3
   Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004
   BARRATT ES, 1994, VIOLENCE MENTAL DISO
   Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964
   Canli T, 2006, P NATL ACAD SCI USA, V103, P16033, DOI 10.1073/pnas.0601674103
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Chiao JY, 2010, P R SOC B, V277, P529, DOI 10.1098/rspb.2009.1650
   Clark L, 2005, PSYCHOPHARMACOLOGY, V182, P570, DOI 10.1007/s00213-005-0104-6
   Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.01
   Crockett MJ, 2009, J NEUROSCI, V29, P11993, DOI 10.1523/JNEUROSCI.2513-09.2009
   Cyders MA, 2007, PSYCHOL ASSESSMENT, V19, P107, DOI 10.1037/1040-3590.19.1.107
   Daruna J. H., 1993, IMPULSIVE CLIENT THE
   Fallgatter AJ, 1999, INT J NEUROPSYCHOP, V2, P115, DOI 10.1017/S1461145799001455
   Flint J, 2013, CURR OPIN NEUROBIOL, V23, P57, DOI 10.1016/j.conb.2012.07.005
   Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037//0003-066X.56.3.218
   Gelernter J, 1997, HUM GENET, V101, P243, DOI 10.1007/s004390050624
   Gelfand MJ, 1998, 25 ANN C INT ASS CRO
   Hare TA, 2005, BIOL PSYCHIAT, V57, P624, DOI 10.1016/j.biopsych.2004.12.038
   Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829
   Hart S. D., 1997, IMPULSIVITY THEORY A, P212
   Homberg JR, 2010, BIOL PSYCHIAT, V15, P513
   Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850
   ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037//0022-3514.52.6.1122
   Jasinska AJ, 2009, J NEUROSCI, V29, P10461, DOI 10.1523/JNEUROSCI.2774-09.2009
   Jennings KA, 2006, J NEUROSCI, V26, P8955, DOI 10.1523/JNEUROSCI.5356-05.2006
   Kaufman J, 2004, P NATL ACAD SCI USA, V101, P17316, DOI 10.1073/pnas.0404376101
   KINDLON D, 1995, J CHILD PSYCHOL PSYC, V36, P645, DOI 10.1111/j.1469-7610.1995.tb02319.x
   Kumakiri C, 1999, NEUROSCI LETT, V263, P205, DOI 10.1016/S0304-3940(99)00098-1
   Lee BT, 2008, GENES BRAIN BEHAV, V7, P899, DOI 10.1111/j.1601-183X.2008.00429.x
   LeMarquand DG, 1998, NEUROPSYCHOPHARMACOL, V19, P333
   LeMarquand DG, 1999, AM J PSYCHIAT, V156, P1771
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037//0033-295X.98.2.224
   Masui K, 2009, PSYCHOLOGIA, V52, P137, DOI 10.2117/psysoc.2009.137
   McMurran M, 2002, AGGRESSIVE BEHAV, V28, P439, DOI 10.1002/ab.80017
   Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068
   Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976
   Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016
   Murphy SE, 2013, MOL PSYCHIATR, V18, P512, DOI 10.1038/mp.2012.19
   Newman JP, 1997, PERS INDIV DIFFER, V23, P583, DOI 10.1016/S0191-8869(97)00078-0
   NEWMAN JP, 1990, PERS INDIV DIFFER, V11, P1101, DOI 10.1016/0191-8869(90)90021-I
   Nomura M, 2004, NEUROIMAGE, V21, P352, DOI 10.1016/j.neuroimage.2003.09.021
   Nomura M, 2006, PSYCHOPHARMACOLOGY, V187, P30, DOI 10.1007/s00213-006-0398-z
   Osinsky R, 2008, EMOTION, V8, P584, DOI 10.1037/a0012826
   Pener-Tessler R, 2013, DEV PSYCHOPATHOL, V25, P151, DOI 10.1017/S095457941200096X
   PLUTCHIK R, 1995, IMPULSIVITY AGGRESSI, P7
   Rao HY, 2007, BIOL PSYCHIAT, V62, P600, DOI 10.1016/j.biopsych.2006.11.028
   Reist C, 2001, AM J MED GENET, V105, P363, DOI 10.1002/ajmg.1360
   Rodriguez-Fornells A, 2002, PERS INDIV DIFFER, V32, P661, DOI 10.1016/S0191-8869(01)00068-X
   Sagaspe P, 2011, NEUROIMAGE, V55, P1825, DOI 10.1016/j.neuroimage.2011.01.027
   Sebastian A, 2013, NEUROIMAGE, V64, P601, DOI 10.1016/j.neuroimage.2012.09.020
   Smeraldi E, 1998, MOL PSYCHIATR, V3, P508, DOI 10.1038/sj.mp.4000425
   SOUBRIE P, 1986, BEHAV BRAIN SCI, V9, P319, DOI 10.1017/S0140525X00022871
   Triandis HC, 2004, ACAD MANAGE EXEC, V18, P88, DOI 10.5465/AME.2004.12689599
   Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054
   Walderhaug E, 2002, PSYCHOPHARMACOLOGY, V164, P385, DOI 10.1007/s00213-002-1238-4
   Whale R, 2000, PSYCHOPHARMACOLOGY, V150, P120, DOI 10.1007/s002130000432
   Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7
   Yoshida K, 2002, PROG NEURO-PSYCHOPH, V26, P383, DOI 10.1016/S0278-5846(01)00287-1
   Zanardi R, 2000, J CLIN PSYCHOPHARM, V20, P105, DOI 10.1097/00004714-200002000-00021
NR 62
TC 7
Z9 7
U1 0
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 16
PY 2015
VL 10
IS 3
AR e0119743
DI 10.1371/journal.pone.0119743
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CD6EY
UT WOS:000351183500117
PM 25775400
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Juhasz, G
   Gonda, X
   Hullam, G
   Eszlari, N
   Kovacs, D
   Lazary, J
   Pap, D
   Petschner, P
   Elliott, R
   Deakin, JFW
   Anderson, IM
   Antal, P
   Lesch, KP
   Bagdy, G
AF Juhasz, Gabriella
   Gonda, Xenia
   Hullam, Gabor
   Eszlari, Nora
   Kovacs, David
   Lazary, Judit
   Pap, Dorottya
   Petschner, Peter
   Elliott, Rebecca
   Deakin, John Francis William
   Anderson, Ian Muir
   Antal, Peter
   Lesch, Klaus-Peter
   Bagdy, Gyorgy
TI Variability in the Effect of 5-HTTLPR on Depression in a Large European
   Population: The Role of Age, Symptom Profile, Type and Intensity of Life
   Stressors
SO PLOS ONE
LA English
DT Article
ID SEROTONIN TRANSPORTER GENE; S-ALLELE; POLYMORPHISM; ASSOCIATION; EVENTS;
   ANXIETY; METAANALYSIS; NEUROTICISM; HYPOTHESIS; MODERATION
AB Background
   Although 5-HTTLPR has been shown to influence the risk of life stress-induced depression in the majority of studies, others have produced contradictory results, possibly due to weak effects and/or sample heterogeneity.
   Methods
   In the present study we investigated how age, type and intensity of life-stressors modulate the effect of 5-HTTLPR on depression and anxiety in a European population cohort of over 2300 subjects. Recent negative life events (RLE), childhood adversity (CHA), lifetime depression, Brief Symptoms Inventory (BSI) depression and anxiety scores were determined in each subject. Besides traditional statistical analysis we calculated Bayesian effect strength and relevance of 5-HTTLPR genotypes in specified models.
   Results
   The short (s) low expressing allele showed association with increased risk of depression related phenotypes, but all nominally significant effects would turn to non-significant after correction for multiple testing in the traditional analysis. Bayesian effect strength and relevance analysis, however, confirmed the role of 5-HTTLPR. Regarding current (BSI) and lifetime depression 5-HTTLPR-by-RLE interactions were confirmed. Main effect, with other words direct association, was supported with BSI anxiety. With more frequent RLE the prevalence or symptoms of depression increased in ss carriers. Although CHA failed to show an interaction with 5-HTTLPR, in young subjects CHA sensitized towards the depression promoting effect of even mild RLE. Furthermore, the direct association of anxiety with the s allele was driven by young (<= 30) individuals.
   Limitations
   Our study is cross-sectional and applies self-report questionnaires.
   Conclusions
   Albeit 5-HTTLPR has only weak/moderate effects, the s allele is directly associated with anxiety and modulates development of depression in homogeneous subgroups.
C1 [Juhasz, Gabriella; Gonda, Xenia; Eszlari, Nora; Kovacs, David; Pap, Dorottya; Petschner, Peter; Bagdy, Gyorgy] Semmelweis Univ, Fac Pharm, Dept Pharmacodynam, H-1085 Budapest, Hungary.
   [Juhasz, Gabriella; Gonda, Xenia; Hullam, Gabor; Eszlari, Nora; Kovacs, David; Pap, Dorottya; Petschner, Peter; Antal, Peter; Bagdy, Gyorgy] Semmelweis Univ, Hungarian Acad Sci, MTA SE Neuropsychopharmacol & Neurochem Res Grp, Budapest, Hungary.
   [Juhasz, Gabriella; Elliott, Rebecca; Deakin, John Francis William; Anderson, Ian Muir] Univ Manchester, Fac Med & Human Sci, Sch Community Based Med, Neurosci & Psychiat Unit, Manchester, Lancs, England.
   [Juhasz, Gabriella; Elliott, Rebecca; Deakin, John Francis William; Anderson, Ian Muir] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.
   [Gonda, Xenia; Lazary, Judit] Semmelweis Univ, Kutvolgyi Clin Ctr, Dept Clin & Theoret Mental Hlth, H-1085 Budapest, Hungary.
   [Hullam, Gabor; Antal, Peter] Budapest Univ Technol & Econ, Dept Measurement & Informat Syst, Budapest, Hungary.
   [Lesch, Klaus-Peter] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Div Mol Psychiat, Wurzburg, Germany.
   [Lesch, Klaus-Peter] Maastricht Univ, Sch Mental Hlth & Neurosci MHENS, Dept Translat Neurosci, NL-6200 MD Maastricht, Netherlands.
RP Juhasz, G (reprint author), Semmelweis Univ, Fac Pharm, Dept Pharmacodynam, H-1085 Budapest, Hungary.
EM gabriella.juhasz@manchester.ac.uk
RI Petschner, Peter/O-1697-2017; Juhasz, Gabriella/O-1753-2017; Gonda,
   Xenia/B-2713-2008; Lesch, Klaus-Peter/J-4906-2013; Bagdy,
   Gyorgy/O-3893-2017; Antal, Peter/G-7894-2012
OI Petschner, Peter/0000-0002-3198-858X; Juhasz,
   Gabriella/0000-0002-5975-4267; Gonda, Xenia/0000-0001-9015-4203; Lesch,
   Klaus-Peter/0000-0001-8348-153X; Bagdy, Gyorgy/0000-0001-8141-3410;
   Antal, Peter/0000-0002-4370-2198; Elliott, Rebecca/0000-0002-7602-010X;
   Anderson, Ian M/0000-0003-2205-9209; Deakin, John/0000-0002-2750-962X
FU Sixth Framework Program of the European Union, NewMood
   [LSHM-CT-2004-503474]; National Institute for Health Research Manchester
   Biomedical Research Centre; Hungarian Brain Research Program
   [KTIA_13_NAP-A-II/14]; National Development Agency
   [KTIA_NAP_13-1-2013-0001]; Hungarian Academy of Sciences (MTA-SE
   Neuropsychopharmacology and Neurochemistry Research Group); Hungarian
   Academy of Sciences;  [TAMOP-4.2.1.B-09/1/KMR-2010-0001]
FX The study was supported by the Sixth Framework Program of the European
   Union, NewMood, LSHM-CT-2004-503474; by the National Institute for
   Health Research Manchester Biomedical Research Centre; the
   TAMOP-4.2.1.B-09/1/KMR-2010-0001; by the Hungarian Brain Research
   Program (Grant KTIA_13_NAP-A-II/14) and National Development Agency
   (Grant KTIA_NAP_13-1-2013-0001); the Hungarian Academy of Sciences
   (MTA-SE Neuropsychopharmacology and Neurochemistry Research Group). Dr.
   Gonda is a recipient of the Bolyai Scholarship of the Hungarian Academy
   of Sciences. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Antal P, 2006, P 3 EUR WORKSH PROB, P9
   Bagdy Gyorgy, 2013, Expert Opin Med Diagn, V7, P417, DOI 10.1517/17530059.2013.821979
   Bagdy Gyorgy, 2012, Neuropsychopharmacol Hung, V14, P213
   Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949
   BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132
   Brown GW, 2008, J AFFECT DISORDERS, V111, P1, DOI 10.1016/j.jad.2008.04.009
   BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X
   Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Champoux M, 2002, MOL PSYCHIATR, V7, P1058, DOI 10.1038/sj.mp.4001157
   Collier DA, 1996, MOL PSYCHIATR, V1, P453
   Culverhouse RC, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-304
   Derogatis LR, 1993, BSI BRIEF SYMPTOM IN
   Drabant EM, 2012, AM J PSYCHIAT, V169, P397, DOI 10.1176/appi.ajp.2011.10111699
   First MB, 2002, STRUCTURED CLIN INTE
   Flint J, 2014, NEURON, V81, P484, DOI 10.1016/j.neuron.2014.01.027
   Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738
   Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068
   Gonda X, 2007, PSYCHIAT RES, V149, P261, DOI 10.1016/j.psychres.2006.05.014
   Gonda X, 2009, EUR ARCH PSY CLIN N, V259, P106, DOI 10.1007/s00406-008-0842-7
   Hoeting JA, 1999, STAT SCI, V14, P382
   Hullam Gabor, 2012, Neuropsychopharmacol Hung, V14, P273
   Juhasz G, 2011, BIOL PSYCHIAT, V69, P762, DOI 10.1016/j.biopsych.2010.11.019
   Juhasz G, 2009, NEUROPSYCHOPHARMACOL, V34, P2019, DOI 10.1038/npp.2009.19
   Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189
   Kendler KS, 2012, MOL PSYCHIATR, V17, P377, DOI 10.1038/mp.2011.182
   Kirilly E, 2012, ACTA PHYSIOL, V205, P41, DOI 10.1111/j.1748-1716.2012.02402.x
   Lazary J, 2008, BIOL PSYCHIAT, V64, P498, DOI 10.1016/j.biopsych.2008.03.030
   Lazary J, 2011, TRENDS PHARMACOL SCI, V32, P270, DOI 10.1016/j.tips.2011.02.013
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174
   Madigan D, 1996, COMMUN STAT THEORY, V25, P2493, DOI 10.1080/03610929608831853
   McLaughlin KA, 2010, PSYCHOL MED, V40, P1647, DOI 10.1017/S0033291709992121
   MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382
   Murphy DL, 2011, CURR OPIN PHARMACOL, V11, P3, DOI 10.1016/j.coph.2011.02.008
   Murphy SE, 2013, MOL PSYCHIATR, V18, P512, DOI 10.1038/mp.2012.19
   Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878
   SNAITH RP, 1982, BRIT J PSYCHIAT, V141, P518, DOI 10.1192/bjp.141.5.518
   Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615
   Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21
   Team RC, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]
   Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764
   Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067
   Uher R, 2011, J AFFECT DISORDERS, V135, P56, DOI 10.1016/j.jad.2011.03.010
NR 45
TC 16
Z9 16
U1 1
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 6
PY 2015
VL 10
IS 3
AR e0116316
DI 10.1371/journal.pone.0116316
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC9KQ
UT WOS:000350689400004
PM 25747798
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Oathes, DJ
   Hilt, LM
   Nitschke, JB
AF Oathes, Desmond J.
   Hilt, Lori M.
   Nitschke, Jack B.
TI Affective Neural Responses Modulated by Serotonin Transporter Genotype
   in Clinical Anxiety and Depression
SO PLOS ONE
LA English
DT Article
ID MAJOR DEPRESSION; FACIAL EXPRESSIONS; ANTERIOR CINGULATE; AMYGDALA
   ACTIVITY; GENETIC-VARIATION; PROMOTER REGION; SOCIAL PHOBIA; DISORDER;
   ACTIVATION; BRAIN
AB Serotonin transporter gene variants are known to interact with stressful life experiences to increase chances of developing affective symptoms, and these same variants have been shown to influence amygdala reactivity to affective stimuli in non-psychiatric populations. The impact of these gene variants on affective neurocircuitry in anxiety and mood disorders has been studied less extensively. Utilizing a triallelic assay (5-HTTLPR and rs25531) to assess genetic variation linked with altered serotonin signaling, this fMRI study investigated genetic influences on amygdala and anterior insula activity in 50 generalized anxiety disorder patients, 26 of whom also met DSM-IV criteria for social anxiety disorder and/or major depressive disorder, and 39 healthy comparison subjects. A Group x Genotype interaction was observed for both the amygdala and anterior insula in a paradigm designed to elicit responses in these brain areas during the anticipation of and response to aversive pictures. Patients who are S/L-G carriers showed less activity than their L-A/L-A counterparts in both regions and less activity than S/L-G healthy comparison subjects in the amygdala. Moreover, patients with greater insula responses reported higher levels of intolerance of uncertainty, an association that was particularly pronounced for patients with two L-A alleles. A genotype effect was not established in healthy controls. These findings link the serotonin transporter gene to affective circuitry findings in anxiety and depression psychopathology and further suggest that its impact on patients may be different from effects typically observed in healthy populations.
C1 [Oathes, Desmond J.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.
   [Hilt, Lori M.] Lawrence Univ, Dept Psychol, Appleton, WI 54912 USA.
   [Nitschke, Jack B.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA.
   [Nitschke, Jack B.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA.
RP Oathes, DJ (reprint author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.
EM desmond.oathes@gmail.com
OI Oathes, Desmond/0000-0001-7346-2669
FU National Institute of Mental Health [F32-MH081667, R01-MH74847,
   K02-MH082130, K08-MH63984]; National Institute of Child Health and Human
   Development [P30-HD03352]
FX This work was supported by the National Institute of Mental Health
   [F32-MH081667 to DJO and R01-MH74847, K02-MH082130, and K08-MH63984 to
   JBN]; and by a core grant to the Waisman Center from the National
   Institute of Child Health and Human Development [P30-HD03352]. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Acevedo BP, 2014, BRAIN BEHAV, V4, P580, DOI 10.1002/brb3.242
   Admon R, 2013, TRENDS COGN SCI, V17, P337, DOI 10.1016/j.tics.2013.05.005
   Barlow D. H., 2001, ANXIETY ITS DISORDER
   Bauernfeind AL, 2013, J HUM EVOL, V64, P263, DOI 10.1016/j.jhevol.2012.12.003
   Blair K, 2008, AM J PSYCHIAT, V165, P1193, DOI 10.1176/appi.ajp.2008.07071060
   Buhr K, 2002, BEHAV RES THER, V40, P931, DOI 10.1016/S0005-7967(01)00092-4
   Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475
   Canli T, 2005, P NATL ACAD SCI USA, V102, P12224, DOI 10.1073/pnas.0503880102
   Carleton RN, 2012, J ANXIETY DISORD, V26, P468, DOI 10.1016/j.janxdis.2012.01.011
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x
   Dannlowski U, 2007, GENES BRAIN BEHAV, V6, P672, DOI 10.1111/j.1601-183X.2006.00297.x
   Dannlowski U, 2008, NEUROPSYCHOPHARMACOL, V33, P418, DOI 10.1038/sj.npp.1301411
   Debiec J, 2014, P NATL ACAD SCI USA, V111, P12222, DOI 10.1073/pnas.1316740111
   Domschke K, 2006, INT J NEUROPSYCHOPH, V9, P349, DOI 10.1017/S1461145705005869
   Drabant EM, 2012, AM J PSYCHIAT, V169, P397, DOI 10.1176/appi.ajp.2011.10111699
   Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204
   Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504
   Etkin A, 2010, AM J PSYCHIAT, V167, P545, DOI 10.1176/appi.ajp.2009.09070931
   Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104
   Friedel E, 2009, PSYCHOPHARMACOLOGY, V205, P261, DOI 10.1007/s00213-009-1536-1
   Furmark T, 2004, NEUROSCI LETT, V362, P189, DOI 10.1016/j.neulet.2004.02.070
   Goldin PR, 2009, ARCH GEN PSYCHIAT, V66, P170, DOI 10.1001/archgenpsychiatry.2008.525
   Goldstein AN, 2013, J NEUROSCI, V33, P10607, DOI 10.1523/JNEUROSCI.5578-12.2013
   Grupe DW, 2013, NAT REV NEUROSCI, V14, P488, DOI 10.1038/nrn3524
   Grupe DW, 2013, CEREB CORTEX, V23, P1874, DOI 10.1093/cercor/bhs175
   Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105
   HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56
   HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x
   Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829
   Hedges LV, 1985, STAT METHODS METAANA
   Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850
   Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379
   JACOBS BL, 1992, PHYSIOL REV, V72, P165
   Jezzard P, 1999, HUM BRAIN MAPP, V8, P80, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<80::AID-HBM2>3.0.CO;2-C
   Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107
   Kalin NH, 2008, MOL PSYCHIATR, V13, P1021, DOI 10.1038/mp.2008.37
   Keedwell PA, 2010, J AFFECT DISORDERS, V120, P120, DOI 10.1016/j.jad.2009.04.031
   Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z
   Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8
   Lang P. J., 1999, INT AFFECTIVE PICTUR
   Lau JYF, 2009, BIOL PSYCHIAT, V65, P349, DOI 10.1016/j.biopsych.2008.08.037
   LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155
   Li Q, 2006, MOL NEUROBIOL, V34, P51, DOI 10.1385/MN:34:1:51
   Lim JE, 2006, MOL PSYCHIATR, V11, P649, DOI 10.1038/sj.mp.4001797
   McClure EB, 2007, ARCH GEN PSYCHIAT, V64, P97, DOI 10.1001/archpsyc.64.1.97
   MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6
   Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993
   Monk CS, 2008, AM J PSYCHIAT, V165, P90, DOI 10.1176/appi.ajp.2007.06111917
   Mueller A, 2011, NEUROPSYCHOPHARMACOL, V36, P1332, DOI 10.1038/npp.2011.11
   Murphy SE, 2013, MOL PSYCHIATR, V18, P512, DOI 10.1038/mp.2012.19
   Nemeroff CB, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-202
   Nitschke JB, 2009, AM J PSYCHIAT, V166, P302, DOI 10.1176/appi.ajp.2008.07101682
   Nitschke JB, 2006, NEUROIMAGE, V29, P106, DOI 10.1016/j.neuroimage.2005.06.068
   Nitschke JB, 2001, COGNITIVE THER RES, V25, P1, DOI 10.1023/A:1026485530405
   Parsey RV, 2006, AM J PSYCHIAT, V163, P48, DOI 10.1176/appi.ajp.163.1.48
   Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042
   Pergamin-Hight L, 2012, BIOL PSYCHIAT, V71, P373, DOI 10.1016/j.biopsych.2011.10.030
   Regier DA, 2013, WORLD PSYCHIATRY, V12, P92, DOI 10.1002/wps.20050
   Sarinopoulos I, 2010, CEREB CORTEX, V20, P929, DOI 10.1093/cercor/bhp155
   Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007
   Simmons AN, 2011, HUM BRAIN MAPP, V32, P1836, DOI 10.1002/hbm.21154
   Somerville LH, 2013, CEREB CORTEX, V23, P49, DOI 10.1093/cercor/bhr373
   Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318
   Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789
   Whalen PJ, 2008, BIOL PSYCHIAT, V63, P858, DOI 10.1016/j.biopsych.2007.08.019
   Williams LM, 2009, NEUROIMAGE, V47, P804, DOI 10.1016/j.neuroimage.2009.05.009
NR 67
TC 5
Z9 5
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 12
PY 2015
VL 10
IS 2
AR e0115820
DI 10.1371/journal.pone.0115820
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CB8WX
UT WOS:000349914000005
PM 25675343
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Shimasaki, A
   Kondo, K
   Saito, T
   Esaki, K
   Otsuka, Y
   Mano, K
   Ikeda, M
   Iwata, N
AF Shimasaki, Ayu
   Kondo, Kenji
   Saito, Takeo
   Esaki, Kosei
   Otsuka, Yasuyo
   Mano, Keiko
   Ikeda, Masashi
   Iwata, Nakao
TI A Genetic Variant in 12q13, a Possible Risk Factor for Bipolar Disorder,
   Is Associated with Depressive State, Accounting for Stressful Life
   Events
SO PLOS ONE
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; MAJOR DEPRESSION; METAANALYSIS; 5-HTTLPR;
   POLYMORPHISMS; EPIDEMIOLOGY; ONSET; LOCI
AB Genome-wide association studies (GWASs) have identified a number of susceptibility genes for schizophrenia (SCZ) and bipolar disorder (BD). However, the identification of risk genes for major depressive disorder (MDD) has been unsuccessful because the etiology of MDD is more influenced by environmental factors; thus, gene-environment (G x E) interactions are important, such as interplay with stressful life events (SLEs). We assessed the GxE interactions and main effects of genes targeting depressive symptoms. Using a case-control design, 922 hospital staff members were evaluated for depressive symptoms according to Beck Depressive Inventory (BDI; "depression" and "control" groups were classified by scores of 10 in the BDI test), SLEs, and personality. A total of sixty-three genetic variants were selected on the basis of previous GWASs of MDD, SCZ, and BD as well as candidate-gene (SLC6A4, BDNF, DBH, and FKBP5) studies. Logistic regression analysis revealed a marginally significant interaction (genetic variant x SLE) at rs4523957 (P-uncorrected = 0.0034) with depression and a significant association of single nucleotide polymorphism identified from evidence of BD GWAS (rs7296288, downstream of DHH at 12q13.1) with depression as the main effect (P-uncorrected = 9.4x10(-4), P-corrected = 0.0424). We also found that SLEs had a larger impact on depression (odds ratio similar to 3), as reported previously. These results suggest that DHH plays a possible role in depression etiology; however, variants from MDD or SCZ GWAS evidence or candidate genes showed no significant associations or minimal effects of interactions with SLEs on depression.
C1 [Shimasaki, Ayu; Kondo, Kenji; Saito, Takeo; Esaki, Kosei; Ikeda, Masashi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan.
   [Otsuka, Yasuyo; Mano, Keiko] Fujita Hlth Univ Hosp, Div Nursing, Toyoake, Aichi, Japan.
RP Ikeda, M (reprint author), Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan.
EM ikeda-ma@fujita-hu.ac.jp
FU Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan;
   "Integrated Research on Neuropsychiatric Disorders'' conducted under the
   Strategic Research Program for Brain Sciences; SENSHIN Medical Research
   Foundation, Japan
FX This work is the result of "Integrated Research on Neuropsychiatric
   Disorders'' conducted under the Strategic Research Program for Brain
   Sciences by the Ministry of Education, Culture, Sports, and Technology
   (MEXT) of Japan (Drs. M Ikeda and N Iwata) and the SENSHIN Medical
   Research Foundation, Japan (Dr. M Ikeda). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adachi Y, 2012, BMJ OPEN, P2
   Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151
   Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291
   Boya FO, 2008, IND HEALTH, V46, P613, DOI 10.2486/indhealth.46.613
   Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90
   BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Costa PT, 1992, PROFESSIONAL MANUAL
   Farmer A, 2002, BRIT J PSYCHIAT, V181, P118
   Fried EI, 2014, PSYCHOL MED, V44, P2067, DOI 10.1017/S0033291713002900
   Hosang GM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-7
   Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850
   Kao CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018696
   Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189
   Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009
   Peyrot WJ, 2013, J AFFECT DISORDERS, V146, P91, DOI 10.1016/j.jad.2012.08.044
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Regier DA, 2013, AM J PSYCHIAT, V170, P59, DOI 10.1176/appi.ajp.2012.12070999
   Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742
   Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878
   Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943
   Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1
   Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21
   Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552
   Tao M, 2011, J AFFECT DISORDERS, V135, P95, DOI 10.1016/j.jad.2011.06.054
   Umehara F, 2002, CELL MOL BIOL, V48, P187
   Zannas AS, 2014, GENES BRAIN BEHAV, V13, P25, DOI 10.1111/gbb.12104
   Zimmermann P, 2011, AM J PSYCHIAT, V168, P1107, DOI 10.1176/appi.ajp.2011.10111577
NR 28
TC 7
Z9 7
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 17
PY 2014
VL 9
IS 12
AR e115135
DI 10.1371/journal.pone.0115135
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AX9IA
UT WOS:000347215600043
PM 25517604
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Vrijsen, JN
   Speckens, A
   Arias-Vasquez, A
   Franke, B
   Becker, ES
   van Oostrom, I
AF Vrijsen, Janna N.
   Speckens, Anne
   Arias-Vasquez, Alejandro
   Franke, Barbara
   Becker, Eni S.
   van Oostrom, Iris
TI No Evidence for the Association between a Polymorphism in the PCLO
   Depression Candidate Gene with Memory Bias in Remitted Depressed
   Patients and Healthy Individuals
SO PLOS ONE
LA English
DT Article
ID STRUCTURED CLINICAL INTERVIEW; SEROTONIN TRANSPORTER GENE; GENOME-WIDE
   ASSOCIATION; COGNITIVE VULNERABILITY; MAJOR DEPRESSION; EMOTIONAL FACES;
   LIFE EVENTS; DISORDER; ATTENTION; MOOD
AB The PCLO rs2522833 candidate polymorphism for depression has been associated to monoaminergic neurotransmission. In healthy and currently depressed individuals, the polymorphism has been found to affect activation of brain areas during memory processing, but no direct association of PCLO with memory bias was found. We hypothesized that the absence of this association might have been obscured by current depressive symptoms or genetically driven individual differences in reactivity to stressful events. Experiencing stressful childhood events fosters dysfunctional assumptions that are related to cognitive biases, and may modulate the predisposition for depression via epigenetic effects. The association between PCLO and memory bias, as well as interaction between PCLO and childhood events was studied in patients remitted from depression (N = 299), as well as a sample of healthy individuals (N = 157). The participants performed an emotional verbal memory task after a sad mood induction. Childhood trauma and adversity were measured with a questionnaire. The Genotype main effect, and Genotype by Childhood Events interaction were analyzed for memory bias in both samples. PCLO risk allele carrying remitted depressed patients did not show more negatively biased memory than non-risk allele carriers, not even patients with stressful childhood events. A similar pattern of results was found in healthy individuals. Memory bias may not be strongly associated with the PCLO rs2522833 polymorphism. We did not find any support for the PCLO-childhood events interaction, but the power of our study was insufficient to exclude this possibility.
C1 [Vrijsen, Janna N.; Speckens, Anne; Arias-Vasquez, Alejandro; Franke, Barbara; van Oostrom, Iris] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands.
   [Arias-Vasquez, Alejandro; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.
   [Arias-Vasquez, Alejandro] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands.
   [Arias-Vasquez, Alejandro; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.
   [Becker, Eni S.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.
RP Vrijsen, JN (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands.
EM Janna.Vrijsen@radboudumc.nl
RI Oostrom, I./L-4559-2015; Arias Vasquez, A./L-4175-2015; Franke,
   Barbara/D-4836-2009; Becker, Eni S/A-2668-2010; Vrijsen,
   Janna/L-4736-2015; Arias Vasquez, Alejandro/E-4762-2012; Speckens,
   Anne/H-8093-2014
OI Franke, Barbara/0000-0003-4375-6572; Becker, Eni S/0000-0003-3524-426X;
   Vrijsen, Janna/0000-0002-7081-9893; Arias Vasquez,
   Alejandro/0000-0002-4786-0169; Speckens, Anne/0000-0001-5266-1554
FU department of Psychiatry of the Radboud University Medical Centre
FX The study was funded by the department of Psychiatry of the Radboud
   University Medical Centre. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Aragam N, 2011, J AFFECT DISORDERS, V133, P516, DOI 10.1016/j.jad.2011.04.054
   Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721
   Beck AT, 1996, BECK DEPRESSION INVE
   Betts M. J., 2007, BIOINFORMATICS GENET, P289
   Bhagwagar Z, 2007, PSYCHOL MED, V38, P307
   Bochdanovits Z, 2009, MOL PSYCHIATR, V14, P650, DOI 10.1038/mp.2009.37
   Bockting CLH, 2006, J CLIN PSYCHIAT, V67, P747, DOI 10.4088/JCP.v67n0508
   BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129
   Bradley M. M., 1999, C1 U FLOR CTR RES PS
   BREWIN CR, 1993, PSYCHOL BULL, V113, P82, DOI 10.1037//0033-2909.113.1.82
   BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   De Raedt R, 2010, COGN AFFECT BEHAV NE, V10, P50, DOI 10.3758/CABN.10.1.50
   DENNY EB, 1992, J ABNORM PSYCHOL, V101, P575, DOI 10.1037/0021-843X.101.3.575
   Ellwart T, 2003, DEPRESS ANXIETY, V17, P197, DOI 10.1002/da.10102
   Firk C, 2007, J PSYCHOPHARMACOL, V21, P538, DOI 10.1177/0269881106075588
   First MB, 1996, STRUCTURED CLIN INTE
   Fitzgerald DA, 2011, NEUROIMAGE, V56, P1783, DOI 10.1016/j.neuroimage.2011.02.061
   Fox E, 2009, P R SOC B, V276, P1747, DOI 10.1098/rspb.2008.1788
   Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4
   Gerritsen L, 2011, MOL PSYCHIATR, V17, P597
   Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305
   Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P386, DOI 10.1037/0021-843x.113.3.386
   Gupta Rashmi, 2012, Front Psychiatry, V3, P99, DOI 10.3389/fpsyt.2012.00099
   Hek K, 2010, HUM MOL GENET, V19, P731, DOI 10.1093/hmg/ddp529
   Joormann J, 2007, J ABNORM PSYCHOL, V116, P80, DOI 10.1037/0021-843X.116.1.80
   Kanai T, 2003, PSYCHOL MED, V33, P839, DOI 10.1017/S0033291703007827
   Kendler KS, 2010, MOL PSYCHIATR, V15, P789, DOI 10.1038/mp.2010.8
   Klein AA, 2013, ADDICT BEHAV, V38, P1687, DOI 10.1016/j.addbeh.2012.10.006
   Kuehner C, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.11
   LeMoult J, 2012, COGNITIVE THER RES, V36, P47, DOI 10.1007/s10608-010-9322-2
   Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916
   MATT GE, 1992, CLIN PSYCHOL REV, V12, P227, DOI 10.1016/0272-7358(92)90116-P
   McCabe SB, 2000, COGNITIVE THER RES, V24, P427, DOI 10.1023/A:1005579719849
   Minelli A, 2012, J AFFECT DISORDERS, V139, P250, DOI 10.1016/j.jad.2012.01.028
   Pergamin-Hight L, 2012, BIOL PSYCHIAT, V71, P373, DOI 10.1016/j.biopsych.2011.10.030
   Perry BD, 1995, INFANT MENT HEALTH J, V16, P271, DOI 10.1002/1097-0355(199524)16:4<271::AID-IMHJ2280160404>3.0.CO;2-B
   Phaf RH, 2006, TECHNICAL REPORT
   Raven J. C., 1958, STANDARD PROGR MATRI
   Ridout N, 2009, BEHAV RES THER, V47, P851, DOI 10.1016/j.brat.2009.06.013
   ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677
   Schott BH, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.10
   Schuhmacher A, 2011, INT J NEUROPSYCHOPH, V14, P237, DOI 10.1017/S1461145710000854
   Shyn SI, 2010, PSYCHIAT CLIN N AM, V33, P125, DOI 10.1016/j.psc.2009.10.004
   SKRE I, 1991, ACTA PSYCHIAT SCAND, V84, P167, DOI 10.1111/j.1600-0447.1991.tb03123.x
   Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125
   Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552
   Teasdale JD, 1988, COGNITION EMOTION, V2, P247, DOI 10.1080/02699938808410927
   van Oostrom I, 2012, BIOL PSYCHOL, V89, P214, DOI 10.1016/j.biopsycho.2011.10.012
   van Tol MJ, 2012, BIOL PSYCHIAT, V71, P593, DOI 10.1016/j.biopsych.2011.11.016
   Verbeek EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079921
   Vogel S, 2014, PSYCHONEUROENDOCRINO, V40, P181, DOI 10.1016/j.psyneuen.2013.11.010
   Vrijsen JN, 2014, GENES BRAIN BEHAV, V13, P508, DOI 10.1111/gbb.12129
   Vrijsen JN, 2014, COGNITIVE THER RES, V38, P334, DOI 10.1007/s10608-013-9590-8
   Vrijsen JN, 2014, PSYCHIAT RES, V217, P134, DOI 10.1016/j.psychres.2014.02.033
   WATKINS PC, 1992, J ABNORM PSYCHOL, V101, P581, DOI 10.1037/0021-843X.101.3.581
   Watson DE, 2005, INT J TOXICOL, V24, P139, DOI 10.1080/10915810590948299
   Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122
   WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630
   WILLIAMS JMG, 1996, REMEMBERING OUR STUD
   Williams LM, 2010, NEUROIMAGE, V53, P918, DOI 10.1016/j.neuroimage.2010.01.084
   Wingenfeld K, 2013, PSYCHOPATHOLOGY, V46, P22, DOI 10.1159/000338609
   Woudstra S, 2012, TRANSL PSYCHIAT, V2, pe99
   Woudstra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061494
NR 67
TC 0
Z9 0
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 7
PY 2014
VL 9
IS 11
AR e112153
DI 10.1371/journal.pone.0112153
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AT3WF
UT WOS:000344863100057
PM 25379724
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Kloke, V
   Schreiber, RS
   Bodden, C
   Mollers, J
   Ruhmann, H
   Kaiser, S
   Lesch, KP
   Sachser, N
   Lewejohann, L
AF Kloke, Vanessa
   Schreiber, Rebecca S.
   Bodden, Carina
   Moellers, Julian
   Ruhmann, Hanna
   Kaiser, Sylvia
   Lesch, Klaus-Peter
   Sachser, Norbert
   Lewejohann, Lars
TI Hope for the Best or Prepare for the Worst? Towards a Spatial Cognitive
   Bias Test for Mice
SO PLOS ONE
LA English
DT Article
ID SEROTONIN TRANSPORTER GENE; EMOTIONAL INFORMATION; LABORATORY
   ENVIRONMENT; ATTENTIONAL BIAS; PROMOTER REGION; ANIMAL BEHAVIOR;
   AFFECTIVE STATE; DEFICIENT MICE; JUDGMENT BIAS; KNOCKOUT MICE
AB Cognitive bias, the altered information processing resulting from the background emotional state of an individual, has been suggested as a promising new indicator of animal emotion. Comparable to anxious or depressed humans, animals in a putatively negative emotional state are more likely to judge an ambiguous stimulus as if it predicts a negative event, than those in positive states. The present study aimed to establish a cognitive bias test for mice based on a spatial judgment task and to apply it in a pilot study to serotonin transporter (5-HTT) knockout mice, a well-established mouse model for the study of anxiety- and depression-related behavior. In a first step, we validated that our setup can assess different expectations about the outcome of an ambiguous stimulus: mice having learned to expect something positive within a maze differed significantly in their behavior towards an unfamiliar location than animals having learned to expect something negative. In a second step, the use of spatial location as a discriminatory stimulus was confirmed by showing that mice interpret an ambiguous stimulus depending on its spatial location, with a position exactly midway between a positive and a negative reference point provoking the highest level of ambiguity. Finally, the anxiety- and depression-like phenotype of the 5-HTT knockout mouse model manifested - comparable to human conditions - in a trend for a negatively distorted interpretation of ambiguous information, albeit this effect was not statistically significant. The results suggest that the present cognitive bias test provides a useful basis to study the emotional state in mice, which may not only increase the translational value of animal models in the study of human affective disorders, but which is also a central objective of animal welfare research.
C1 [Kloke, Vanessa; Schreiber, Rebecca S.; Bodden, Carina; Moellers, Julian; Ruhmann, Hanna; Kaiser, Sylvia; Sachser, Norbert; Lewejohann, Lars] Univ Munster, Dept Behav Biol, D-48149 Munster, Germany.
   [Kloke, Vanessa; Schreiber, Rebecca S.; Kaiser, Sylvia; Sachser, Norbert; Lewejohann, Lars] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, D-48149 Munster, Germany.
   [Lesch, Klaus-Peter] Univ Wurzburg, Div Mol Psychiat, Lab Translat Neurosci, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany.
   [Lewejohann, Lars] Univ Osnabruck, Osnabruck, Germany.
RP Kloke, V (reprint author), Univ Munster, Dept Behav Biol, D-48149 Munster, Germany.
EM vanessa.kloke@uni-muenster.de
RI Lewejohann, Lars/H-3717-2013; Lesch, Klaus-Peter/J-4906-2013
OI Lewejohann, Lars/0000-0002-0202-4351; Lesch,
   Klaus-Peter/0000-0001-8348-153X; Bodden, Carina/0000-0002-8749-8846
FU German Science Foundation (DFG) [SFB/TRR58]; DFG; Open Access
   Publication Fund of University of Munster
FX This study was supplied by a grant from the German Science Foundation
   (DFG,http://www.dfg.de) to N. S. and K. P. L. (SFB/TRR58, Project A1).
   The authors acknowledge support of financing open access publishing by
   the DFG and the Open Access Publication Fund of University of Munster
   (http://www.unimuenster.de). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Anderson MH, 2013, PSYCHOPHARMACOLOGY, V226, P601, DOI 10.1007/s00213-012-2932-5
   Araragi N, 2013, CURR DRUG TARGETS, V14, P549, DOI 10.2174/1389450111314050005
   Armstrong T, 2012, CLIN PSYCHOL REV, V32, P704, DOI 10.1016/j.cpr.2012.09.004
   Attar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080355
   BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579
   Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017
   Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721
   Beevers CG, 2009, J ABNORM PSYCHOL, V118, P670, DOI 10.1037/a0016198
   Bengel D, 1998, MOL PHARMACOL, V53, P649
   Bethell EJ, 2012, ANIM WELFARE, V21, P185, DOI 10.7120/09627286.21.2.185
   Boleij H, 2012, BEHAV BRAIN RES, V233, P45, DOI 10.1016/j.bbr.2012.04.039
   BRADLEY BP, 1995, BEHAV RES THER, V33, P755, DOI 10.1016/0005-7967(95)00029-W
   Brilot BO, 2010, ANIM COGN, V13, P721, DOI 10.1007/s10071-010-0323-z
   Browning M, 2012, BIOL PSYCHIAT, V72, P572, DOI 10.1016/j.biopsych.2012.04.014
   Browning M, 2010, COGN AFFECT BEHAV NE, V10, P8, DOI 10.3758/CABN.10.1.8
   Brydges NM, 2011, ANIM BEHAV, V81, P169, DOI 10.1016/j.anbehav.2010.09.030
   Burman O, 2011, APPL ANIM BEHAV SCI, V132, P160, DOI 10.1016/j.applanim.2011.04.001
   Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014
   Burman OHP, 2009, PHYSIOL BEHAV, V98, P345, DOI 10.1016/j.physbeh.2009.06.012
   Carola V, 2008, BIOL PSYCHIAT, V63, P840, DOI 10.1016/j.biopsych.2007.08.013
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   CASTO R, 1989, AM J PHYSIOL, V256, pR1121
   Cimadevilla JM, 2001, BRAIN RES BULL, V54, P559, DOI 10.1016/S0361-9230(01)00448-8
   Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670
   Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825
   Douglas C, 2012, APPL ANIM BEHAV SCI, V139, P65, DOI 10.1016/j.applanim.2012.02.018
   Doyle RE, 2010, APPL ANIM BEHAV SCI, V122, P28, DOI 10.1016/j.applanim.2009.11.003
   Engelmann M, 1996, PSYCHONEUROENDOCRINO, V21, P391, DOI 10.1016/0306-4530(96)00006-6
   Enkel T, 2010, NEUROPSYCHOPHARMACOL, V35, P1008, DOI 10.1038/npp.2009.204
   Eysenck M. W., 2005, COGNITIVE PSYCHOL ST
   EYSENCK MW, 1991, J ABNORM PSYCHOL, V100, P144, DOI 10.1037//0021-843X.100.2.144
   Guillot PV, 1996, BEHAV BRAIN RES, V77, P211, DOI 10.1016/0166-4328(95)00163-8
   Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a
   Heiming RS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.026.2009
   Jansen F, 2010, BEHAV BRAIN RES, V207, P21, DOI 10.1016/j.bbr.2009.09.033
   Kalueff AV, 2007, GENES BRAIN BEHAV, V6, P389, DOI 10.1111/j.1601-183X.2006.00270.x
   Kalueff AV, 2007, BRAIN RES, V1169, P87, DOI 10.1016/j.brainres.2007.07.009
   Kalueff AV, 2007, TRENDS PHARMACOL SCI, V28, P122, DOI 10.1016/j.tips.2007.01.002
   Karabeg MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078238
   Kircanski K, 2012, WIRES COGN SCI, V3, P301, DOI 10.1002/wcs.1177
   Knapp DJ, 1995, J NEUROSCI METH, V62, P1, DOI 10.1016/0165-0270(95)00044-5
   Koizumi A, 2010, NEUROREPORT, V21, P422, DOI 10.1097/WNR.0b013e32833833f0
   Lang TJ, 2012, EUR J PERSONALITY, V26, P145, DOI 10.1002/per.855
   Latham N, 2004, APPL ANIM BEHAV SCI, V86, P261, DOI 10.1016/j.applanim.2004.02.006
   Lewejohann L, 2006, GENES BRAIN BEHAV, V5, P64, DOI 10.1111/j.1601-183X.2005.00140.x
   Lewejohann L, 2010, BEHAV BRAIN RES, V211, P220, DOI 10.1016/j.bbr.2010.03.035
   Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6
   MACKINTOSH JH, 1973, ANIM BEHAV, V21, P464, DOI 10.1016/S0003-3472(73)80006-5
   MacLeod AK, 1996, J ABNORM PSYCHOL, V105, P286, DOI 10.1037//0021-843X.105.2.286
   MacLeod AK, 1997, COGNITION EMOTION, V11, P467, DOI 10.1080/026999397379881
   Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007
   Mathews A, 2002, COGNITION EMOTION, V16, P331, DOI 10.1080/02699930143000518
   Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916
   MATT GE, 1992, CLIN PSYCHOL REV, V12, P227, DOI 10.1016/0272-7358(92)90116-P
   Mendl M, 2011, CURR BIOL, V21, pR463, DOI 10.1016/j.cub.2011.05.028
   Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030
   Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023
   Miranda R, 2007, COGNITIVE THER RES, V31, P71, DOI 10.1007/s10608-006-9063-4
   Moriarty O, 2012, J NEUROSCI METH, V204, P1, DOI 10.1016/j.jneumeth.2011.10.024
   Neave HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080556
   OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037//0097-7403.2.2.97
   Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002
   Perez-Edgar K, 2010, BIOL PSYCHOL, V83, P269, DOI 10.1016/j.biopsycho.2009.08.009
   Pergamin-Hight L, 2012, BIOL PSYCHIAT, V71, P373, DOI 10.1016/j.biopsych.2011.10.030
   Pompl PN, 1999, J NEUROSCI METH, V87, P87, DOI 10.1016/S0165-0270(98)00169-1
   Richter SH, 2012, COGN AFFECT BEHAV NE, V12, P527, DOI 10.3758/s13415-012-0101-2
   ROBERTS WA, 1992, LEARNING AND MEMORY : THE BEHAVIORAL AND BIOLOGICAL SUBSTRATES, P7
   Rygula R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051959
   Salmeto AL, 2011, BRAIN RES, V1373, P124, DOI 10.1016/j.brainres.2010.12.007
   Silva AJ, 1998, NEUROBIOL LEARN MEM, V70, P44, DOI 10.1006/nlme.1998.3837
   Stober J, 2000, COGNITION EMOTION, V14, P725, DOI 10.1080/02699930050117693
   Stollstorff M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00327
   Van den Hove D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022715
   Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007
   Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3
NR 76
TC 16
Z9 16
U1 1
U2 38
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 19
PY 2014
VL 9
IS 8
AR e105431
DI 10.1371/journal.pone.0105431
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AN6XM
UT WOS:000340742100095
PM 25137069
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Nardi, B
   Marini, A
   Turchi, C
   Arimatea, E
   Tagliabracci, A
   Bellantuono, C
AF Nardi, Bernardo
   Marini, Alessandra
   Turchi, Chiara
   Arimatea, Emidio
   Tagliabracci, Adriano
   Bellantuono, Cesario
TI Role of 5-HTTLPR Polymorphism in the Development of the Inward/Outward
   Personality Organization: A Genetic Association Study
SO PLOS ONE
LA English
DT Article
ID SEROTONIN TRANSPORTER GENE; STRESSFUL LIFE EVENTS; DIFFERENTIAL
   SUSCEPTIBILITY; AFFECTIVE-DISORDERS; ENVIRONMENTAL-INFLUENCES; MEANING
   ORGANIZATIONS; PROMOTER POLYMORPHISM; THREATENING STIMULI; HUMAN
   AMYGDALA; DEPRESSION
AB Reciprocity with primary caregivers affects subjects' adaptive abilities toward the construction of the most useful personal meaning organization (PMO) with respect to their developmental environment. Within cognitive theory the post-rationalist approach has outlined two basic categories of identity construction and of regulation of cognitive and emotional processes: the Outward and the Inward PMO. The presence of different, consistent clinical patterns in Inward and Outward subjects is paralleled by differences in cerebral activation during emotional tasks on fMRI and by different expression of some polymorphisms in serotonin pathways. Since several lines of evidence support a role for the 5-HTTLPR polymorphism in mediating individual susceptibility to environmental emotional stimuli, this study was conducted to investigate its influence in the development of the Inward/Outward PMO. PMO was assessed and the 5-HTTLPR polymorphism investigated in 124 healthy subjects who were subdivided into an Inward (n = 52) and an Outward (n = 72) group. Case-control comparisons of short allele (S) frequencies showed significant differences between Inwards and Outwards (p = 0.036, chi 2 test; p = 0.026, exact test). Genotype frequencies were not significantly different although values slightly exceeded p <= 0.05 (p = 0.056, chi 2 test; p = 0.059, exact test). Analysis of the 5-HTTLPR genotypes according to the recessive inheritance model showed that the S/S genotype increased the likelihood of developing an Outward PMO (p = 0.0178, chi 2 test; p = 0.0143, exact test; OR = 3.43, CI (95%) = 1.188-9.925). A logistic regression analysis confirmed the association between short allele and S/S genotypes with the Outward PMO also when gender and age were considered. However none of the differences remained significant after correction for multiple testing, even though using the recessive model they approach significance. Overall our data seem to suggest a putative genetic basis for interindividual differences in PMO development.
C1 [Nardi, Bernardo; Marini, Alessandra; Arimatea, Emidio; Bellantuono, Cesario] Polytech Univ Marche, Psychiat Unit, Dept Expt & Clin Med, Ancona, Italy.
   [Turchi, Chiara; Tagliabracci, Adriano] Polytech Univ Marche, Sect Legal Med, Dept Biomed Sci & Publ Hlth, Ancona, Italy.
RP Turchi, C (reprint author), Polytech Univ Marche, Sect Legal Med, Dept Biomed Sci & Publ Hlth, Ancona, Italy.
EM c.turchi@univpm.it
OI Tagliabracci, Adriano/0000-0002-4434-0475; Turchi,
   Chiara/0000-0001-9211-810X; Arimatea, Emidio/0000-0003-3201-8830
CR Akkermann K, 2012, J PSYCHIATR RES, V46, P38, DOI 10.1016/j.jpsychires.2011.09.013
   Alexander N, 2012, BIOL PSYCHIAT, V72, P49, DOI 10.1016/j.biopsych.2012.01.030
   Arciero G, 2004, COGNITION PSYCHOTERA, P261
   Arciero G., 2000, CONSTRUCTIONS DISORD, P91
   Barry RA, 2008, J CHILD PSYCHOL PSYC, V49, P1313, DOI 10.1111/j.1469-7610.2008.01935.x
   Beevers CG, 2011, J ABNORM PSYCHOL, V120, P187, DOI 10.1037/a0022125
   Beevers CG, 2010, BIOL PSYCHOL, V83, P260, DOI 10.1016/j.biopsycho.2009.08.007
   Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44
   Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376
   Benjet C, 2010, J CHILD PSYCHOL PSYC, V51, P173, DOI 10.1111/j.1469-7610.2009.02149.x
   Bertolino A, 2005, BIOL PSYCHIAT, V57, P1517, DOI 10.1016/j.biopsych.2005.02.031
   Bevilacqua L, 2011, TRENDS COGN SCI, V15, P401, DOI 10.1016/j.tics.2011.07.009
   Bowlby J, 1982, ATTACHMENT LOSS ATTA, V1
   Brummett BH, 2008, BEHAV GENET, V38, P476, DOI 10.1007/s10519-008-9219-y
   Carli V, 2011, EUR PSYCHIAT, V26, P471, DOI 10.1016/j.eurpsy.2011.04.008
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Chen MC, 2009, PSYCHONEUROENDOCRINO, V34, P681, DOI 10.1016/j.psyneuen.2008.11.006
   Collier DA, 1996, MOL PSYCHIATR, V1, P453
   CRITTENDEN PM, 1992, DEV PSYCHOPATHOL, V4, P209, DOI 10.1017/S0954579400000110
   Dougherty LR, 2010, BIOL PSYCHOL, V83, P93, DOI 10.1016/j.biopsycho.2009.10.009
   Ebstein RP, 2006, MOL PSYCHIATR, V11, P427, DOI 10.1038/sj.mp.4001814
   Edelman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048597
   Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611
   Fergusson DM, 2011, BRIT J PSYCHIAT, V198, P129, DOI 10.1192/bjp.bp.110.085993
   Fonagy P, 1977, DEV PSYCHOPATHOL, V9, P679
   Fox E, 2011, BIOL PSYCHIAT, V70, P1049, DOI 10.1016/j.biopsych.2011.07.004
   Frigerio A, 2009, J CHILD PSYCHOL PSYC, V50, P1513, DOI 10.1111/j.1469-7610.2009.02126.x
   Frodl T, 2010, NEUROPSYCHOPHARMACOL, V35, P1383, DOI 10.1038/npp.2010.8
   Frokjaer VG, 2012, EUR NEUROPSYCHOPHARM
   Gibb BE, 2009, J ABNORM PSYCHOL, V118, P734, DOI 10.1037/a0016765
   Gotlib IH, 2008, BIOL PSYCHIAT, V63, P847, DOI 10.1016/j.biopsych.2007.10.008
   Guidano V. F., 1987, COMPLEXITY SELF
   Guidano V.F., 1991, SELF PROCESS POSTRAT
   Guidano VF, 1984, COGNITIVE PROCESSES
   Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146
   Heils A, 1996, J NEUROCHEM, V66, P2621
   Hermann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044352
   Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024
   Josephs RA, 2012, PSYCHONEUROENDOCRINO, V37, P752, DOI 10.1016/j.psyneuen.2011.09.006
   Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189
   Kaufman J, 2004, P NATL ACAD SCI USA, V101, P17316, DOI 10.1073/pnas.0404376101
   Klein AM, 2012, PSYCHOTHER PSYCH MED, V62, P95, DOI 10.1055/s-0032-1306320
   Kobiella A, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.29
   Koenen KC, 2009, J TRAUMA STRESS, V22, P416, DOI 10.1002/jts.20435
   Kuepper Y, 2012, GENES BRAIN BEHAV, V11, P643, DOI 10.1111/j.1601-183X.2012.00783.x
   Kuhnen CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054632
   Lasky-Su JA, 2005, AM J MED GENET B, V133B, P110, DOI 10.1016/j.ajmg.b.30104
   LeDoux J., 2002, SYNAPTIC SELF OUR BR
   LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282
   Marcus G, 2004, BIRD MIND
   Marsh AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025148
   Mazzola V, 2010, PLOS ONE, V16
   McGuffin P, 2011, BRIT J PSYCHIAT, V198, P424, DOI 10.1192/bjp.bp.110.085225
   Minelli A, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-50
   Mueller A, 2012, INT J PSYCHOPHYSIOL, V83, P302, DOI 10.1016/j.ijpsycho.2011.11.007
   Mueller A, 2010, PSYCHONEUROENDOCRINO, V35, P289, DOI 10.1016/j.psyneuen.2009.07.002
   Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016
   Munafo MR, 2009, AM J MED GENET B, V150B, P271, DOI 10.1002/ajmg.b.30808
   Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009
   Nakamura M, 2000, MOL PSYCHIATR, V5, P32, DOI 10.1038/sj.mp.4000698
   Nardi B., 2010, EUROPEAN PSYCHOTHERA, V9, P57
   Nardi B., 2012, INT J PSYCHOL STUDIE, V4, P174, DOI DOI 10.5539/IJPS.V4N2P174
   NARDI B., 2008, EUROPEAN PSYCHOTHERA, V8, P5
   Nardi B, 2012, ACTA NEUROPSYCHIATR, V24, P336, DOI 10.1111/j.1601-5215.2011.00644.x
   Nardi B, 2012, CLIN PSYCHOL PSYCHOT, V19, P78, DOI 10.1002/cpp.740
   Nardi B, 2011, PSYCHIAT GENET, V21, P269, DOI 10.1097/YPG.0b013e32834371bc
   Nederhof E, 2010, GENES BRAIN BEHAV, V9, P968, DOI 10.1111/j.1601-183X.2010.00637.x
   Nishikawa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047608
   O'Hara R, 2012, AM J GERIAT PSYCHIAT, V20, P452, DOI 10.1097/JGP.0b013e31823e2d03
   Owens M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048482
   Petersen IT, 2012, DEV PSYCHOL, V48, P1463, DOI 10.1037/a0027471
   Piva F, 2011, HUM PSYCHOPHARM CLIN, V26, P365, DOI 10.1002/hup.1214
   Piva F, 2010, HUM PSYCHOPHARM CLIN, V25, P153, DOI 10.1002/hup.1100
   Pluess M, 2013, PSYCHOL BULL, V139, P901, DOI 10.1037/a0030196
   Pluess M, 2010, PROG NEURO-PSYCHOPH, V34, P1070, DOI 10.1016/j.pnpbp.2010.05.028
   Priess-Groben HA, 2013, J ABNORM CHILD PSYCH, V41, P281, DOI 10.1007/s10802-012-9672-1
   Risch, 2009, JAMA-J AM MED ASSOC, V302, P492
   Rubino V, 2007, BRAIN RES BULL, V74, P250, DOI 10.1016/j.brainresbull.2007.06.019
   Sjoberg RL, 2006, INT J NEUROPSYCHOPH, V9, P443, DOI 10.1017/S1461145705005936
   Smeraldi E, 2006, PSYCHIAT GENET, V16, P153, DOI 10.1097/01.ypg.0000218611.53064.a0
   Starr LR, 2012, J ABNORM CHILD PSYCH
   Stoltenberg SF, 2012, INT J EAT DISORDER, V45, P492, DOI 10.1002/eat.20976
   Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067
   Uher R, 2011, J AFFECT DISORDERS, V135, P56, DOI 10.1016/j.jad.2011.03.010
   Verschoor E, 2012, EUR NEUROPSYCHOPHARM, V22, P546, DOI 10.1016/j.euroneuro.2011.12.003
   Wang ZW, 2011, DEPRESS ANXIETY, V28, P1067, DOI 10.1002/da.20872
   Way BM, 2011, PSYCHOSOM MED, V73, P310, DOI 10.1097/PSY.0b013e31821195ed
   Wermter AK, 2010, EUR CHILD ADOLES PSY, V19, P199, DOI 10.1007/s00787-009-0082-z
   Wust S, 2009, PSYCHONEUROENDOCRINO, V34, P972, DOI 10.1016/j.psyneuen.2009.01.011
   Zannas AS, 2012, STRESS, V15, P425, DOI 10.3109/10253890.2011.634263
NR 93
TC 6
Z9 6
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 16
PY 2013
VL 8
IS 12
AR e82192
DI 10.1371/journal.pone.0082192
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 276GD
UT WOS:000328735700042
PM 24358153
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Navarro-Mateu, F
   Escamez, T
   Koenen, KC
   Alonso, J
   Sanchez-Meca, J
AF Navarro-Mateu, Fernando
   Escamez, Teresa
   Koenen, Karestan C.
   Alonso, Jordi
   Sanchez-Meca, Julio
TI Meta-Analyses of the 5-HTTLPR Polymorphisms and Post-Traumatic Stress
   Disorder
SO PLOS ONE
LA English
DT Article
ID SEROTONIN TRANSPORTER GENE; EMOTIONAL REGULATION; CHILDHOOD ADVERSITY;
   SYSTEMATIC REVIEWS; OEF/OIF VETERANS; PROMOTER REGION; SOCIAL SUPPORT;
   LIFE EVENTS; ASSOCIATION; GENOTYPE
AB Objective: To conduct a meta-analysis of all published genetic association studies of 5-HTTLPR polymorphisms performed in PTSD cases
   Methods Data Sources: Potential studies were identified through PubMed/MEDLINE, EMBASE, Web of Science databases (Web of Knowledge, WoK), PsychINFO, PsychArticles and HuGeNet (Human Genome Epidemiology Network) up until December 2011. Study Selection: Published observational studies reporting genotype or allele frequencies of this genetic factor in PTSD cases and in non-PTSD controls were all considered eligible for inclusion in this systematic review. Data Extraction: Two reviewers selected studies for possible inclusion and extracted data independently following a standardized protocol. Statistical analysis: A biallelic and a triallelic meta-analysis, including the total S and S' frequencies, the dominant (S+/LL and S'+/L'L') and the recessive model (SS/L+ and S'S'/L'+), was performed with a random-effect model to calculate the pooled OR and its corresponding 95% CI. Forest plots and Cochran's Q-Statistic and I-2 index were calculated to check for heterogeneity. Subgroup analyses and meta-regression were carried out to analyze potential moderators. Publication bias and quality of reporting were also analyzed.
   Results: 13 studies met our inclusion criteria, providing a total sample of 1874 patients with PTSD and 7785 controls in the biallelic meta-analyses and 627 and 3524, respectively, in the triallelic. None of the meta-analyses showed evidence of an association between 5-HTTLPR and PTSD but several characteristics (exposure to the same principal stressor for PTSD cases and controls, adjustment for potential confounding variables, blind assessment, study design, type of PTSD, ethnic distribution and Total Quality Score) influenced the results in subgroup analyses and meta-regression. There was no evidence of potential publication bias.
   Conclusions: Current evidence does not support a direct effect of 5-HTTLPR polymorphisms on PTSD. Further analyses of gene-environment interactions, epigenetic modulation and new studies with large samples and/or meta-analyses are required.
C1 [Navarro-Mateu, Fernando] Serv Murciano Salud, Subdirecc Gen Salud Mental & Asistencia Psiquiatr, Unidad Docencia Invest & Formac Salud Mental UDIF, Murcia, Spain.
   [Navarro-Mateu, Fernando] CIBER Epidemiol & Salud Publ CIBERESP, Murcia, Spain.
   [Escamez, Teresa] Fdn Formac & Invest Sanitarias FFIS Reg Murcia, IMIB BIOBANC MUR, Biobanco HUVA AECC FFIS, Murcia, Spain.
   [Koenen, Karestan C.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA.
   [Alonso, Jordi] IMIM Inst Hosp Mar Invest Med, Barcelona, Spain.
   [Alonso, Jordi] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain.
   [Sanchez-Meca, Julio] Univ Murcia, Fac Psicol, Dept Psicol Basica & Metodol, Murcia, Spain.
RP Navarro-Mateu, F (reprint author), Serv Murciano Salud, Subdirecc Gen Salud Mental & Asistencia Psiquiatr, Unidad Docencia Invest & Formac Salud Mental UDIF, Murcia, Spain.
EM fernando.navarro@carm.es
RI Navarro-Mateu, Fernando/H-9055-2017; Alonso, Jordi/A-5514-2010
OI Navarro-Mateu, Fernando/0000-0002-3228-623X; Alonso,
   Jordi/0000-0001-8627-9636
FU Regional Health Authorities of Murcia (Consejeria de Sanidad y Politica
   Social and Servicio Murciano de Salud); Fundacion para la Formacion e
   Investigacion Sanitaria (FFIS) of the Murcia Region
FX This work has been financed by the Regional Health Authorities of Murcia
   (Consejeria de Sanidad y Politica Social and Servicio Murciano de Salud)
   and the Fundacion para la Formacion e Investigacion Sanitaria (FFIS) of
   the Murcia Region. The funding agencies had no role in study design,
   data collection and analysis, decision to publish or preparation of the
   manuscript. Jim van Os
CR Beach SRH, 2010, AM J MED GENET B, V153B, P710, DOI 10.1002/ajmg.b.31028
   Borenstein M., 2005, COMPREHENSIVE METAAN
   Bray M, 2006, HUGENET HUGE REV HDB
   Brugha TS, 2012, BRIT J PSYCHIAT, V200, P446, DOI 10.1192/bjp.bp.111.098103
   Bryant RA, 2010, BIOL PSYCHIAT, V67, P1217, DOI 10.1016/j.biopsych.2010.03.016
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Cho HJ, 2005, MOL PSYCHIATR, V10, P771, DOI 10.1038/sj.mp.4001663
   Clarke H, 2010, PSYCHOL MED, V40, P1767, DOI 10.1017/S0033291710000516
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Esteller M, 2006, CARCINOGENESIS, V27, P1121, DOI 10.1093/carcin/bgl033
   Feinn R, 2005, AM J MED GENET B, V133B, P79, DOI 10.1002/ajmg.b.30132
   Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069
   Grabe HJ, 2009, AM J PSYCHIAT, V166, P926, DOI 10.1176/appi.ajp.2009.08101542
   GREEN BL, 1994, J TRAUMA STRESS, V7, P341, DOI 10.1007/BF02102782
   Handwerger K L., 2010, THESIS PROQUEST INFO
   Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002
   Holman EA, 2011, J TRAUMA STRESS, V24, P497, DOI 10.1002/jts.20671
   Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62
   Huedo-Medina T, 2006, 19 CHIP
   Kaufman J, 2009, BIOL PSYCHIAT, V65, p106S
   Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4
   Kilpatrick DG, 2007, AM J PSYCHIAT, V164, P1693, DOI 10.1176/appi.ajp.2007.06122007
   King AP, 2011, BIOL PSYCHIAT, V69, p74S
   King AP, 2010, BIOL PSYCHIAT, V67, p209S
   King AP, 2009, BIOL PSYCHIAT, V65, p6S
   Koenen KC, 2008, EUR ARCH PSY CLIN N, V258, P82, DOI 10.1007/s00406-007-0787-2
   Koenen K, 2006, AM J MED GENET B, V141B, P742
   Koenen KC, 2007, J TRAUMA STRESS, V20, P737, DOI 10.1002/jts.20205
   Koenen KC, 2011, DEPRESS ANXIETY, V28, P639, DOI 10.1002/da.20825
   Koenen KC, 2009, J TRAUMA STRESS, V22, P416, DOI 10.1002/jts.20435
   Koenen KC, 2009, AM J EPIDEMIOL, V169, P704, DOI 10.1093/aje/kwn397
   Kolassa IT, 2010, J CLIN PSYCHIAT, V71, P543, DOI 10.4088/JCP.08m04787blu
   Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   Li D, 2007, MOL PSYCHIATR, V12, P47, DOI 10.1038/sj.mp.4001890
   Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/aje/kwf054
   Little J, 2009, ANN INTERN MED, V150, P206, DOI 10.7326/0003-4819-150-3-200902030-00011
   Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001
   Valente NLM, 2011, J MOL NEUROSCI, V44, P59, DOI 10.1007/s12031-011-9513-7
   Mellman TA, 2009, PSYCHOSOM MED, V71, P627, DOI 10.1097/PSY.0b013e3181a54341
   Mercer KB, 2012, ARCH GEN PSYCHIAT, V69, P89, DOI 10.1001/archgenpsychiatry.2011.109
   Morey RA, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-76
   Munafo MR, 2006, NEUROPSYCHOBIOLOGY, V53, P1, DOI 10.1159/000089915
   Mushtaq D, 2012, J AFFECT DISORDERS, V136, P955, DOI 10.1016/j.jad.2011.08.033
   Nakamura M, 2000, MOL PSYCHIATR, V5, P32, DOI 10.1038/sj.mp.4000698
   Nugent NR, 2008, AM J MED GENET C, V148C, P127, DOI 10.1002/ajmg.c.30169
   Parsey RV, 2006, AM J PSYCHIAT, V163, P48, DOI 10.1176/appi.ajp.163.1.48
   Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185
   Sagoo GS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000028
   Sanchez-Meca J, 2008, PSYCHOL METHODS, V13, P31, DOI 10.1037/1082-989X.13.1.31
   Sayin A, 2010, DNA CELL BIOL, V29, P71, DOI 10.1089/dna.2009.0936
   Sterne JAC, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P99
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Takano A, 2007, BIOL PSYCHIAT, V62, P588, DOI 10.1016/j.biopsych.2006.11.007
   Terracciano A, 2010, NEUROPSYCHOPHARMACOL, V35, P1083, DOI 10.1038/npp.2009.213
   Thakur GA, 2009, J TRAUMA STRESS, V22, P240, DOI 10.1002/jts.20405
   Toyokawa S, 2012, SOC SCI MED, V74, P67, DOI 10.1016/j.socscimed.2011.09.036
   Uher R, 2010, MOL PSYCHIATR, V15, P18, DOI 10.1038/mp.2009.123
   von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040296
   Wang ZW, 2011, DEPRESS ANXIETY, V28, P1067, DOI 10.1002/da.20872
   Wang ZW, 2009, BIOL PSYCHIAT, V65, p119S
   Xie PX, 2012, AM J MED GENET B, V159B, P644, DOI 10.1002/ajmg.b.32068
   Xie PX, 2009, ARCH GEN PSYCHIAT, V66, P1201, DOI 10.1001/archgenpsychiatry.2009.153
   Zalsman G, 2006, AM J PSYCHIAT, V163, P1588, DOI 10.1176/appi.ajp.163.9.1588
NR 65
TC 25
Z9 25
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 25
PY 2013
VL 8
IS 6
AR e66227
DI 10.1371/journal.pone.0066227
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 175IB
UT WOS:000321223000010
PM 23825531
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Blomeyer, D
   Buchmann, AF
   Lascorz, J
   Zimmermann, US
   Esser, G
   Desrivieres, S
   Schmidt, MH
   Banaschewski, T
   Schumann, G
   Laucht, M
AF Blomeyer, Dorothea
   Buchmann, Arlette F.
   Lascorz, Jesus
   Zimmermann, Ulrich S.
   Esser, Guenter
   Desrivieres, Sylvane
   Schmidt, Martin H.
   Banaschewski, Tobias
   Schumann, Gunter
   Laucht, Manfred
TI Association of PER2 Genotype and Stressful Life Events with Alcohol
   Drinking in Young Adults
SO PLOS ONE
LA English
DT Article
ID IDENTIFICATION TEST AUDIT; DRUG-ABUSE; CLOCK GENE; RELIABILITY;
   DISORDERS; ETHANOL; PERIOD; AGE; VULNERABILITY; ADOLESCENCE
AB Background: Clock genes govern circadian rhythms and shape the effect of alcohol use on the physiological system. Exposure to severe negative life events is related to both heavy drinking and disturbed circadian rhythmicity. The aim of this study was 1) to extend previous findings suggesting an association of a haplotype tagging single nucleotide polymorphism of PER2 gene with drinking patterns, and 2) to examine a possible role for an interaction of this gene with life stress in hazardous drinking.
   Methods: Data were collected as part of an epidemiological cohort study on the outcome of early risk factors followed since birth. At age 19 years, 268 young adults (126 males, 142 females) were genotyped for PER2 rs56013859 and were administered a 45-day alcohol timeline follow-back interview and the Alcohol Use Disorders Identification Test (AUDIT). Life stress was assessed as the number of severe negative life events during the past four years reported in a questionnaire and validated by interview.
   Results: Individuals with the minor G allele of rs56013859 were found to be less engaged in alcohol use, drinking at only 72% of the days compared to homozygotes for the major A allele. Moreover, among regular drinkers, a gene x environment interaction emerged (p = .020). While no effects of genotype appeared under conditions of low stress, carriers of the G allele exhibited less hazardous drinking than those homozygous for the A allele when exposed to high stress.
   Conclusions: These findings may suggest a role of the circadian rhythm gene PER2 in both the drinking patterns of young adults and in moderating the impact of severe life stress on hazardous drinking in experienced alcohol users. However, in light of the likely burden of multiple tests, the nature of the measures used and the nominal evidence of interaction, replication is needed before drawing firm conclusions.
C1 [Blomeyer, Dorothea; Buchmann, Arlette F.; Schmidt, Martin H.; Banaschewski, Tobias; Laucht, Manfred] Heidelberg Univ, Dept Child & Adolescent Psychiat & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany.
   [Lascorz, Jesus] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.
   [Zimmermann, Ulrich S.] Tech Univ Dresden, Dept Psychiat & Psychotherapy, Univ Hosp Carl Gustav Carus, D-01062 Dresden, Germany.
   [Esser, Guenter; Laucht, Manfred] Univ Potsdam, Dept Psychol, Potsdam, Germany.
   [Desrivieres, Sylvane; Schumann, Gunter] Kings Coll London, Social Genet & Dev Psychiat Ctr MRC, Inst Psychiat, London WC2R 2LS, England.
RP Laucht, M (reprint author), Heidelberg Univ, Dept Child & Adolescent Psychiat & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany.
EM manfred.laucht@zi-mannheim.de
RI Zimmermann, Ulrich/B-9357-2011; Desrivieres, Sylvane/B-7399-2011
OI Desrivieres, Sylvane/0000-0002-9120-7060
FU Deutsche Forschungsgemeinschaft (DFG); Federal Ministry for Education
   and Research, Baden-Wuerttemberg Consortium for Addiction Research;
   National Genome Research Network; Medical Research Council [G9817803B]
FX This study was supported by grants from the Deutsche
   Forschungsgemeinschaft (DFG), the Federal Ministry for Education and
   Research as part of the Baden-Wuerttemberg Consortium for Addiction
   Research and from the 'National Genome Research Network'. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099
   Agapito M, 2010, ALCOHOL CLIN EXP RES, V34, P1613, DOI 10.1111/j.1530-0277.2010.01246.x
   Babor T. F., 2001, AUDIT ALCOHOL USE DI
   Blomeyer D, 2008, BIOL PSYCHIAT, V63, P146, DOI 10.1016/j.biopsych.2007.04.026
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041
   Clarke TK, 2008, ADDICT BIOL, V13, P1, DOI 10.1111/j.1369-1600.2007.00084.x
   Clarke TK, 2012, ADDICT BIOL, V17, P202, DOI 10.1111/j.1369-1600.2010.00263.x
   Cohen J, 1988, STAT POWER ANAL BEHA
   Costanzo PR, 2007, J STUD ALCOHOL DRUGS, V68, P727, DOI 10.15288/jsad.2007.68.727
   Dawson DA, 2005, ALCOHOL ALCOHOLISM, V40, P453, DOI 10.1093/alcalc/agh176
   Dong L, 2011, AM J PSYCHIAT, V168, P1090, DOI 10.1176/appi.ajp.2011.10111579
   Ducci F, 2008, ADDICTION, V103, P1414, DOI 10.1111/j.1360-0443.2008.02203.x
   Dybek I, 2006, J STUD ALCOHOL, V67, P473, DOI 10.15288/jsa.2006.67.473
   Flint J, 2008, CURR OPIN PSYCHIATR, V21, P315, DOI 10.1097/YCO.0b013e328306a791
   Gamble KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018395
   Harford TC, 2005, ALCOHOL CLIN EXP RES, V29, P810, DOI 10.1097/01.ALC.0000164381.67723.76
   Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593
   Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52
   Kuntsche E, 2007, J STUD ALCOHOL DRUGS, V68, P76, DOI 10.15288/jsad.2007.68.76
   Laucht M, 2000, J AM ACAD CHILD PSY, V39, P1229, DOI 10.1097/00004583-200010000-00009
   Laucht M, 1997, J CHILD PSYCHOL PSYC, V38, P843, DOI 10.1111/j.1469-7610.1997.tb01602.x
   Laucht M, 2007, ARCH GEN PSYCHIAT, V64, P585, DOI 10.1001/archpsyc.64.5.585
   Laucht M, 2009, BIOL PSYCHIAT, V66, P102, DOI 10.1016/j.biopsych.2009.02.010
   Maier-Diewald W, 1983, MUNICH INTERVIEW ASS
   McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102
   Monti PM, 2005, ALCOHOL CLIN EXP RES, V29, P207, DOI 10.1097/01.ALC.0000153551.11000.F3
   Park CL, 2002, J STUD ALCOHOL, V63, P486, DOI 10.15288/jsa.2002.63.486
   Perkins HW, 1999, J STUD ALCOHOL, V60, P219, DOI 10.15288/jsa.1999.60.219
   PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254
   POHORECKY LA, 1991, ALCOHOL CLIN EXP RES, V15, P438, DOI 10.1111/j.1530-0277.1991.tb00543.x
   Rosenwasser AM, 2005, PHYSIOL BEHAV, V84, P537, DOI 10.1016/j.physbeh.2005.01.016
   San Jose B, 2000, ALCOHOL CLIN EXP RES, V24, P1207
   Scheurich A, 2005, EUR ADDICT RES, V11, P50, DOI 10.1159/000081417
   Schumann G, 2008, ARCH GEN PSYCHIAT, V65, P826, DOI 10.1001/archpsyc.65.7.826
   Siegmund S, 2005, ALCOHOL CLIN EXP RES, V29, P1139, DOI 10.1097/01.ALC.0000171928.40418.46
   SOBELL LC, 1992, ADDICT BEHAV, V17, P507, DOI 10.1016/0306-4603(92)90011-J
   Spanagel R, 2005, NAT MED, V11, P35, DOI 10.1038/nm1163
   Spanagel R, 2005, ALCOHOL CLIN EXP RES, V29, P1550, DOI 10.1097/01.alc.0000175074.70807.fd
   Uhart M, 2009, ADDICT BIOL, V14, P43, DOI 10.1111/j.1369-1600.2008.00131.x
   Volk RJ, 1997, ADDICTION, V92, P197, DOI 10.1111/j.1360-0443.1997.tb03652.x
   Wills TA, 1985, COPING SUBSTANCE USE, P3
   WITTCHEN HU, 1989, J AFFECT DISORDERS, V16, P77, DOI 10.1016/0165-0327(89)90059-1
NR 44
TC 36
Z9 36
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 22
PY 2013
VL 8
IS 3
AR e59136
DI 10.1371/journal.pone.0059136
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 111VQ
UT WOS:000316549400039
PM 23533602
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Hohoff, C
   Gorji, A
   Kaiser, S
   Willscher, E
   Korsching, E
   Ambree, O
   Arolt, V
   Lesch, KP
   Sachser, N
   Deckert, J
   Lewejohann, L
AF Hohoff, Christa
   Gorji, Ali
   Kaiser, Sylvia
   Willscher, Edith
   Korsching, Eberhard
   Ambree, Oliver
   Arolt, Volker
   Lesch, Klaus-Peter
   Sachser, Norbert
   Deckert, Juergen
   Lewejohann, Lars
TI Effect of Acute Stressor and Serotonin Transporter Genotype on Amygdala
   First Wave Transcriptome in Mice
SO PLOS ONE
LA English
DT Article
ID CORTICOTROPIN-RELEASING-FACTOR; PRIMARY RESPONSE GENES; SPATIAL MEMORY;
   KNOCKOUT MICE; RAT-BRAIN; IN-VIVO; EXPRESSION; ANXIETY; EMOTION;
   PLASTICITY
AB The most prominent brain region evaluating the significance of external stimuli immediately after their onset is the amygdala. Stimuli evaluated as being stressful actuate a number of physiological processes as an immediate stress response. Variation in the serotonin transporter gene has been associated with increased anxiety- and depression-like behavior, altered stress reactivity and adaptation, and pathophysiology of stress-related disorders. In this study the instant reactions to an acute stressor were measured in a serotonin transporter knockout mouse model. Mice lacking the serotonin transporter were verified to be more anxious than their wild-type conspecifics. Genome-wide gene expression changes in the amygdala were measured after the mice were subjected to control condition or to an acute stressor of one minute exposure to water. The dissection of amygdalae and stabilization of RNA was conducted within nine minutes after the onset of the stressor. This extremely short protocol allowed for analysis of first wave primary response genes, typically induced within five to ten minutes of stimulation, and was performed using Affymetrix GeneChip Mouse Gene 1.0 ST Arrays. RNA profiling revealed a largely new set of differentially expressed primary response genes between the conditions acute stress and control that differed distinctly between wild-type and knockout mice. Consequently, functional categorization and pathway analysis indicated genes related to neuroplasticity and adaptation in wild-types whereas knockouts were characterized by impaired plasticity and genes more related to chronic stress and pathophysiology. Our study therefore disclosed different coping styles dependent on serotonin transporter genotype even directly after the onset of stress and accentuates the role of the serotonergic system in processing stressors and threat in the amygdala. Moreover, several of the first wave primary response genes that we found might provide promising targets for future therapeutic interventions of stress-related disorders also in humans.
C1 [Hohoff, Christa; Ambree, Oliver; Arolt, Volker] Univ Munster, Dept Psychiat, D-48149 Munster, Germany.
   [Gorji, Ali] Univ Munster, Inst Neurophysiol, D-48149 Munster, Germany.
   [Kaiser, Sylvia; Sachser, Norbert; Lewejohann, Lars] Univ Munster, Dept Behav Biol, D-48149 Munster, Germany.
   [Kaiser, Sylvia; Arolt, Volker; Sachser, Norbert; Lewejohann, Lars] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, D-48149 Munster, Germany.
   [Willscher, Edith] Interdisciplinary Ctr Clin Res IZKF, Core Unit, Munster, Germany.
   [Korsching, Eberhard] Univ Munster, Inst Bioinformat, D-48149 Munster, Germany.
   [Lesch, Klaus-Peter; Deckert, Juergen] Univ Wurzburg, Dept Psychiat, Wurzburg, Germany.
RP Lewejohann, L (reprint author), Univ Munster, Dept Behav Biol, D-48149 Munster, Germany.
EM ljohann@phenotyping.de
RI Lesch, Klaus-Peter/J-4906-2013; Lewejohann, Lars/H-3717-2013
OI Lesch, Klaus-Peter/0000-0001-8348-153X; Lewejohann,
   Lars/0000-0002-0202-4351
FU fund "Innovative Medical Research" of the University of Muenster Medical
   School [HO 2 2 05 09]; German Research Foundation (DFG) [SFB/TRR58]
FX This study was supported by the fund "Innovative Medical Research" of
   the University of Muenster Medical School
   (http://campus.uni-muenster.de/360.html?&L=1) to C. H. (HO 2 2 05 09)
   and by a grant from the German Research Foundation (DFG;
   http://www.dfg.de) to N.S. and K.P.L. (SFB/TRR58, Project A1). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adasme T, 2011, P NATL ACAD SCI USA, V108, P3029, DOI 10.1073/pnas.1013580108
   Ali F, 2009, GENES BRAIN BEHAV, V8, P435, DOI 10.1111/j.1601-183X.2009.00489.x
   Andrews WD, 2007, J ANAT, V211, P188, DOI 10.1111/j.1469-7580.2007.00750.x
   Andrus BM, 2012, MOL PSYCHIATR, V17, P49, DOI 10.1038/mp.2010.119
   Bengel D, 1998, MOL PHARMACOL, V53, P649
   Bengtson CP, 2012, ADV EXP MED BIOL, V970, P377, DOI 10.1007/978-3-7091-0932-8_17
   Bertolino A, 2005, BIOL PSYCHIAT, V57, P1517, DOI 10.1016/j.biopsych.2005.02.031
   Brent D, 2010, PHARMACOGENOMICS, V11, P793, DOI 10.2217/PGS.10.64
   Breuner CW, 2006, HORM METAB RES, V38, P260, DOI 10.1055/s-2005-925347
   Canli T, 2005, P NATL ACAD SCI USA, V102, P12224, DOI 10.1073/pnas.0503880102
   Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964
   Carroll JC, 2007, BEHAV GENET, V37, P214, DOI 10.1007/s10519-006-9129-9
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Chaouloff F, 1999, NEUROPSYCHOPHARMACOL, V21, pS28, DOI 10.1016/S0893-133X(99)00008-1
   Colon-Cesario WI, 2006, LEARN MEMORY, V13, P734, DOI 10.1101/lm.407706
   Comings DE, 2003, AM J MED GENET B, V118B, P110, DOI 10.1002/ajmg.b.10056
   Cottingham C, 2011, J BIOL CHEM, V286, P36063, DOI 10.1074/jbc.M111.261578
   CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9
   Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812
   Eastwood SL, 2008, NEUROPSYCHOPHARMACOL, V33, P933, DOI 10.1038/sj.npp.1301457
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Erhardt A, 2008, MOL PSYCHIATR, V13, P242, DOI 10.1038/sj.mp.4002094
   Fabre V, 2011, EUR NEUROPSYCHOPHARM, V21, P33, DOI 10.1016/j.euroneuro.2010.10.004
   Firouzabadi N, 2012, PSYCHIAT RE IN PRESS
   Flugge G, 2003, EUR J NEUROSCI, V17, P917, DOI 10.1046/j.1460-9568.2003.02510.x
   Fowler T, 2011, MOL CELL, V44, P348, DOI [10.1016/j.molcel.2011.09.014, 10.1016/j.molce1.2011.09.014]
   French L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001049
   Haefner S, 2008, NEUROPSYCHOBIOLOGY, V58, P154, DOI 10.1159/000182891
   Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829
   Heils A, 1996, J NEUROCHEM, V66, P2621
   Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007
   HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.bi.60.070191.001433
   Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-183X.2003.00050.x
   Holmes A, 2003, BIOL PSYCHIAT, V54, P953, DOI 10.1016/j.biopsych.2003.09.003
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012
   Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632
   Johnson PL, 2011, J PSYCHOPHARMACOL, V25, P26, DOI 10.1177/0269881109353464
   Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107
   Lesch KP, 2007, EMBO REP, V8, pS24, DOI 10.1038/sj.embor.7401008
   LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   Lewejohann L, 2010, BEHAV BRAIN RES, V211, P220, DOI 10.1016/j.bbr.2010.03.035
   Lisowski P, 2013, J MOL NEUROSCI, V50, P33, DOI 10.1007/s12031-012-9850-1
   Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068
   Matsuoka T, 2008, SYNAPSE, V62, P1, DOI 10.1002/syn.20455
   McArthur S, 2010, J IMMUNOL, V185, P6317, DOI 10.4049/jimmunol.1001095
   MOLLER C, 1994, CELL MOL NEUROBIOL, V14, P415, DOI 10.1007/BF02088828
   Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010
   Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284
   Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8
   Nanda SA, 2008, GENES BRAIN BEHAV, V7, P639, DOI 10.1111/j.1601-183X.2008.00401.x
   Need AC, 2012, AM J HUM GE IN PRESS
   Neumann ID, 2011, PROG NEURO-PSYCHOPH, V35, P1357, DOI 10.1016/j.pnpbp.2010.11.028
   Nietzer SL, 2011, BEHAV BRAIN RES, V220, P42, DOI 10.1016/j.bbr.2011.01.011
   Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009
   RILEY V, 1981, SCIENCE, V212, P1100, DOI 10.1126/science.7233204
   Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651
   Rouwette T, 2011, NEUROSCIENCE, V183, P15, DOI 10.1016/j.neuroscience.2011.03.054
   Savchenko VL, 2011, NEUROTOX RES, V20, P226, DOI 10.1007/s12640-010-9236-5
   Shekhar A, 2005, STRESS, V8, P209, DOI 10.1080/10253890500504557
   Stefanis NC, 2011, GENES BRAIN BEHAV, V10, P536, DOI 10.1111/j.1601-183X.2011.00690.x
   Stork O, 2001, LEARN MEMORY, V8, P209, DOI 10.1101/lm.39401
   Van den Hove D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022715
   Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007
   Zhang W, 2008, GENES BRAIN BEHAV, V7, P385, DOI 10.1111/j.1601-183X.2007.00361.x
NR 67
TC 8
Z9 8
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 11
PY 2013
VL 8
IS 3
AR e58880
DI 10.1371/journal.pone.0058880
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 107WI
UT WOS:000316251100098
PM 23536833
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Lindstedt, F
   Karshikoff, B
   Schalling, M
   Hoglund, CO
   Ingvar, M
   Lekander, M
   Kosek, E
AF Lindstedt, Fredrik
   Karshikoff, Bianka
   Schalling, Martin
   Hoglund, Caroline Olgart
   Ingvar, Martin
   Lekander, Mats
   Kosek, Eva
TI Serotonin-1A Receptor Polymorphism (rs6295) Associated with Thermal Pain
   Perception
SO PLOS ONE
LA English
DT Article
ID NOCICEPTIVE FLEXION REFLEX; NOXIOUS CONDITIONING STIMULATION; SPINAL
   5-HT1A RECEPTORS; DORSAL RAPHE NEURONS; KNOCK-OUT MICE; ANTIDEPRESSANT
   RESPONSE; HEAT PAIN; SUBJECTIVE EXPERIENCE; POSTOPERATIVE PAIN; GENE
   POLYMORPHISM
AB Background: Serotonin (5-HT) is highly involved in pain regulation and serotonin-1A (5-HT1A) receptors are important in determining central 5-HT tone. Accordingly, variation in the 5-HT1A receptor gene (HTR1A) may contribute to inter-individual differences in human pain sensitivity. The minor G-allele of the HTR1A single nucleotide polymorphism (SNP) rs6295 attenuates firing of serotonergic neurons and reduces postsynaptic expression of the receptor. Experiments in rodents suggest that 5-HT1A-agonism modulates pain in opposite directions at mild compared to high noxious intensities. Based upon this and several other similar observations, we hypothesized that G-carriers would exhibit a relative hypoalgesia at mild thermal stimuli but tend towards hyperalgesia at higher noxious intensities.
   Methods: Fourty-nine healthy individuals were selectively genotyped for rs6295. Heat-and cold-pain thresholds were assessed along with VAS-ratings of a range of suprathreshold noxious heat intensities (45 degrees C-49 degrees C). Nociceptive-flexion reflex (NFR) thresholds were also assessed. Results: Volunteers did not deviate significantly from Hardy-Weinberg equilibrium. G-carriers were less sensitive to threshold-level thermal pain. This relative hypoalgesia was abolished at suprathreshold noxious intensities where G-carriers instead increased their ratings of heat-pain significantly more than C-homozygotes. No differences with regard to NFR-thresholds emerged.
   Conclusion/Significance: To the best of our knowledge this is the first study of human pain perception on the basis of variation in HTR1A. The results illustrate the importance of including a range of stimulus intensities in assessments of pain sensitivity. In speculation, we propose that an attenuated serotonergic tone may be related to a 'hypo- to hyperalgesic' response-pattern. The involved mechanisms could be of clinical interest as variation in pain regulation is known to influence the risk of developing pain pathologies. Further investigations are therefore warranted.
C1 [Lindstedt, Fredrik; Karshikoff, Bianka; Hoglund, Caroline Olgart; Ingvar, Martin; Lekander, Mats; Kosek, Eva] Karolinska Inst, Osher Ctr Integrat Med, Stockholm, Sweden.
   [Lindstedt, Fredrik; Karshikoff, Bianka; Ingvar, Martin; Kosek, Eva] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.
   [Hoglund, Caroline Olgart] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.
   [Schalling, Martin] Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden.
   [Schalling, Martin] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.
   [Lekander, Mats] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden.
RP Lindstedt, F (reprint author), Karolinska Inst, Osher Ctr Integrat Med, Stockholm, Sweden.
EM fredrik.lindstedt@ki.se
RI Karshikoff, Bianka/I-9602-2019
OI Karshikoff, Bianka/0000-0003-1154-8103; Ingvar,
   Martin/0000-0002-9041-5714; Schalling, Martin/0000-0001-5011-2922
FU Karolinska Institute; Swedish Rheumatism Association and Stockholm
   County Council; Swedish Research Council [2011-4807]; Swedish Heart-Lung
   Foundation; Petrus and Augusta Hedlunds Stiftelse; Center for Allergy
   Research; Swedish Council for Working Life and Social Research; Swedish
   Society for Medicine; National board of Health and Welfare and Stockholm
   Stress Center
FX This study was funded by The Karolinska Institute, Swedish Rheumatism
   Association and Stockholm County Council (EK); The Swedish Research
   Council (www.vr.se), grant nr 2011-4807 (MS); The Swedish Heart-Lung
   Foundation (COH); Petrus and Augusta Hedlunds Stiftelse, The Center for
   Allergy Research, Swedish Heart-Lung Foundation, Swedish Council for
   Working Life and Social Research, The Swedish Society for Medicine, The
   National board of Health and Welfare and Stockholm Stress Center (ML).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aguglia A, J AFFECTIVE IN PRESS
   Albert PR, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-21
   Albert PR, 2010, FRONTIERS NEUROSCIEN, V4
   Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042
   Bar KJ, 2011, J CLIN PSYCHOPHARM, V31, P103, DOI 10.1097/JCP.0b013e3182046797
   Bardin L, 2004, EUR J PAIN, V8, P253, DOI 10.1016/j.ejpain.2003.09.002
   Bardin L, 2011, BEHAV PHARMACOL, V22, P390, DOI 10.1097/FBP.0b013e328349aae4
   Benarroch EE, 2008, NEUROLOGY, V71, P217, DOI 10.1212/01.wnl.0000318225.51122.63
   Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008
   Bonnefont J, 2005, PAIN, V114, P482, DOI 10.1016/j.pain.2005.01.019
   Bouali S, 2003, EUR J NEUROSCI, V18, P2203, DOI 10.1046/j.1460-9568.2003.02960.x
   Buono MJ, 2007, PHYSIOL MEAS, V28, P855, DOI 10.1088/0967-3334/28/8/008
   Buritova J, 2005, EUR J PHARMACOL, V514, P121, DOI 10.1016/j.ejphar.2005.03.016
   Buritova J, 2003, BRAIN RES, V974, P212, DOI 10.1016/S0006-8993(03)02582-4
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Clauw Daniel J, 2009, Am J Med, V122, pS3, DOI 10.1016/j.amjmed.2009.09.006
   Coggeshall RE, 2005, PROG NEUROBIOL, V77, P299, DOI 10.1016/j.pneurobio.2005.11.002
   Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100
   Coghill RC, 2010, HEADACHE, V50, P1531, DOI 10.1111/j.1526-4610.2010.01763.x
   Corruble E, 2000, PSYCHOPATHOLOGY, V33, P307, DOI 10.1159/000029163
   Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022
   Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1
   Czesak M, 2006, J NEUROSCI, V26, P1864, DOI 10.1523/JNEUROSCI.2643-05.2006
   Czesak M, 2012, J BIOL CHEM, V287, P6615, DOI 10.1074/jbc.M111.293027
   David SP, 2005, J NEUROSCI, V25, P2586, DOI 10.1523/JNEUROSCI.3769-04.2005
   de Almeida J, 2008, J NEUROCHEM, V107, P488, DOI 10.1111/j.1471-4159.2008.05649.x
   Dickens C, 2003, PSYCHOSOM MED, V65, P369, DOI 10.1097/01.PSY.0000041622.69462.06
   FASMER OB, 1986, PHARMACOL BIOCHEM BE, V25, P883, DOI 10.1016/0091-3057(86)90402-8
   Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006
   Foulkes T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000086
   France CR, 2009, PAIN, V145, P211, DOI 10.1016/j.pain.2009.06.022
   Granot M, 2011, CLIN J PAIN
   Granot M, 2009, CURR OPIN ANESTHESIO, V22, P425, DOI 10.1097/ACO.0b013e32832a40e1
   HOYER D, 1986, BRAIN RES, V376, P85, DOI 10.1016/0006-8993(86)90902-9
   Huang YY, 2004, INT J NEUROPSYCHOPH, V7, P441, DOI 10.1017/S1461145704004663
   Huo FQ, 2008, PAIN, V139, P398, DOI 10.1016/j.pain.2008.05.013
   Huo FQ, 2010, NEUROCHEM INT, V57, P749, DOI 10.1016/j.neuint.2010.08.011
   Jovanovic H, 2011, NEUROIMAGE, V55, P1178, DOI 10.1016/j.neuroimage.2010.12.060
   Kato M, 2009, AM J MED GENET B, V150B, P115, DOI 10.1002/ajmg.b.30783
   Kosek E, 2000, PAIN, V88, P69, DOI 10.1016/S0304-3959(00)00310-9
   Kosek E, 1997, PAIN, V70, P41, DOI 10.1016/S0304-3959(96)03295-2
   Kosek E, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-37
   Kraus A, 2009, PAIN, V143, P179, DOI 10.1016/j.pain.2008.12.018
   LaCroix-Fralish ML, 2009, ANNU REV PHARMACOL, V49, P97, DOI 10.1146/annurev-pharmtox-061008-103222
   Lautenbacher J S, 1998, PSYCHOSOM MED, V61, P822
   LAUTENBACHER S, 1992, PERCEPT PSYCHOPHYS, V52, P685, DOI 10.3758/BF03211705
   Le Francois B, 2008, NEUROPHARMACOLOGY, V55, P977, DOI 10.1016/j.neuropharm.2008.06.046
   LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6
   Lemonde S, 2004, INT J NEUROPSYCHOPH, V7, P501, DOI 10.1017/S1461145704004699
   Lemonde S, 2003, J NEUROSCI, V23, P8788
   Leo Raphael J, 2005, Curr Treat Options Neurol, V7, P403, DOI 10.1007/s11940-005-0032-0
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   LINDBLOM B, 1988, GENE ANAL TECH, V5, P97, DOI 10.1016/0735-0651(88)90003-9
   Lindstedt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018252
   Lindstedt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017752
   Loucif AJC, 2006, J NEUROBIOL, V66, P1475, DOI 10.1002/neu.20321
   Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5
   Malaguti A, 2011, DEPRESS ANXIETY, V28, P568, DOI 10.1002/da.20815
   Markkula R, 2009, EUR J PAIN, V13, P744, DOI 10.1016/j.ejpain.2008.09.007
   Martikainen IK, 2007, BRAIN RES, V1172, P21, DOI 10.1016/j.brainres.2007.07.036
   Matsukawa T, 2000, CRIT CARE MED, V28, P532, DOI 10.1097/00003246-200002000-00041
   Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6
   Millan MJ, 1995, SEMIN NEUROSCI, V7, P409, DOI 10.1016/1044-5765(95)90005-5
   Neziri AY, 2010, EUROPEAN J IN PRESS
   Ohayon MM, 2009, J PSYCHIATR RES, V43, P1243, DOI 10.1016/j.jpsychires.2009.10.007
   Ohno Yukihiro, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P148
   Orii R, 2003, ANESTHESIOLOGY, V98, P1223, DOI 10.1097/00000542-200305000-00026
   Perrin FE, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.98
   Polter AM, 2010, CELL SIGNAL, V22, P1406, DOI 10.1016/j.cellsig.2010.03.019
   PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4
   Rhudy JL, 2007, PAIN, V128, P244, DOI 10.1016/j.pain.2006.09.024
   Riley JL, 1999, PAIN, V81, P225, DOI 10.1016/S0304-3959(98)00258-9
   Ruoff GE, 1996, J FAM PRACTICE, V43, pS25
   RUOFF GE, 1996, J FAM PRACTICE, V43, pS34
   Sandrini G, 2005, PROG NEUROBIOL, V77, P353, DOI 10.1016/j.pneurobio.2005.11.003
   Savitz J, 2009, PROG NEUROBIOL, V88, P17, DOI 10.1016/j.pneurobio.2009.01.009
   Serretti A, 2006, CURR DRUG TARGETS, V7, P1659, DOI 10.2174/138945006779025419
   Skljarevski V, 2002, PAIN, V96, P3, DOI 10.1016/S0304-3959(02)00018-0
   Snaith R Philip, 2003, Health Qual Life Outcomes, V1, P29, DOI 10.1186/1477-7525-1-29
   Sodhi MSK, 2004, INT REV NEUROBIOL, V59, P111
   Sommer Claudia, 2006, Curr Pain Headache Rep, V10, P101, DOI 10.1007/s11916-006-0020-4
   SPROUSE JS, 1987, SYNAPSE, V1, P3, DOI 10.1002/syn.890010103
   Valencia C, 2011, J PAIN, V12, P133, DOI 10.1016/j.jpain.2010.06.002
   Wang YY, 2009, J CHEM NEUROANAT, V38, P75, DOI 10.1016/j.jchemneu.2009.04.003
   Wasserman Danuta, 2006, Behav Brain Funct, V2, P14, DOI 10.1186/1744-9081-2-14
   Wu S, 1999, PSYCHIATR GENET, V9, P105, DOI 10.1097/00041444-199906000-00010
   Wust S, 2009, PSYCHONEUROENDOCRINO, V34, P972, DOI 10.1016/j.psyneuen.2009.01.011
   YARNITSKY D, 1995, PAIN, V60, P329, DOI 10.1016/0304-3959(94)00132-X
   Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033
   Yarnitsky D, 2010, EUR J PAIN, V14, P339, DOI 10.1016/j.ejpain.2010.02.004
   Young EE, 2011, J MED GENETICS
   Zhou HY, 2007, J NEUROPHYSIOL, V97, P871, DOI 10.1152/jn.00964.2006
NR 92
TC 15
Z9 16
U1 1
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 31
PY 2012
VL 7
IS 8
AR e43221
DI 10.1371/journal.pone.0043221
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 998EY
UT WOS:000308221300010
PM 22952650
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Savas, S
   Hyde, A
   Stuckless, SN
   Parfrey, P
   Younghusband, HB
   Green, R
AF Savas, Sevtap
   Hyde, Angela
   Stuckless, Susan N.
   Parfrey, Patrick
   Younghusband, H. Banfield
   Green, Roger
TI Serotonin Transporter Gene (SLC6A4) Variations Are Associated with Poor
   Survival in Colorectal Cancer Patients
SO PLOS ONE
LA English
DT Article
ID MOOD DISORDERS; BREAST-CANCER; DUAL ROLES; DEPRESSION; LIFE; ANXIETY;
   INTERLEUKIN-6; NEWFOUNDLAND; INFLAMMATION; VASOPRESSIN
AB Prognosis in colorectal cancer patients is quite variable, even after adjustment for clinical parameters such as disease stage and microsatellite instability status. It is possible that the psychological distress experienced by patients, including anxiety and depression, may be correlated with poor prognosis. In the present study, we hypothesize that genetic variations within three genes biologically linked to the stress response, namely serotonin transporter (SLC6A4), brain-derived neurotrophic factor (BDNF), and arginine vasopressin receptor (AVPR1B) genes are associated with prognosis in colorectal cancer patients. We used a population-based cohort of 280 patients who were followed for up to 12.5 years after diagnosis. Our multivariate analysis showed that a tagSNP in the SLC6A4 gene (rs12150214) was a predictor of shorter overall survival (HR: 1.572, 95% CI: 1.142-2.164, p = 0.005) independent of stage, age, grade and MSI status. Additionally, a multivariate analysis using the combined genotypes of three polymorphisms in this gene demonstrated that the presence of any of the minor alleles at these polymorphic loci was an independent predictor of both shorter overall survival (HR: 1.631, 95% CI: 1.190-2.236, p = 0.002) and shorter disease specific survival (HR: 1.691, 95% CI: 1.138-2.512, p = 0.009). The 5-HTT protein coded by the SLC6A4 gene has also been implicated in inflammation. While our results remain to be replicated in other patient cohorts, we suggest that the genetic variations in the SLC6A4 gene contribute to poor survival in colorectal cancer patients.
C1 [Savas, Sevtap; Hyde, Angela; Younghusband, H. Banfield; Green, Roger] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada.
   [Savas, Sevtap] Mem Univ Newfoundland, Fac Med, Discipline Oncol, St John, NF, Canada.
   [Stuckless, Susan N.; Parfrey, Patrick] Mem Univ Newfoundland, Clin Epidemiol Unit, Fac Med, St John, NF, Canada.
RP Savas, S (reprint author), Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada.
EM savas@mun.ca
OI Savas, Sevtap/0000-0002-7324-938X
FU Canadian Institute of Health Research Institute of Genetics; Canadian
   Gene Cure Foundation; Memorial University of Newfoundland; Research and
   Development Corporation (RDC) of Newfoundland; CIHR; Atlantic Innovation
   Fund
FX This work was supported by the Canadian Institute of Health Research
   Institute of Genetics and the Canadian Gene Cure Foundation, Memorial
   University of Newfoundland, Research and Development Corporation (RDC)
   of Newfoundland, Interdisciplinary Team in Colorectal Cancer funded by
   CIHR, and Interdisciplinary Team in Human Genetics funded by the
   Atlantic Innovation Fund. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_
   Anisman H, 2009, J PSYCHIATR NEUROSCI, V34, P4
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Becker C, 2005, CELL CYCLE, V4, P217
   Canadian Cancer Society's Steering Committee, 2010, CAN CANC STAT 2010
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Chourbaji S, 2011, NEUROSCI BIOBEHAV R, V35, P599, DOI 10.1016/j.neubiorev.2010.07.003
   Dempster EL, 2007, ARCH GEN PSYCHIAT, V64, P1189, DOI 10.1001/archpsyc.64.10.1189
   DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M
   Ferrone C, 2010, J CLIN ONCOL, V28, P4045, DOI 10.1200/JCO.2010.27.9992
   Green RC, 2007, FAM CANCER, V6, P53, DOI 10.1007/s10689-006-9104-x
   Griebel Guy, 2003, Current Drug Targets - CNS and Neurological Disorders, V2, P191, DOI 10.2174/1568007033482850
   Gripp S, 2007, J CLIN ONCOL, V25, P3313, DOI 10.1200/JCO.2006.10.5411
   Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012
   Hamer M, 2009, J PSYCHOSOM RES, V66, P255, DOI 10.1016/j.jpsychores.2008.11.002
   Haub S, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01479.x
   Haub S, 2010, NEUROGASTROENT MOTIL, V22, pe229
   Johansson M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-283
   Kirstein M, 2002, CELL MOL LIFE SCI, V59, P1787, DOI 10.1007/PL00012506
   KUCHLER T, 2007, J CLIN ONCOL, V25, P2702, DOI DOI 10.1200/JCO.2006.08.2883
   Landgraf Rainer, 2006, CNS & Neurological Disorders-Drug Targets, V5, P167, DOI 10.2174/187152706776359664
   Lazary J, 2008, BIOL PSYCHIAT, V64, P498, DOI 10.1016/j.biopsych.2008.03.030
   Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571
   Morikawa T, 2011, JAMA-J AM MED ASSOC, V305, P1685, DOI 10.1001/jama.2011.513
   Murphy DL, 2011, CURR OPIN PHARMACOL, V11, P3, DOI 10.1016/j.coph.2011.02.008
   Okayama A, 2007, ASIAN PAC J CANCER P, V8, P191
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Phillips KA, 2008, J CLIN ONCOL, V26, P4666, DOI 10.1200/JCO.2007.14.8718
   Pucci S, 2009, CELL CYCLE, V8, P473, DOI 10.4161/cc.8.3.7652
   Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359
   Savas S, 2009, HUM MUTAT, V30, P1369, DOI 10.1002/humu.21078
   Sharma A, 2007, ANN SURG ONCOL, V14, P3435, DOI 10.1245/s10434-007-9554-x
   Sharp T, 2011, CURR OPIN PHARMACOL, V11, P45, DOI 10.1016/j.coph.2011.02.003
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Spiller R, 2008, NEUROPHARMACOLOGY, V55, P1072, DOI 10.1016/j.neuropharm.2008.07.016
   Su SY, 2009, CIRC-CARDIOVASC GENE, V2, P614, DOI 10.1161/CIRCGENETICS.109.870386
   Surget A, 2008, EUR J PHARMACOL, V583, P340, DOI 10.1016/j.ejphar.2007.11.065
   Ugnat AM, 2005, EUR J CANCER PREV, V14, P91, DOI 10.1097/00008469-200504000-00004
   Wein S, 2010, CANCER J, V16, P493, DOI 10.1097/PPO.0b013e3181f28b64
   Weinberger T, 2010, PSYCHIAT CLIN N AM, V33, P409, DOI 10.1016/j.psc.2010.01.005
   Woods MO, 2005, CLIN CANCER RES, V11, P6853, DOI 10.1158/1078-0432.CCR-05-0726
   Zamarron BF, 2011, INT J BIOL SCI, V7, P651, DOI 10.7150/ijbs.7.651
NR 42
TC 12
Z9 14
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 24
PY 2012
VL 7
IS 7
AR e38953
DI 10.1371/journal.pone.0038953
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 978NX
UT WOS:000306751300002
PM 22911682
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Ziebarth, JD
   Cook, MN
   Wang, XS
   Williams, RW
   Lu, L
   Cui, Y
AF Ziebarth, Jesse D.
   Cook, Melloni N.
   Wang, Xusheng
   Williams, Robert W.
   Lu, Lu
   Cui, Yan
TI Treatment- and Population-Dependent Activity Patterns of Behavioral and
   Expression QTLs
SO PLOS ONE
LA English
DT Article
ID QUANTITATIVE TRAIT LOCI; RECOMBINANT INBRED MICE; GENE-EXPRESSION;
   ETHANOL SENSITIVITY; HIPPOCAMPAL-NEURONS; ALCOHOL DEPENDENCE; SYSTEMS
   GENETICS; MESSENGER-RNA; MOUSE STRAINS; RAT-BRAIN
AB Genetic control of gene expression and higher-order phenotypes is almost invariably dependent on environment and experimental conditions. We use two families of recombinant inbred strains of mice (LXS and BXD) to study treatment-and genotype-dependent control of hippocampal gene expression and behavioral phenotypes. We analyzed responses to all combinations of two experimental perturbations, ethanol and restraint stress, in both families, allowing for comparisons across 8 combinations of treatment and population. We introduce the concept of QTL activity patterns to characterize how associations between genomic loci and traits vary across treatments. We identified several significant behavioral QTLs and many expression QTLs (eQTLs). The behavioral QTLs are highly dependent on treatment and population. We classified eQTLs into three groups: cis-eQTLs (expression variation that maps to within 5 Mb of the cognate gene), syntenic trans-eQTLs (the gene and the QTL are on the same chromosome but not within 5 Mb), and non-syntenic trans-eQTLs (the gene and the QTL are on different chromosomes). We found that most non-syntenic trans-eQTLs were treatment-specific whereas both classes of syntenic eQTLs were more conserved across treatments. We also found there was a correlation between regions along the genome enriched for eQTLs and SNPs that were conserved across the LXS and BXD families. Genes with eQTLs that co-localized with the behavioral QTLs and displayed similar QTL activity patterns were identified as potential candidate genes associated with the phenotypes, yielding identification of novel genes as well as genes that have been previously associated with responses to ethanol.
C1 [Ziebarth, Jesse D.; Williams, Robert W.; Cui, Yan] Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Memphis, TN USA.
   [Ziebarth, Jesse D.; Cui, Yan] Univ Tennessee, Dept Microbiol Immunol & Biochem, Hlth Sci Ctr, Memphis, TN USA.
   [Cook, Melloni N.] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA.
   [Wang, Xusheng; Williams, Robert W.; Lu, Lu] Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, Memphis, TN USA.
   [Lu, Lu] Nantong Univ, Jiangsu Key Lab Neuroregenert, Nantong, Peoples R China.
RP Ziebarth, JD (reprint author), Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Memphis, TN USA.
EM lulu@uthsc.edu; ycui2@uthsc.edu
RI Williams, Robert/H-8789-2016
OI Williams, Robert/0000-0001-8924-4447; Cui, Yan/0000-0002-7577-6845
FU University of Tennessee Center for Integrative and Translational
   Genomics; NIH [U01 AA014425, AA013499, AA017590]; Department of Defense
   [W81XHW-05-01-0227]; National Natural Science Foundation of China
   [30771200, 30971591]
FX This work was supported by The University of Tennessee Center for
   Integrative and Translational Genomics; NIH Grants U01 AA014425,
   AA013499, AA017590; a Department of Defense grant W81XHW-05-01-0227; and
   National Natural Science Foundation of China Grants 30771200 and
   30971591. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332
   Bardag-Gorce F, 2009, ALCOHOL CLIN EXP RES, V33, P684, DOI 10.1111/j.1530-0277.2008.00885.x
   Bennett B, 2008, GENES BRAIN BEHAV, V7, P659, DOI 10.1111/j.1601-183X.2008.00403.x
   Bennett B, 2002, ALCOHOL CLIN EXP RES, V26, P149, DOI 10.1097/00000374-200202000-00001
   Bennett B, 2006, J PHARMACOL EXP THER, V319, P299, DOI 10.1124/jpet.106.103572
   Blednov YA, 2005, BEHAV BRAIN RES, V165, P110, DOI 10.1016/j.bbr.2005.06.026
   Bousios S, 2001, J STEROID BIOCHEM, V78, P401, DOI 10.1016/S0960-0760(01)00123-6
   Brady KT, 1999, ALCOHOL RES HEALTH, V23, P263
   Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232
   Briand LA, 2010, BRAIN RES, V1314, P219, DOI 10.1016/j.brainres.2009.11.002
   Browman KE, 2000, ALCOHOL CLIN EXP RES, V24, P17, DOI 10.1111/j.1530-0277.2000.tb04547.x
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757
   Damodaran S, 2006, EUR J PHARMACOL, V547, P75, DOI 10.1016/j.ejphar.2006.08.005
   Darbandi-Tonkabon R, 2004, J PHARMACOL EXP THER, V308, P502, DOI 10.1124/jpet.103.058123
   DEVOR EJ, 1989, ANNU REV GENET, V23, P19, DOI 10.1146/annurev.ge.23.120189.000315
   Downing C, 2006, ALCOHOL CLIN EXP RES, V30, P1111, DOI 10.1111/j.1530-0277.2006.00137.x
   Edenberg HJ, 2006, HUM MOL GENET, V15, P1539, DOI 10.1093/hmg/ddl073
   Ehlers CL, 2010, ADDICT BIOL, V15, P185, DOI 10.1111/j.1369-1600.2009.00195.x
   Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758
   Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692
   Gou AY, 2009, NUCLEIC ACIDS RES, V37, pD840
   Grubb SC, 2009, NUCLEIC ACIDS RES, V37, pD720, DOI 10.1093/nar/gkn778
   Hitzemann R, 2004, ALCOHOL CLIN EXP RES, V28
   JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118
   Jacobson LH, 2007, BEHAV GENET, V37, P171, DOI 10.1007/s10519-006-9106-3
   Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996
   Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005
   Kirby A, 2010, GENETICS, V185, P1081, DOI 10.1534/genetics.110.115014
   Li Y, 2008, TRENDS GENET, V24, P518, DOI 10.1016/j.tig.2008.08.001
   Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0
   Lu H, 2011, NUTR NEUROSCI, V14, P80, DOI 10.1179/1476830511Y.0000000004
   Malmanger B, 2006, MAMM GENOME, V17, P1193, DOI 10.1007/s00335-006-0070-2
   MCCLEARN G. E., 1970, Contributions to behavior-genetic analysis., P3
   Mozhui K, 2010, J NEUROSCI, V31, P5367
   Mulligan MK, 2006, P NATL ACAD SCI USA, V103, P6368, DOI 10.1073/pnas.0510188103
   Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7
   Petrie J, 2001, ALCOHOL CLIN EXP RES, V25, P819, DOI 10.1111/j.1530-0277.2001.tb02285.x
   Prescott CA, 2006, MOL PSYCHIATR, V11, P603, DOI 10.1038/sj.mp.4001811
   Quigley D, 2009, NAT REV GENET, V10, P651, DOI 10.1038/nrg2617
   Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964
   Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002
   Ryabinin AE, 1998, PSYCHOPHARMACOLOGY, V139, P34, DOI 10.1007/s002130050687
   Ryabinin AE, 1997, MOL PSYCHIATR, V2, P32, DOI 10.1038/sj.mp.4000206
   Sayette MA, 1999, ALCOHOL RES HEALTH, V23, P250
   Schmidt MV, 2007, BRAIN RES, V1174, P1, DOI 10.1016/j.brainres.2007.08.023
   Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083
   Song M.J., 2009, EURASIP J BIOINFORM, V2009
   Strutz-Seebohm N, 2005, J PHYSIOL-LONDON, V565, P381, DOI 10.1113/jphysiol.2004.079582
   Thome J, 2001, BIOL PSYCHIAT, V50, P809, DOI 10.1016/S0006-3223(01)01229-X
   Treadwell JA, 2004, NEUROCHEM RES, V29, P357, DOI 10.1023/B:NERE.0000013738.06437.a6
   Ueyama T, 1997, NEUROSCI RES, V28, P103, DOI 10.1016/S0168-0102(97)00030-8
   van Nas A, 2010, GENETICS, V185, P1059, DOI 10.1534/genetics.110.116087
   Wang XS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-O7
   Williams RW, 2004, MAMM GENOME, V15, P637, DOI 10.1007/s00335-004-2380-6
   Winkler A, 1999, MOL BRAIN RES, V72, P166, DOI 10.1016/S0169-328X(99)00218-1
   Yau JLW, 2001, NEUROSCI LETT, V309, P141, DOI 10.1016/S0304-3940(01)02054-7
   Yore MA, 2010, NEUROSCIENCE, V169, P1017, DOI 10.1016/j.neuroscience.2010.05.053
   Yun SJ, 2002, NEUROSCI LETT, V318, P85, DOI 10.1016/S0304-3940(01)02492-2
   Zhou Y, 2010, BRAIN RES, V1314, P235, DOI 10.1016/j.brainres.2009.11.015
   Ziebarth JD, 2010, BIOM SCI ENG C BSEC, P1
   ZOELLER RT, 1994, MOL BRAIN RES, V24, P185
   Zuo LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026726
NR 63
TC 12
Z9 13
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 16
PY 2012
VL 7
IS 2
AR e31805
DI 10.1371/journal.pone.0031805
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 925XS
UT WOS:000302796200100
PM 22359631
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Marsh, AA
   Crowe, SL
   Yu, HH
   Gorodetsky, EK
   Goldman, D
   Blair, RJR
AF Marsh, Abigail A.
   Crowe, Samantha L.
   Yu, Henry H.
   Gorodetsky, Elena K.
   Goldman, David
   Blair, R. J. R.
TI Serotonin Transporter Genotype (5-HTTLPR) Predicts Utilitarian Moral
   Judgments
SO PLOS ONE
LA English
DT Article
ID NEGATIVE AFFECTIVITY; PREFRONTAL CORTEX; SUSCEPTIBILITY; POLYMORPHISM;
   PSYCHOPATHY; DEPRESSION; AMYGDALA; RISK; GENE
AB Background: The psychological and neurobiological processes underlying moral judgment have been the focus of extensive recent research. Here we show that serotonin transporter (5-HTTLPR) genotype predicts responses to moral dilemmas featuring foreseen harm to an innocent.
   Methodology/Principal Findings: Participants in this study judged the acceptability of actions that would unintentionally or intentionally harm an innocent victim in order to save others' lives. An analysis of variance revealed a genotype 6 scenario interaction, F(2, 63)=4.52, p=.02. Results showed that, relative to long allele homozygotes (LL), carriers of the short (S) allele showed particular reluctance to endorse utilitarian actions resulting in foreseen harm to an innocent individual. LL genotype participants rated perpetrating unintentional harm as more acceptable (M=4.98, SEM=0.20) than did SL genotype participants (M=4.65, SEM=0.20) or SS genotype participants (M=4.29, SEM=0.30). No group differences in moral judgments were observed in response to scenarios featuring intentional harm.
   Conclusions/Significance: The results indicate that inherited variants in a genetic polymorphism that influences serotonin neurotransmission influence utilitarian moral judgments as well. This finding is interpreted in light of evidence that the S allele is associated with elevated emotional responsiveness.
C1 [Marsh, Abigail A.] Georgetown Univ, Dept Psychol, Washington, DC 20057 USA.
   [Marsh, Abigail A.; Crowe, Samantha L.; Yu, Henry H.; Blair, R. J. R.] NIMH, Mood & Anxiety Program, Bethesda, MD 20892 USA.
   [Gorodetsky, Elena K.; Goldman, David] NIAAA, Sect Human Neurogenet, Bethesda, MD 90034 USA.
RP Marsh, AA (reprint author), Georgetown Univ, Dept Psychol, Washington, DC 20057 USA.
EM aam72@georgetown.edu
RI Goldman, David/F-9772-2010
OI Goldman, David/0000-0002-1724-5405
FU National Institute of Mental Health/Nathional Institutes of Health
FX This research was supported by the Intramural Research Program at the
   National Institute of Mental Health/Nathional Institutes of Health. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Blair RJR, 2007, TRENDS COGN SCI, V11, P387, DOI 10.1016/j.tics.2007.07.003
   Borg JS, 2006, J COGNITIVE NEUROSCI, V18, P803, DOI 10.1162/jocn.2006.18.5.803
   Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Collier DA, 1996, MOL PSYCHIATR, V1, P453
   Crockett MJ, 2010, P NATL ACAD SCI USA, V107, P17433, DOI 10.1073/pnas.1009396107
   Emanuel EJ, 2001, NEW ENGL J MED, V345, P915, DOI 10.1056/NEJM200109203451211
   Glenn AL, 2011, NEUROSCI BIOBEHAV R, V35, P612, DOI 10.1016/j.neubiorev.2010.07.005
   Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872
   Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011
   Harmon A, 2010, NY TIMES        0918
   Jacobs N, 2006, ARCH GEN PSYCHIAT, V63, P989, DOI 10.1001/archpsyc.63.9.989
   Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631
   Kogut T, 2005, ORGAN BEHAV HUM DEC, V97, P106, DOI 10.1016/j.obhdp.2005.02.003
   Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007
   Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463
   Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413
   WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465
NR 18
TC 21
Z9 22
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 5
PY 2011
VL 6
IS 10
AR e25148
DI 10.1371/journal.pone.0025148
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 834NA
UT WOS:000295966900010
PM 21998637
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Pang, RD
   Wang, Z
   Klosinski, LP
   Guo, YM
   Herman, DH
   Celikel, T
   Dong, HW
   Holschneider, DP
AF Pang, Raina D.
   Wang, Zhuo
   Klosinski, Lauren P.
   Guo, Yumei
   Herman, David H.
   Celikel, Tansu
   Dong, Hong Wei
   Holschneider, Daniel P.
TI Mapping Functional Brain Activation Using [C-14]-Iodoantipyrine in Male
   Serotonin Transporter Knockout Mice
SO PLOS ONE
LA English
DT Article
ID ANXIETY-RELATED TRAITS; CEREBRAL BLOOD-FLOW; DEFICIENT MICE; 5-HTTLPR
   GENOTYPE; INDICATOR FRACTIONATION; VENTRAL HIPPOCAMPUS;
   GENETIC-VARIATION; FEAR EXTINCTION; OUT MICE; AMYGDALA
AB Background: Serotonin transporter knockout mice have been a powerful tool in understanding the role played by the serotonin transporter in modulating physiological function and behavior. However, little work has examined brain function in this mouse model. We tested the hypothesis that male knockout mice show exaggerated limbic activation during exposure to an emotional stressor, similar to human subjects with genetically reduced transcription of the serotonin transporter.
   Methodology/Principal Findings: Functional brain mapping using [C-14]-iodoantipyrine was performed during recall of a fear conditioned tone. Regional cerebral blood flow was analyzed by statistical parametric mapping from autoradiographs of the three-dimensionally reconstructed brains. During recall, knockout mice compared to wild-type mice showed increased freezing, increased regional cerebral blood flow of the amygdala, insula, and barrel field somatosensory cortex, decreased regional cerebral blood flow of the ventral hippocampus, and conditioning-dependent alterations in regional cerebral blood flow in the medial prefrontal cortex (prelimbic, infralimbic, and cingulate). Anxiety tests relying on sensorimotor exploration showed a small (open field) or paradoxical effect (marble burying) of loss of the serotonin transporter on anxiety behavior, which may reflect known abnormalities in the knockout animal's sensory system. Experiments evaluating whisker function showed that knockout mice displayed impaired whisker sensation in the spontaneous gap crossing task and appetitive gap cross training.
   Conclusions: This study is the first to demonstrate altered functional activation in the serotonin transporter knockout mice of critical nodes of the fear conditioning circuit. Alterations in whisker sensation and functional activation of barrel field somatosensory cortex extend earlier reports of barrel field abnormalities, which may confound behavioral measures relying on sensorimotor exploration.
C1 [Pang, Raina D.; Klosinski, Lauren P.; Herman, David H.; Celikel, Tansu; Holschneider, Daniel P.] Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA.
   [Wang, Zhuo; Guo, Yumei; Holschneider, Daniel P.] Univ So Calif, Dept Psychiat & Behav Sci, Los Angeles, CA USA.
   [Holschneider, Daniel P.] Univ So Calif, Dept Neurol, Los Angeles, CA USA.
   [Celikel, Tansu; Holschneider, Daniel P.] Univ So Calif, Dept Cell & Neurobiol, Los Angeles, CA USA.
   [Dong, Hong Wei] Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA.
RP Pang, RD (reprint author), Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA.
EM holschne@usc.edu
RI Celikel, Tansu/P-4235-2018
FU NARSAD: The Brain & Behavior Research Fund
FX NARSAD: The Brain & Behavior Research Fund. The funders had no role in
   the study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Baganz NL, 2008, P NATL ACAD SCI USA, V105, P18976, DOI 10.1073/pnas.0800466105
   Bengel D, 1998, MOL PHARMACOL, V53, P649
   Bilder RM, 2009, NEUROSCIENCE, V164, P30, DOI 10.1016/j.neuroscience.2009.01.027
   Bissiere S, 2008, BIOL PSYCHIAT, V63, P821, DOI 10.1016/j.biopsych.2007.10.022
   Carroll JC, 2007, BEHAV GENET, V37, P214, DOI 10.1007/s10519-006-9129-9
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Celikel T, 2007, P NATL ACAD SCI USA, V104, P1395, DOI 10.1073/pnas.0610267104
   Chubakov A R, 1993, Neurosci Behav Physiol, V23, P271, DOI 10.1007/BF01182928
   Dai JX, 2008, P NATL ACAD SCI USA, V105, P11981, DOI 10.1073/pnas.0801329105
   Dong H.W., 2008, ALLEN REFERENCE ATLA
   Dubois A, 2008, NEUROIMAGE, V40, P482, DOI 10.1016/j.neuroimage.2007.11.054
   Esaki T, 2005, P NATL ACAD SCI USA, V102, P5582, DOI 10.1073/pnas.0501509102
   Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031
   Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA
   FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122
   Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256
   Gillespie NA, 2005, PSYCHOL MED, V35, P101, DOI 10.1017/S0033291704002727
   Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601
   Gorton LM, 2010, BEHAV BRAIN RES, V213, P253, DOI 10.1016/j.bbr.2010.05.009
   Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186
   Greenberg BD, 1999, AM J MED GENET, V88, P83, DOI 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.0.CO;2-0
   GYERTYAN I, 1995, BEHAV PHARMACOL, V6, P24
   Hansen N, 2011, NEUROSCI LETT, V495, P93, DOI 10.1016/j.neulet.2011.03.035
   Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005
   Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146
   Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366
   Hohoff C, 2009, J NEURAL TRANSM, V116, P679, DOI 10.1007/s00702-009-0215-z
   Hoistad M, 2008, NEUROIMAGE, V40, P1016, DOI 10.1016/j.neuroimage.2007.12.043
   Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-183X.2003.00050.x
   HOLSCHNEIDER D, 2010, GASTROENTEROLOGY, V138, pS765
   Holschneider DP, 2008, METHODS, V45, P255, DOI 10.1016/j.ymeth.2008.04.006
   Holschneider DP, 2004, NEUROSCI BIOBEHAV R, V28, P449, DOI 10.1016/j.neubiorev.2004.06.007
   JONES SC, 1991, J CEREBR BLOOD F MET, V11, P236, DOI 10.1038/jcbfm.1991.55
   Kalueff AV, 2006, NEUROREPORT, V17, P1347, DOI 10.1097/01.wnr.0000230514.08962.76
   Karg K., 2011, ARCH GEN PSYCHIAT
   Katsuragi S, 1999, BIOL PSYCHIAT, V45, P368, DOI 10.1016/S0006-3223(98)00090-0
   Keene CS, 2008, BEHAV NEUROSCI, V122, P1070, DOI 10.1037/a0012895
   Lee JH, 2005, INT J CONTROL AUTOM, V3, P32
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   Linder AE, 2008, AM J PHYSIOL-HEART C, V294, pH1745, DOI 10.1152/ajpheart.91415.2007
   Line SJ, 2011, EUR NEUROPSYCHOPHARM, V21, P108, DOI 10.1016/j.euroneuro.2010.08.005
   Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6
   Lukoyanov NV, 2006, BEHAV BRAIN RES, V173, P229, DOI 10.1016/j.bbr.2006.06.026
   Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97
   Matsumoto M, 2004, BRAIN RES, V1022, P221, DOI 10.1016/j.brainres.2004.06.078
   Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008
   Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016
   Munafo MR, 2009, AM J MED GENET B, V150B, P271, DOI 10.1002/ajmg.b.30808
   Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284
   Nguyen PT, 2004, NEUROIMAGE, V23, P252, DOI 10.1016/j.neuroimage.2004.05.014
   Ni W, 2006, CLIN EXP PHARMACOL P, V33, P575, DOI 10.1111/j.1440-1681.2006.04410.x
   NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X
   PATLAK CS, 1984, J CEREBR BLOOD F MET, V4, P47, DOI 10.1038/jcbfm.1984.7
   Persico AM, 2001, J NEUROSCI, V21, P6862
   Petrovic P, 2004, J COGNITIVE NEUROSCI, V16, P1289, DOI 10.1162/0898929041920469
   Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463
   PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037//0735-7044.106.2.274
   SAKURADA O, 1978, AM J PHYSIOL, V234, pH59
   Salichon N, 2001, J NEUROSCI, V21, P884
   Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005
   Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848
   Tjurmina OA, 2002, ENDOCRINOLOGY, V143, P4520, DOI 10.1210/en.2002-220416
   VANUITERT RL, 1978, STROKE, V9, P67, DOI 10.1161/01.STR.9.1.67
   Vogel C, 2003, J NEUROSCI, V23, P708
   Voigts J, 2008, J NEUROPHYSIOL, V100, P504, DOI 10.1152/jn.00012.2008
   Wehner Jeanne M, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0805cs27
   Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007
   YASUI Y, 1991, J COMP NEUROL, V303, P355, DOI 10.1002/cne.903030303
   Zhang WN, 2001, BEHAV BRAIN RES, V126, P159, DOI 10.1016/S0166-4328(01)00256-X
   Zhou FC, 2002, BRAIN RES, V942, P109, DOI 10.1016/S0006-8993(02)02709-9
NR 70
TC 26
Z9 26
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 23
PY 2011
VL 6
IS 8
AR e23869
DI 10.1371/journal.pone.0023869
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 811YA
UT WOS:000294253500035
PM 21886833
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Lindstedt, F
   Berrebi, J
   Greayer, E
   Lonsdorf, TB
   Schalling, M
   Ingvar, M
   Kosek, E
AF Lindstedt, Fredrik
   Berrebi, Jonathan
   Greayer, Erik
   Lonsdorf, Tina B.
   Schalling, Martin
   Ingvar, Martin
   Kosek, Eva
TI Conditioned Pain Modulation Is Associated with Common Polymorphisms in
   the Serotonin Transporter Gene
SO PLOS ONE
LA English
DT Article
ID NOXIOUS INHIBITORY CONTROLS; NOCICEPTIVE FLEXION REFLEX; RAT
   SPINAL-CORD; DORSAL-HORN; 5-HTTLPR POLYMORPHISM; REGULATORY REGION;
   SCORING CRITERIA; NFR THRESHOLD; ISCHEMIC PAIN; FIBROMYALGIA
AB Background: Variation in the serotonin transporter (5-HTT) gene (SLC6A4) has been shown to influence a wide range of affective processes. Low 5-HTT gene-expression has also been suggested to increase the risk of chronic pain. Conditioned pain modulation (CPM) - i.e. 'pain inhibits pain' - is impaired in chronic pain states and, reciprocally, aberrations of CPM may predict the development of chronic pain. Therefore we hypothesized that a common variation in the SLC6A4 is associated with inter-individual variation in CPM. Forty-five healthy subjects recruited on the basis of tri-allelic 5-HTTLPR genotype, with inferred high or low 5-HTT-expression, were included in a double-blind study. A submaximal-effort tourniquet test was used to provide a standardized degree of conditioning ischemic pain. Individualized noxious heat and pressure pain thresholds (PPTs) were used as subjective test-modalities and the nociceptive flexion reflex (NFR) was used to provide an objective neurophysiological window into spinal processing.
   Results: The low, as compared to the high, 5-HTT-expressing group exhibited significantly reduced CPM-mediated pain inhibition for PPTs (p = 0.02) and heat-pain (p = 0.02). The CPM-mediated inhibition of the NFR, gauged by increases in NFR-threshold, did not differ significantly between groups (p = 0.75). Inhibition of PPTs and heat-pain were correlated (Spearman's rho = 0.35, p = 0.02), whereas the NFR-threshold increase was not significantly correlated with degree of inhibition of these subjectively reported modalities.
   Conclusions: Our results demonstrate the involvement of the tri-allelic 5-HTTLPR genotype in explaining clinically relevant inter-individual differences in pain perception and regulation. Our results also illustrate that shifts in NFR-thresholds do not necessarily correlate to the modulation of experienced pain. We discuss various possible mechanisms underlying these findings and suggest a role of regulation of 5-HT receptors along the neuraxis as a function of differential 5-HTT-expression.
C1 [Lindstedt, Fredrik; Berrebi, Jonathan; Greayer, Erik; Lonsdorf, Tina B.; Ingvar, Martin; Kosek, Eva] Karolinska Inst, Stockholm Brain Inst, Osher Ctr Integrat Med, Dept Clin Neurosci, Stockholm, Sweden.
   [Lonsdorf, Tina B.] Univ Hosp Eppendorf, Dept Syst Neurosci, Hamburg, Germany.
   [Lonsdorf, Tina B.; Schalling, Martin] Karolinska Inst, Neurogenet Unit, Dept Mol Med & Surg, Stockholm, Sweden.
   [Lonsdorf, Tina B.; Schalling, Martin] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.
RP Lindstedt, F (reprint author), Karolinska Inst, Stockholm Brain Inst, Osher Ctr Integrat Med, Dept Clin Neurosci, Stockholm, Sweden.
EM fredrik.lindstedt@ki.se
RI Lonsdorf, Tina/K-8657-2017
OI Ingvar, Martin/0000-0002-9041-5714; Lonsdorf, Tina/0000-0003-1501-4846
FU Osher foundation; Swedish Research Council [2009-2322, 2008-3307];
   Karolinska Institutet; Karolinska University Hospital
FX This study was funded by the Osher foundation (www.osherfoundation.org)
   and the Swedish Research Council (www.vr.se), grant nr 2009-2322 (MI)
   and 2008-3307 (MS). The study was further supported by funds from
   Karolinska Institutet and Karolinska University Hospital (MS). The
   funders had no role in study design, data collection and analysis,
   decision to publish, preparation of the manuscript.
CR Ablin JN, 2009, CURR PAIN HEADACHE R, V13, P343, DOI 10.1007/s11916-009-0056-3
   Arendt-Nielsen L, 2008, PAIN, V140, P465, DOI 10.1016/j.pain.2008.09.027
   Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042
   Bardin L, 2004, EUR J PAIN, V8, P253, DOI 10.1016/j.ejpain.2003.09.002
   Bardin L, 2003, PHARMACOLOGY, V67, P182, DOI 10.1159/000068404
   BARS DL, 1979, PAIN, V6, P305
   Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008
   Boettger MK, 2007, EUR J PAIN, V11, P819, DOI 10.1016/j.ejpain.2006.12.004
   BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815
   Bouhassira D, 2003, BRAIN, V126, P1068, DOI 10.1093/brain/awg106
   Brenner B, 2007, J NEUROCHEM, V102, P206, DOI 10.1111/j.1471-4159.2007.04542.x
   Buskila D, 2007, BEST PRACT RES CL RH, V21, P535, DOI 10.1016/j.berh.2007.02.011
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   CHITOUR D, 1982, BRAIN RES, V236, P329, DOI 10.1016/0006-8993(82)90718-1
   Christidis N, 2007, CLIN J PAIN, V23, P467, DOI 10.1097/AJP.0b013e318058abb1
   Cohen H, 2002, ARTHRITIS RHEUM, V46, P845, DOI 10.1002/art.10103
   Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022
   Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131
   Danziger N, 1998, PAIN, V75, P85, DOI 10.1016/S0304-3959(97)00208-X
   DICKENSON AH, 1980, BRAIN RES, V200, P293, DOI 10.1016/0006-8993(80)90921-X
   DICKENSON AH, 1981, BRAIN RES, V216, P313, DOI 10.1016/0006-8993(81)90133-5
   France CR, 2009, PAIN, V145, P211, DOI 10.1016/j.pain.2009.06.022
   Goffaux P, 2007, PAIN, V130, P137, DOI 10.1016/j.pain.2006.11.011
   Golimbet VE, 2010, MOL BIOL+, V44, P223, DOI 10.1134/S0026893310020068
   Holden JE, 2005, NEUROSCIENCE, V135, P1255, DOI 10.1016/j.neuroscience.2005.07.023
   Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62
   Jensen KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006016
   Karg K., 2011, ARCH GEN PSYCHIAT
   Kayser V, 2007, PAIN, V130, P235, DOI 10.1016/j.pain.2006.11.015
   Kosek E, 2000, PAIN, V88, P69, DOI 10.1016/S0304-3959(00)00310-9
   Kosek E, 1997, PAIN, V70, P41, DOI 10.1016/S0304-3959(96)03295-2
   Kosek E, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-37
   KRAUS E, 1982, BRAIN RES, V231, P461, DOI 10.1016/0006-8993(82)90384-5
   LaCroix-Fralish ML, 2009, ANNU REV PHARMACOL, V49, P97, DOI 10.1146/annurev-pharmtox-061008-103222
   LANNERSTEN L, 2010, PAIN IN PRESS
   Lariviere M, 2007, CLIN J PAIN, V23, P506, DOI 10.1097/AJP.0b013e31806a23e8
   Le Bars D, 2002, BRAIN RES REV, V40, P29, DOI 10.1016/S0165-0173(02)00186-8
   LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6
   Leonard G, 2009, PAIN, V147, P217, DOI 10.1016/j.pain.2009.09.009
   LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   MARKS D, 2009, CURR NEUROPHARMACOL, V4, P331
   Millan MJ, 1995, BEHAV BRAIN RES, V73, P69
   Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6
   MOORE PA, 1979, PAIN, V6, P375, DOI 10.1016/0304-3959(79)90055-1
   Nahmias F, 2009, PAIN, V147, P224, DOI 10.1016/j.pain.2009.09.016
   NISHIOKA K, 1995, LIFE SCI, V56, P485, DOI 10.1016/0024-3205(94)00477-A
   Noskova T, 2008, PROG NEURO-PSYCHOPH, V32, P1735, DOI 10.1016/j.pnpbp.2008.07.012
   Nussbaum EL, 1998, PHYS THER, V78, P160, DOI 10.1093/ptj/78.2.160
   Offenbaecher M, 1999, ARTHRITIS RHEUM-US, V42, P2482, DOI 10.1002/1529-0131(199911)42:11<2482::AID-ANR27>3.0.CO;2-B
   Phillips Ceri J, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P591, DOI 10.1586/14737167.6.5.591
   Pinerua-Shuhaibar L, 1999, J AFFECT DISORDERS, V56, P119, DOI 10.1016/S0165-0327(99)00051-8
   Potvin S, 2010, EUR J PAIN, V14, P742, DOI 10.1016/j.ejpain.2009.12.004
   Price DD, 2003, PAIN, V106, P215, DOI 10.1016/j.pain.2003.10.016
   Pud D, 2009, PAIN, V144, P16, DOI 10.1016/j.pain.2009.02.015
   Rhudy JL, 2007, PAIN, V128, P244, DOI 10.1016/j.pain.2006.09.024
   RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S
   Sandrini G, 2006, CEPHALALGIA, V26, P782, DOI 10.1111/j.1468-2982.2006.01130.x
   Sandrini G, 2005, PROG NEUROBIOL, V77, P353, DOI 10.1016/j.pneurobio.2005.11.003
   Serretti A, 2006, CURR DRUG TARGETS, V7, P1659, DOI 10.2174/138945006779025419
   Simmons AN, 2009, INT J NEUROPSYCHOPH, V12, P1009, DOI 10.1017/S1461145709990149
   Skljarevski V, 2002, PAIN, V96, P3, DOI 10.1016/S0304-3959(02)00018-0
   Spaeth M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2715
   Sur C, 1996, EUR J NEUROSCI, V8, P2753, DOI 10.1111/j.1460-9568.1996.tb01570.x
   Szilagyi A, 2006, HEADACHE, V46, P478, DOI 10.1111/j.1526-4610.2006.00379.x
   Wei F, 2010, J NEUROSCI, V30, P8624, DOI 10.1523/JNEUROSCI.5389-09.2010
   Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789
   WILLEIT M, NEUROIMAGE IN PRESS
   WILLER JC, 1984, BRAIN, V107, P1095, DOI 10.1093/brain/107.4.1095
   WILLER JC, 1989, J NEUROPHYSIOL, V62, P1028
   Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033
   Yarnitsky D, 2010, EUR J PAIN, V14, P339, DOI 10.1016/j.ejpain.2010.02.004
NR 72
TC 46
Z9 48
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 28
PY 2011
VL 6
IS 3
AR e18252
DI 10.1371/journal.pone.0018252
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 743XV
UT WOS:000289053800034
PM 21464942
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Lindstedt, F
   Lonsdorf, TB
   Schalling, M
   Kosek, E
   Ingvar, M
AF Lindstedt, Fredrik
   Lonsdorf, Tina B.
   Schalling, Martin
   Kosek, Eva
   Ingvar, Martin
TI Perception of Thermal Pain and the Thermal Grill Illusion Is Associated
   with Polymorphisms in the Serotonin Transporter Gene
SO PLOS ONE
LA English
DT Article
ID RAT SPINAL-CORD; SKIN TEMPERATURE; DECREASED SENSITIVITY; 5-HT1A-LIKE
   RECEPTOR; ADJUSTMENT DISORDER; TREATMENT RESPONSE; REGULATORY REGION;
   MAJOR DEPRESSION; PERIPHERAL-NERVE; MICE LACKING
AB Aim: The main aim of this study was to assess if the perception of thermal pain thresholds is associated with genetically inferred levels of expression of the 5-HT transporter (5-HTT). Additionally, the perception of the so-called thermal grill illusion (TGI) was assessed. Forty-four healthy individuals (27 females, 17 males) were selected a-priori based on their 5-HTTLPR/rs25531 ('tri-allelic 5-HTTLPR') genotype, with inferred high or low 5-HTT expression. Thresholds for heat- and cold-pain were determined along with the sensory and affective dimensions of the TGI.
   Results: Thresholds to heat-and cold-pain correlated strongly (rho = -0.58, p<0.001). Individuals in the low 5-HTT-expressing group were significantly less sensitive to heat-pain (p = 0.02) and cold-pain (p = 0.03), compared to the high-expressing group. A significant gender-by-genotype interaction also emerged for cold-pain perception (p = 0.02); low 5-HTT-expressing females were less sensitive. The TGI was rated as significantly more unpleasant (affective-motivational dimension) than painful (sensory-discriminatory dimension), (p<0.001). Females in the low 5-HTT expressing group rated the TGI as significantly less unpleasant than high 5-HTT expressing females (p, 0.05), with no such differences among men.
   Conclusion/Significance: We demonstrate an association between inferred low 5-HTT expression and elevated thresholds to thermal pain in healthy non-depressed individuals. Despite the fact that reduced 5-HTT expression is a risk factor for chronic pain we found it to be related to hypoalgesia for threshold thermal pain. Low 5-HTT expression is, however, also a risk factor for depression where thermal insensitivity is often seen. Our results may thus contribute to a better understanding of the molecular underpinnings of such paradoxical hypoalgesia. The results point to a differential regulation of thermoafferent-information along the neuraxis on the basis of 5-HTT expression and gender. The TGI, suggested to rely on the central integration of thermoafferent-information, may prove a valuable tool in probing the affective-motivational dimension of these putative mechanisms.
C1 [Lindstedt, Fredrik; Lonsdorf, Tina B.; Kosek, Eva; Ingvar, Martin] Karolinska Inst, Osher Ctr Integrat Med, Stockholm Brain Inst, Dept Clin Neurosci, Stockholm, Sweden.
   [Lonsdorf, Tina B.] Univ Hosp Eppendorf, Dept Syst Neurosci, Hamburg, Germany.
   [Lonsdorf, Tina B.; Schalling, Martin] Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden.
   [Lonsdorf, Tina B.; Schalling, Martin] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.
RP Lindstedt, F (reprint author), Karolinska Inst, Osher Ctr Integrat Med, Stockholm Brain Inst, Dept Clin Neurosci, Stockholm, Sweden.
EM fredrik.lindstedt@ki.se
RI Lonsdorf, Tina/K-8657-2017
OI Ingvar, Martin/0000-0002-9041-5714; Lonsdorf, Tina/0000-0003-1501-4846
FU Osher foundation; Swedish Research Council [2009-2322, 2008-3307];
   Karolinska Institutet; Karolinska University Hospital
FX This study was funded by the Osher foundation (www.osherfoundation.org)
   and the Swedish Research Council (www.vr.se), grant nr 2009-2322 (MI)
   and 2008-3307 (MS). The study was further supported by funds from
   Karolinska Institutet and Karolinska University Hospital (MS). The
   funders had no role in study design, data collection and analysis,
   decision to publish, preparation of the manuscript.
CR ARNTZ A, 1991, BEHAV RES THER, V29, P41, DOI 10.1016/S0005-7967(09)80006-5
   ARNTZ A, 1994, PAIN, V56, P307, DOI 10.1016/0304-3959(94)90169-4
   Bar KR, 2006, EUR J PAIN, V10, P467, DOI 10.1016/j.ejpain.2005.07.001
   Bar KJ, 2005, PAIN, V117, P97, DOI 10.1016/j.pain.2005.05.016
   BENICIO NF, 2010, GENDER DIFFERENCES 1, V183, P157
   Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802
   Berglund B, 2002, PAIN, V96, P177, DOI 10.1016/S0304-3959(01)00443-2
   BERIC A, 1988, PAIN, V34, P109, DOI 10.1016/0304-3959(88)90155-8
   Berna C, 2010, BIOL PSYCHIAT, V67, P1083, DOI 10.1016/j.biopsych.2010.01.014
   Boettger MK, 2007, EUR J PAIN, V11, P819, DOI 10.1016/j.ejpain.2006.12.004
   Boettger MK, 2011, PAIN, V152, P123, DOI 10.1016/j.pain.2010.10.003
   Bouali S, 2003, EUR J NEUROSCI, V18, P2203, DOI 10.1046/j.1460-9568.2003.02960.x
   Bouhassira D, 2005, PAIN, V114, P160, DOI 10.1016/j.pain.2004.12.014
   Brummett BH, 2008, BEHAV GENET, V38, P476, DOI 10.1007/s10519-008-9219-y
   Buono MJ, 2007, PHYSIOL MEAS, V28, P855, DOI 10.1088/0967-3334/28/8/008
   Buskila D, 2007, BEST PRACT RES CL RH, V21, P535, DOI 10.1016/j.berh.2007.02.011
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   CHERYCROZE S, 1983, PAIN, V17, P109, DOI 10.1016/0304-3959(83)90137-9
   Clauw Daniel J, 2009, Am J Med, V122, pS3, DOI 10.1016/j.amjmed.2009.09.006
   Corruble E, 2000, PSYCHOPATHOLOGY, V33, P307, DOI 10.1159/000029163
   Craig AD, 2008, PAIN, V135, P215, DOI 10.1016/j.pain.2008.01.022
   Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022
   CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144
   Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0
   Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131
   Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1
   Dannlowski U, 2010, NEUROIMAGE, V53, P893, DOI 10.1016/j.neuroimage.2009.11.073
   DAVIDSON PO, 1969, J PSYCHOSOM RES, V13, P83, DOI 10.1016/0022-3999(69)90023-3
   Dickens C, 2003, PSYCHOSOM MED, V65, P369, DOI 10.1097/01.PSY.0000041622.69462.06
   Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843
   Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006
   Fortier E, 2010, NEUROSCI LETT, V485, P261, DOI 10.1016/j.neulet.2010.09.026
   FREY BN, 2009, EUROPEAN PSYCHIAT, V24, pS681
   Fruhstorfer H, 2003, EUR J PAIN-LONDON, V7, P63, DOI 10.1016/S1090-3801(02)00056-3
   FURMAN DJ, SOCIAL COGNITIVE AFF
   Golimbet VE, 2010, MOL BIOL+, V44, P223, DOI 10.1134/S0026893310020068
   Graff-Guerrero A, 2005, NEUROIMAGE, V25, P1197, DOI 10.1016/j.neuroimage.2004.12.020
   Green BG, 2007, SOMATOSENS MOT RES, V24, P71, DOI 10.1080/08990220701388117
   Hesketh PJ, 2006, SUPPORT CARE CANCER, V14, P354, DOI 10.1007/s00520-005-0914-4
   Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008
   Hodges MR, 2010, J APPL PHYSIOL, V108, P1425, DOI 10.1152/japplphysiol.01270.2009
   Ito A, 2004, BONE, V35, P697, DOI 10.1016/j.bone.2004.04.012
   Ito A, 2000, J NEUROSCI, V20, P6302, DOI 10.1523/JNEUROSCI.20-16-06302.2000
   Jensen KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006016
   Jochum T, 2007, BEHAV BRAIN RES, V183, P18, DOI 10.1016/j.bbr.2007.05.022
   KARG K, 2011, ARCH GEN PSYCHIAT AR, V2010, P2189
   Kayser V, 2007, PAIN, V130, P235, DOI 10.1016/j.pain.2006.11.015
   Kern D, 2008, PAIN, V139, P653, DOI 10.1016/j.pain.2008.07.001
   Kern D, 2008, PAIN, V135, P291, DOI 10.1016/j.pain.2007.12.001
   Kim DK, 2005, NEUROPHARMACOLOGY, V49, P798, DOI 10.1016/j.neuropharm.2005.08.010
   Kornstein SG, 2000, AM J PSYCHIAT, V157, P1445, DOI 10.1176/appi.ajp.157.9.1445
   Kosek E, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-37
   Kundermann B, 2009, J PSYCHIATR RES, V43, P1253, DOI 10.1016/j.jpsychires.2009.04.012
   Kwang T, 2010, DEPRESS ANXIETY, V27, P746, DOI 10.1002/da.20708
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   Lothe A, 2009, NEUROIMAGE, V47, P482, DOI 10.1016/j.neuroimage.2009.04.067
   Lowry CA, 2009, J PSYCHOPHARMACOL, V23, P392, DOI 10.1177/0269881108099956
   Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5
   LYNN B, 1977, PAIN, V3, P353, DOI 10.1016/0304-3959(77)90065-3
   Maluchenko NV, 2009, B EXP BIOL MED+, V147, P462, DOI 10.1007/s10517-009-0559-2
   MARLIER L, 1991, J NEUROCYTOL, V20, P310, DOI 10.1007/BF01235548
   MARSTON OJ, 2011, EUROPEAN J IN PRESS
   MATSUDA T, 1991, LIFE SCI, V48, P1627, DOI 10.1016/0024-3205(91)90122-R
   Matsukawa T, 2000, CRIT CARE MED, V28, P532, DOI 10.1097/00003246-200002000-00041
   McAllen RM, 2010, EUR J APPL PHYSIOL, V109, P27, DOI 10.1007/s00421-009-1295-z
   McQueen JK, 1999, MOL BRAIN RES, V63, P241, DOI 10.1016/S0169-328X(98)00281-2
   Millan MJ, 1995, BEHAV BRAIN RES, V73, P69
   Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6
   Millan MJ, 1995, SEMIN NEUROSCI, V7, P409, DOI 10.1016/1044-5765(95)90005-5
   Moalem G, 2005, NEUROSCIENCE, V134, P1399, DOI 10.1016/j.neuroscience.2005.05.046
   Mogil JS, 1999, J NEUROSCI, V19
   Moskowitz M, 2006, FOCUS, VIV, P465
   Neziri AY, 2010, EUROPEAN J IN PRESS
   Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308
   Noskova T, 2008, PROG NEURO-PSYCHOPH, V32, P1735, DOI 10.1016/j.pnpbp.2008.07.012
   Offenbaecher M, 1999, ARTHRITIS RHEUM-US, V42, P2482, DOI 10.1002/1529-0131(199911)42:11<2482::AID-ANR27>3.0.CO;2-B
   Oh EJ, 2000, J NEUROPHYSIOL, V84, P51
   Page NM, 2005, PEPTIDES, V26, P1356, DOI 10.1016/j.peptides.2005.03.030
   Palm F, 2008, EUR J PAIN, V12, P790, DOI 10.1016/j.ejpain.2007.11.009
   Pertovaara A, 1996, EXP BRAIN RES, V107, P497
   Polgar E, 2002, NEUROSCIENCE, V109, P799, DOI 10.1016/S0306-4522(01)00304-9
   POTVIN S, 2010, EUROPEAN J IN PRESS
   PRICE DD, 1987, PAIN, V28, P297, DOI 10.1016/0304-3959(87)90065-0
   Price Donald D, 2002, Mol Interv, V2, P392, DOI 10.1124/mi.2.6.392
   Rhudy JL, 2000, PAIN, V84, P65, DOI 10.1016/S0304-3959(99)00183-9
   Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006
   Rucci P, 2009, AM J MED GENET B, V150B, P907, DOI 10.1002/ajmg.b.30917
   Schwier C, 2010, J PAIN, V11, P287, DOI 10.1016/j.jpain.2009.07.012
   Serretti A, 2006, CURR DRUG TARGETS, V7, P1659, DOI 10.2174/138945006779025419
   Simmons AN, 2009, INT J NEUROPSYCHOPH, V12, P1009, DOI 10.1017/S1461145709990149
   Strigo IA, 2008, ARCH GEN PSYCHIAT, V65, P1275, DOI 10.1001/archpsyc.65.11.1275
   Strigo IA, 2008, PSYCHOSOM MED, V70, P338, DOI 10.1097/PSY.00136181656a48
   Suzuki R, 2004, TRENDS PHARMACOL SCI, V25, P613, DOI 10.1016/j.tips.2004.10.002
   Thunberg T., 1896, UPPSALA LAKFOREN FOR, V2, P489
   Vigod SN, 2009, CURR OPIN PSYCHIATR, V22, P396, DOI 10.1097/YCO.0b013e3283297127
   Vogel C, 2003, J NEUROSCI, V23, P708
   Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789
   Wesseldijk F, 2008, ANESTH ANALG, V106, P1862, DOI 10.1213/ane.0b013618172cf4
   Willis WD, 2001, ANN NY ACAD SCI, V933, P142
   Wise TN, 2007, PAIN MED, V8, pS75, DOI 10.1111/j.1526-4637.2007.00352.x
   Wust S, 2009, PSYCHONEUROENDOCRINO, V34, P972, DOI 10.1016/j.psyneuen.2009.01.011
NR 101
TC 45
Z9 49
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 15
PY 2011
VL 6
IS 3
AR e17752
DI 10.1371/journal.pone.0017752
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 736SH
UT WOS:000288513900020
PM 21423614
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Lederle, L
   Weber, S
   Wright, T
   Feyder, M
   Brigman, JL
   Crombag, HS
   Saksida, LM
   Bussey, TJ
   Holmes, A
AF Lederle, Lauren
   Weber, Susanna
   Wright, Tara
   Feyder, Michael
   Brigman, Jonathan L.
   Crombag, Hans S.
   Saksida, Lisa M.
   Bussey, Timothy J.
   Holmes, Andrew
TI Reward-Related Behavioral Paradigms for Addiction Research in the Mouse:
   Performance of Common Inbred Strains
SO PLOS ONE
LA English
DT Article
ID REPEATED MATERNAL SEPARATION; GOAL-DIRECTED BEHAVIOR; KNOCK-OUT MICE;
   HABIT FORMATION; PREFRONTAL CORTEX; AMPA RECEPTOR; STRESS; ANXIETY;
   EXTINCTION; REINFORCER
AB The mouse has emerged as a uniquely valuable species for studying the molecular and genetic basis of complex behaviors and modeling neuropsychiatric disease states. While valid and reliable preclinical assays for reward-related behaviors are critical to understanding addiction-related processes, and various behavioral procedures have been developed and characterized in rats and primates, there have been relatively few studies using operant-based addiction-relevant behavioral paradigms in the mouse. Here we describe the performance of the C57BL/6J inbred mouse strain on three major reward-related paradigms, and replicate the same procedures in two other commonly used inbred strains (DBA/2J, BALB/cJ). We examined Pavlovian-instrumental transfer (PIT) by measuring the ability of an auditory cue associated with food reward to promote an instrumental (lever press) response. In a separate experiment, we assessed the acquisition and extinction of a simple stimulus-reward instrumental behavior on a touchscreen-based task. Reinstatement of this behavior was then examined following either continuous exposure to cues (conditioned reinforcers, CRs) associated with reward, brief reward and CR exposure, or brief reward exposure followed by continuous CR exposure. The third paradigm examined sensitivity of an instrumental (lever press) response to devaluation of food reward (a probe for outcome insensitive, habitual behavior) by repeated pairing with malaise. Results showed that C57BL/6J mice displayed robust PIT, as well as clear extinction and reinstatement, but were insensitive to reinforcer devaluation. DBA/2J mice showed good PIT and (rewarded) reinstatement, but were slow to extinguish and did not show reinforcer devaluation or significant CR-reinstatement. BALB/cJ mice also displayed good PIT, extinction and reinstatement, and retained instrumental responding following devaluation, but, unlike the other strains, demonstrated reduced Pavlovian approach behavior (food magazine head entries). Overall, these assays provide robust paradigms for future studies using the mouse to elucidate the neural, molecular and genetic factors underpinning reward-related behaviors relevant to addiction research.
C1 [Lederle, Lauren; Weber, Susanna; Wright, Tara; Feyder, Michael; Brigman, Jonathan L.; Holmes, Andrew] NIAAA, Sect Behav Sci & Genet, Lab Integrat Neurosci, NIH, Rockville, MD 20852 USA.
   [Crombag, Hans S.] Univ Sussex, Sch Psychol, Behav & Clin Neurosci Res Grp, Brighton, E Sussex, England.
   [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England.
   [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Med Res Council, Cambridge, England.
   [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England.
RP Lederle, L (reprint author), NIAAA, Sect Behav Sci & Genet, Lab Integrat Neurosci, NIH, Rockville, MD 20852 USA.
EM holmesan@mail.nih.gov
RI Saksida, Lisa/M-2753-2016; Brigman, Jonathan/O-4978-2016; Bussey,
   Timothy/M-2758-2016
OI Saksida, Lisa/0000-0002-8416-8171; Bussey, Timothy/0000-0001-7518-4041
FU National Institute on Alcohol Abuse and Alcoholism
FX Research supported by National Institute on Alcohol Abuse and Alcoholism
   Intramural Research Program. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Anisman H, 2001, BEHAV NEUROSCI, V115, P443, DOI 10.1037/0735-7044.115.2.443
   Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007
   BALLEINE BW, 1995, J EXP PSYCHOL ANIM B, V21, P203, DOI 10.1037//0097-7403.21.3.203
   Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1
   BAXTER DJ, 1982, ANIM LEARN BEHAV, V10, P201, DOI 10.3758/BF03212271
   BELKNAP JK, 1993, PSYCHOPHARMACOLOGY, V112, P503, DOI 10.1007/BF02244901
   Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1
   Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9
   Boyce-Rustay JM, 2008, BEHAV BRAIN RES, V186, P133, DOI 10.1016/j.bbr.2007.07.031
   Brigman JL, 2008, LEARN MEMORY, V15, P50, DOI 10.1101/lm.777308
   Brigman JL, 2010, CEREB CORTEX, V20, P1955, DOI 10.1093/cercor/bhp266
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Chen YC, 2009, NEUROPSYCHOPHARMACOL, V34, P1454, DOI 10.1038/npp.2008.182
   Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001
   Crabbe J C, 1994, Alcohol Alcohol Suppl, V2, P67
   Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327
   CRAWLEY JN, 2009, WHATS WRONG MY MOUSE
   Crombag HS, 2008, EUR J NEUROSCI, V27, P3284, DOI 10.1111/j.1460-9568.2008.06299.x
   Crombag HS, 2008, LEARN MEMORY, V15, P299, DOI 10.1101/lm.762508
   Crombag HS, 2010, LEARN MEMORY, V17, P807, DOI 10.1101/lm.1610510
   CROMBAG HS, 2008, BEHAV BRAIN RES
   CRUSIO WE, 2008, STANDARDS PUBLICATIO
   Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825
   DICKINSON A, 1983, Q J EXP PSYCHOL-B, V35, P35, DOI 10.1080/14640748308400912
   DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010
   Epstein DH, 2006, PSYCHOPHARMACOLOGY, V189, P1, DOI 10.1007/s00213-006-0529-6
   ESTES WK, 1948, J EXP PSYCHOL, V38, P173, DOI 10.1037/h0057525
   Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579
   Hefner K, 2008, J NEUROSCI, V28, P8074, DOI 10.1523/JNEUROSCI.4904-07.2008
   Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07.006.2007, 10.3389/neuro.07/006.2007]
   Holland P, 1998, NEUROPHARMACOLOGY, V37, P461, DOI 10.1016/S0028-3908(98)00038-0
   Holland PC, 2003, EUR J NEUROSCI, V17, P1680, DOI 10.1046/j.1460-9568.2003.02585.x
   Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005
   Izquierdo A, 2006, BEHAV BRAIN RES, V171, P181, DOI 10.1016/j.bbr.2006.03.029
   Jackson KJ, 2009, NEUROPHARMACOLOGY, V57, P347, DOI 10.1016/j.neuropharm.2009.07.020
   Janowsky A, 2001, J PHARMACOL EXP THER, V298, P634
   Johnson AW, 2007, J NEUROSCI, V27, P13430, DOI 10.1523/JNEUROSCI.4320-07.2007
   Johnson AW, 2007, BEHAV NEUROSCI, V121, P1192, DOI 10.1037/0735-7044.121.6.1192
   Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403
   Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215
   KHEIRBEK MA, LEARN MEM, V17, P148
   Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400
   LOVIBOND PF, 1988, BIOL PSYCHOL, V27, P199, DOI 10.1016/0301-0511(88)90052-X
   MACKINTOSH NJ, 1974, PSYCHOL ANIMAL LEARN
   Mead AN, 2003, J NEUROSCI, V23, P1041
   Mead AN, 2003, J NEUROSCI, V23, P9500
   Millstein RA, 2006, GENES BRAIN BEHAV, V5, P346, DOI 10.1111/j.1601-183X.2005.00172.x
   Millstein RA, 2007, NEUROSCI BIOBEHAV R, V31, P3, DOI 10.1016/j.neubiorev.2006.05.003
   Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010
   Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006
   Norcross M, 2008, PSYCHOPHARMACOLOGY, V200, P413, DOI 10.1007/s00213-008-1215-7
   Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309
   RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553
   Sanders AC, 2007, NEUROPSYCHOPHARMACOL, V32, P2321, DOI 10.1038/sj.npp.1301368
   Schoenbaum G, 2005, CEREB CORTEX, V15, P1162, DOI 10.1093/cercor/bhh216
   See RE, 2005, EUR J PHARMACOL, V526, P140, DOI 10.1016/j.ejphar.2005.09.034
   Wiltgen BJ, 2007, EUR J NEUROSCI, V25, P2491, DOI 10.1111/j.1460-9568.2007.05487.x
   Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919
   Yin HH, 2006, NEUROBIOL LEARN MEM, V85, P283, DOI 10.1016/j.nlm.2005.12.001
   Yu CX, 2009, J NEUROSCI, V29, P15100, DOI 10.1523/JNEUROSCI.4215-09.2009
NR 60
TC 31
Z9 31
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 10
PY 2011
VL 6
IS 1
AR e15536
DI 10.1371/journal.pone.0015536
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 710LL
UT WOS:000286513100006
PM 21249214
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

EF